• Home
  • SPECIALITY
    • General Medicine
    • Cardiology
    • Critical Care Medicine
    • Dermatology
    • Dentistry
    • Diabetology
    • ENT
    • Gastroenterology & Hepatology
    • HIV / AIDS
    • Infectious Diseases
    • Musculoskeletal Diseases
    • Neuropsychiatry
    • Obstetrics & Gynecology
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Respiratory Medicine
    • Surgery
    • Urology
  • TOPICS
    Currently there are no topics under this speciality
  • SCIENTIFIC RESOURCES
  • Product Index
  • Infographics
Logo
Filter

 

Search form

Get Ciplamed App

google play ios
Login
Register
Menu
  • New Content
  • Medical News
  • eCMEs
  • Scientific Resources
    • Expert's Views
    • Our Publications
    • Slide Library
    • Guidelines
    • Our Research
    • Key Trials
    • Conference Proceedings
    • Patient Education
    • Clinical Tools
    • Device Demos
    • Journals
    • Useful Links
    • Expert's Views
    • Our Publications
    • Slide Library
    • Guidelines
    • Our Research
    • Key Trials
    • Conference Proceedings
    • Patient Education
    • Clinical Tools
    • Device Demos
    • Journals
    • Useful Links
  • Topics
    • Acne
    • Addiction
    • Adolescent Health
    • Aging Skin
    • Allergic Rhinitis
    • Allergy
    • Allied
    • Allied Interventions in HIV/AIDS
    • Analgesia in the ICU
    • Anti-infectives
    • Antibacterials
    • Antiretroviral Management in Adults and Adolescents
    • Antiretroviral Management in Pediatrics
    • Anxiety & Depression
    • Arrhythmia
    • Asthma
    • Atrial Fibrillation
    • BPH
    • Bacterial Infections
    • Benign Prostatic Hyperplasia
    • Bipolar Disorder
    • Bladder Dysfunction
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • CNS
    • COPD
    • Cardiology
    • Cardiovascular Disorder
    • Chronic Kidney Disease
    • Colorectal Cancer
    • Congenital Heart Disease
    • Contraception
    • Dementia
    • Dengue
    • Dermatological Disorder
    • Diabetes
    • Drug - Drug Interactions
    • Gastrointestinal Disorder
    • Dry Eye
    • Dyslipidemia
    • ENT Infections
    • Ebola Virus Disease
    • EpidemiologyEpidemiology
    • Epilepsy
    • Fungal Infections
    • Gallbladder & Biliary Tract
    • Gastroenterological Tract
    • Gastroenterology and Nutrition
    • Gastrointestinal Cancers
    • General
    • Genito-Urinary Disorders
    • Glaucoma
    • Gout
    • Gynecological Cancers
    • HIV / AIDS
    • HIV Resistance
    • HIV Testing
    • HIV and Aging
    • HIV prevention aproaches
    • Haematological Malignancies
    • Hair Care
    • Hair and Scalp Disease
    • Headache
    • Heart Failure
    • Heart Failure and Cardiomyopathy
    • Hematology
    • Hepatitis
    • Herpes
    • Hyperpigmentation
    • Hypertension
    • IHD
    • IPF
    • Infection Control and Prevention
    • Infection Prevention & Control
    • Infections
    • Infertility
    • Inflammation / Infection
    • Influenza
    • Ischemic Heart Disease
    • Kidney & Urinary Tract
    • Laryngology
    • Liver
    • Lower GI Tract
    • Lung Cancer
    • MRSA
    • Malaria
    • Malaria
    • Management of HIV in Key Populations
    • Management of Non-infectious Comorbidities in HIV
    • Medical Abortion
    • Menopause
    • Movement Disorder
    • Multiple Sclerosis
    • Neonatology
    • Neurology
    • Osteoporosis
    • PAH
    • Pancreas
    • Psoriasis
    • hearing loss
    • Tuberculosis
    • Rheumatic Disorders
    • Respiratory and Allergy
    • Renal Cancer
    • Acne
    • Addiction
    • Allergy
    • Anti-infectives
    • BPH
    • Cardiovascular Disorder
    • Dermatological Disorder
    • Diabetes
    • Dyslipidemia
    • Ebola Virus Disease
    • Gastrointestinal Disorder
    • Headache
    • Hepatitis
    • Hypertension
    • Infection Prevention & Control
    • Infections
    • Influenza
    • Inhalation Devices
    • Kidney & Urinary Tract
    • Malaria
    • Medico-Legal
    • Musculoskeletal Disorder
    • Neurological Disorder
    • Respiratory Tract Disorder
    • Viral Infection
  • Infographics
  • Product Index
  • Medico-Legal

You are here

Home»»New Content

New Content

PALOMA 2 Trial: Efficacy and Safety of Palbociclib plus Letrozole for Postmenopausal Women with Advanced Breast Cancer
Key Trials, Published on: 27 Jan 2023

PALOMA 2 trial showed that the addition palbociclib with letrozole significantly improved outcomes in the first-line treatment of ER-positive, HER2-negative advanced breast cancer.

FEATHER Study: Effects of Febuxostat Therapy in Patients with Stage 3 CKD and Asymptomatic Hyperuricemia
Key Trials, Published on: 24 Jan 2023

FEATHER study evaluated the effect of febuxostat on eGFR decline in patients with stage 3 CKD and asymptomatic hyperuricemia. The findings reveal no significant suppressing effect on eGFR decline.

Comparison of Mirabegron and Solifenacin in Prevention of Catheter-Related Bladder Discomfort
Key Trials, Published on: 24 Jan 2023

Efficacy and safety of mirabegron was non-inferior to that of solifenacin and could be a viable alternative for the prevention of catheter-related bladder discomfort in patients undergoing transurethral resection.

ADA: Standard of Medical Care in Diabetes (2023)
Guidelines, Published on: 11 Jan 2023
KDIGO: Management of Diabetes in CKD-An Update (2022)
Guidelines, Published on: 11 Jan 2023
JBDS: Management of Adults with Diabetes on Dialysis (2022)
Guidelines, Published on: 21 Dec 2022
BHIVA: Guidelines On Antiretroviral Treatment for Adults Living with HIV-1 (2022)
Guidelines, Published on: 12 Dec 2022
Chronic Obstructive Pulmonary Disease
eCMEs, Published on: 09 Dec 2022

This 43rd PURIVEW will introduce to the viewers the latest GOLD 2023 guidelines. The experts also discuss new paradigms in COPD diagnosis, pulmo rehab and non-pharmacological approach for COPD management.

Efficacy of Triple vs Double Oral Therapy in Newly Diagnosed PAH Patients
Key Trials, Published on: 01 Dec 2022

Although both the treatment regimens - initial triple and double therapy significantly reduced the pulmonary vascular resistance (PVR) in newly diagnosed pulmonary arterial hypertension (PAH) patients by week 26, the difference was insignificant between groups. Both the treatment regimens improved the hemodynamic parameters and other clinical outcomes; however, there were no significant differences between the groups. Both the treatments were well tolerated by the patients. Exploratory analyses suggested a signal for reduced risk of disease progression with initial triple versus initial double oral therapy.

GOLD 2023: Updates and Impact on Indian Clinical Practice
eCMEs, Published on: 24 Nov 2022

Brief presentation on updates in GOLD 2023 guidelines for COPD and a panel discussion to understand the effects of updates on Indian patients.

 

ASCO 2022 Update in Gastrointestinal Cancer: Hepato-Biliary
Conference Proceedings, Published on: 12 Oct 2022

Key highlights from Gastrointestinal Cancer- Hepatobiliary of the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting held from 2nd to 6th June 2022.

ERS 2022:Pharmacotherapy for Sleep Disordered Breathing
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:mRNA Science and the Next Generation of Vaccines: Transforming the Management of Respiratory Infections
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Hyperpolarized Gas MRI: A New Frontier in Functional Pulmonary Imaging
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Diagnosis and Management of Pneumonitis in Lung Cancer Systemic Therapy
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Best Abstracts in Pulmonary Rehabilitation and Chronic Care
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Comorbidities and Symptoms in Interstitial Lung Diseases: Think Out of the Box
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:How to Prevent Progression in Idiopathic Interstitial Pneumonia
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Update on the Diagnosis and Treatment of Pulmonary Hypertension
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:NEJM/ERS Joint Session
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:What is Hot in Interstitial Lung Diseases
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:ALERT: COVID and Interstitial Lung Diseases
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Updates on Inhalers for COPD and Asthma
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Lung Function Testing from Preschool Age to Adolescence: Are we Done with Spirometry?
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Diagnostic Work-Up of Asthma: More Than Spirometry
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Update on Clinical Trials in Allergy, Asthma, and COPD
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Towards Elimination of COPD
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:The Future of Inhalation Therapy in COPD
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Time to Raise Standards of Care for Patients with COPD
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:COPD Treatment: New Mechanisms and Novel Insights
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Maintenance and Reliever Therapy with Budesonide/Formoterol versus Fixed Dose Fluticasone/Salmeterol in Patients with COPD
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Exacerbations in COPD: Biomarkers and Management
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Evolving Questions in Chronic Obstructive Pulmonary Disease Management
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:ALERT 1: COPD and Hospital Management
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Take a Deep Breath: The Evolving Role of Biologics in Pediatric Severe Asthma
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Safety Profile of Triple ICS/LABA/LAMA FDC in the Treatment of Asthma: A Meta-Analysis
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Airway Diseases Precision Medicine for Asthma, Chronic Obstructive Pulmonary Disease, and Chronic Cough: New Drugs, Biomarkers, and Approaches
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Chronic Airway Diseases from Phenotypes to Severity
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Asthma Management and Appropriate Reliever Use: Apparent Challenges
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Association of Short-Acting-Agonist (SABA) Overuse and Risk of COPD Among Adult Asthma Patients
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ERS 2022:Your Chronic Respiratory Disease Patients – What Do You Know About their Risk of Infectious Disease?
Conference Proceedings, Published on: 10 Oct 2022

Key session presented at the European Respiratory Society (ERS) International Congress 2022, 3rd-6th Sept. 2022, Barcelona.

ADA/KDIGO: Diabetes Management in CKD (2022)
Guidelines, Published on: 07 Oct 2022
PURVIEW: Practical Updates for Respiratory Physicians
eCMEs, Published on: 06 Oct 2022

This webcast gives information on the newer drugs available for nebulization; the special considerations in different setups; important points about home nebulization, and guidance on how to choose the right nebulizer for patients.

ASCO 2022: Update in Kidney & Bladder Cancer
Conference Proceedings, Published on: 27 Sep 2022

Key highlights in Kidney & bladder cancer of the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting held from 2nd to 6th June 2022.

ADA/EASD: Management of Hyperglycemia in Type-2 Diabetes Mellitus (2022)
Guidelines, Published on: 26 Sep 2022
National COPD Update 2022: Day 2
eCMEs, Published on: 20 Sep 2022

This event gives details with regards to the early initiation of therapy to prevent disease progression & exacerbations & the importance of rehabilitation in the management protocol.

National COPD Update 2022: Day 1
eCMEs, Published on: 20 Sep 2022

This event gives details with regards to the treatable traits in COPD and their impact on lung function decline & the predictors of mortality in COPD 

AAP: Prevention and Control of Influenza in Children (2022-2023)
Guidelines, Published on: 13 Sep 2022
ESC/ERS: Diagnosis and Treatment of Pulmonary Hypertension (2022)
Guidelines, Published on: 07 Sep 2022
IVES Improves Clinical Outcomes and Quality of Life in Women with Idiopathic Refractory OAB Regardless of Treatment Frequency
Key Trials, Published on: 06 Sep 2022

Intravaginal electrical stimulation (IVES) along with bladder training (BT) improved the clinical parameters and incontinence-related quality-of-life irrespective of the treatment frequency in women with idiopathic refractory overactive bladder (OAB). The clinical efficacy and patient satisfaction with IVES therapy twice a week or 5 times a week was comparable; nevertheless IVES 5 times per week reduced the treatment duration.

ASCO 2022: Update in Colorectal Cancer
Conference Proceedings, Published on: 01 Sep 2022

Key highlights in Colorectal cancer of the American Society of Clinical Oncology (ASCO) 2022 Congress held from 3rd to 7th June 2022.

Combination of Tadalafil and Silodosin in the Treatment of Men with LUTS Associated with BPH
Key Trials, Published on: 24 Aug 2022

The lower urinary tract symptoms (LUTS) are significantly improved with either tadalafil 5 mg daily or silodosin 8 mg daily in men with LUTS associated with benign prostatic hyperplasia (BPH). However, the combination of both is more effective in improving the voiding symptoms and maximum flow rate in men with LUTS associated with BPH, with or without erectile dysfunction (ED).

Medical Management of Osteoporosis – Teriparatide, Denosumab, Antiresoptives : Which, When, What & How Long ?
Expert's Views, Published on: 17 Aug 2022

In this talk, the doctor outlines the pharmacological management options for osteoporosis with teriparatide, denosumab and other antiresorptives.

Azithromycin Treatment in Paediatric Primary Ciliary Dyskinesia
Key Trials, Published on: 08 Aug 2022

The present study assessed efficacy and safety of azithromycin treatment in paediatric primary ciliary dyskinesia (PCD). The findings showed that long-term azithromycin treatment reduced respiratory infection frequency and improved lung function in paediatric PCD patients with worse lung function.

H1N1: Re-emergence of the Forgotten Virus
eCMEs, Published on: 06 Aug 2022

This webinar gives in depth knowledge on the guidelines to diagnose & manage H1N1 infections. It also talks about how to differentiate Covid-19 & influenza infections & the early pointers towards influenza. It will give knowledge about the appropriate vaccination protocols to follow.

Efficacy and Safety of Once-Daily Combination of Fluticasone Furoate and Vilanterol in Asthma Control
Key Trials, Published on: 05 Aug 2022

Once-daily combination treatment of fluticasone furoate and vilanterol resulted in better asthma control without increasing the risk of serious adverse events as compared with maintenance therapy using ICS alone or in combination with LABA.

Asthma Symptom Control with Once-daily FF/VI 100/25 mcg versus Twice-daily B/F 160/4.5 mcg
Key Trials, Published on: 04 Aug 2022

The present study compared asthma symptom control in patients who   initiated once-daily fluticasone furoate/vilanterol (FF/VI) 100/25 mcg and twice-daily B/F 160/4.5 mcg. The findings indicated that once-daily FF/VI 100/25 mcg was associated with better asthma control than twice-daily budesonide/formoterol (B/F) 160/4.5 mcg.

Role of Esomeprazole in Healing after Choanal Atresia Repair
Key Trials, Published on: 03 Aug 2022

According to the study, esomeprazole reduced the incidence of choanal restenosis in patients undergoing surgery for the repair of choanal atresia repair. Esomeprazole should therefore be used in these patients as an effective anti-reflux agent.

Indian PCV Panel/VRSI: Management of PCV- An Update (2022)
Guidelines, Published on: 01 Aug 2022
EHA 2022:Top 10 Updates in Hematological Malignancies
Conference Proceedings, Published on: 26 Jul 2022

Key highlights in Hematological Malignancies of the European Hematology Association (EHA) 2022 Congress held from 9th to 17th June 2022.

ASCO 2022: Update in Prostate Cancer
Conference Proceedings, Published on: 22 Jul 2022

Key highlights in Prostate cancer of the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting held from 2nd to 6th June 2022.

What if PDE5 Inhibitors Fail? (Second-line Management & Surgery)
eCMEs, Published on: 20 Jul 2022

Advanced therapies for ED, management of non-responders to PDE5 inhibitors, second line management (Intracavernosal injections), third line/surgical management (Penile prostheses implants). 

Medical Management of ED
eCMEs, Published on: 20 Jul 2022

Oral therapy for ED (PDE5 inhibitors)- Pharmacokinetics, Mechanism of action, safety & efficacy profile, side effects, comparison with other PDE5 inhibitors, different patient profile case studies of ED. 

Basic Evaluation & Diagnosis of ED
eCMEs, Published on: 20 Jul 2022

History taking in patients with ED, practical evaluation- tests done for diagnostics like ffice sildenafil test, Office ICIVAD test, hormonal analysis.

ASCO 2022 Update in Hematological Malignancies (Multiple Myeloma)
Conference Proceedings, Published on: 19 Jul 2022

Key highlights in Hematological Malignancies (Multiple Myeloma) of the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting held from 3rd to 7th June 2022.

PROOF Study: Effectiveness of Salmon Calcitonin Nasal Spray in Reducing Risk of New Vertebral Fractures in Osteoporotic Postmenopausal Women
Key Trials, Published on: 19 Jul 2022

PROOF study assessed the reduction in the risk of new vertebral fractures with salmon calcitonin nasal spray treatment in postmenopausal women with osteoporosis. The study found that salmon calcitonin nasal spray at a dose of 200 IU is a safe and effective treatment for postmenopausal women with established spinal osteoporosis.

ASCO 2022: Update in Central Nervous System Cancer
Conference Proceedings, Published on: 12 Jul 2022

Key highlights from the Lung cancer of the American Society of Clinical Oncology (ASCO) 2022 Congress held from 3rd to 7th June 2022.

ASCO 2022: Update Hematological Malignancies (Leukemia)
Conference Proceedings, Published on: 12 Jul 2022

Key highlights in Hematological Malignancies (Leukemia) of the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting held from 3rd to 7th June 2022.

Impact of COVID-19 Pandemic on Management of Urolithiasis
Key Trials, Published on: 12 Jul 2022

The impact of COVID-19 on urolithiasis has been highlighted in this systematic review. The onset of COVID-19 pandemic resulted in differences in the number of patients presenting to hospital, rates of complications, and management of urinary calculi, including surgical interventions. The findings are useful in elucidating the impact of early pandemic, variations in practices, and would be beneficial for future comparisons.

Efficacy and Safety of Cefixime in Management of URTI Patients
Key Trials, Published on: 11 Jul 2022

The present study evaluated cefixime in URTI patient in Indian clinical setting. The study confirmed the effectiveness and safety of short course of cefixime therapy in URTI.

Incidence of Osteosarcoma in Patients with History of Teriparatide Treatment
Key Trials, Published on: 11 Jul 2022

This is a post-marketing surveillance study aimed to determine the osteosarcoma incidence in patients with a history of teriparatide treatment. The study found that the incidence of osteosarcoma associated with teriparatide use during the 15-year US surveillance period was no different than expected based on the background incidence rate of osteosarcoma.

EAN/MDS: Treatment of Parkinson/s Disease-Invasive Therapies (2022)
Guidelines, Published on: 08 Jul 2022
Evolving Role of Teriparatide
Expert's Views, Published on: 06 Jul 2022

In this talk, the doctor outlines the evolutionary role of teriparatide in various conditions and patient benefits.

Once-Weekly Dulaglutide improves Glycemic Control in Youths with Type 2 Diabetes Mellitus
Key Trials, Published on: 06 Jul 2022

The study demonstrated that once-weekly dulaglutide was superior to placebo in improving glycemic control in youths with uncontrolled T2DM.

ASCO 2022: Update in Lung Cancer
Conference Proceedings, Published on: 04 Jul 2022

Key highlights in Lung cancer of the American Society of Clinical Oncology (ASCO) 2022 Congress held from 3rd to 7th June 2022.

Lean Diabetes: A Unique form of Diabetes
Key Trials, Published on: 01 Jul 2022

This is a first-of-its-kind study to demonstrate that diabetes patients with low BMI have a unique metabolic profile. This form of diabetes should be considered as a distinct entity and should be investigated further.

ESPGHAN: Management and Follow-up of Children and Adolescents with Coeliac Disease
Guidelines, Published on: 30 Jun 2022
ASCO 2022: Update in Hematological Malignancies (Non-Hodgkin’s Lymphoma)
Conference Proceedings, Published on: 29 Jun 2022

Key highlights in Hematological Malignancies (Non-Hodgkin’s Lymphoma) presented at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting held from 2nd to 6th June 2022. 

ASCO 2022: Update in Breast cancer
Conference Proceedings, Published on: 29 Jun 2022

Key highlights in Breast cancer at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting held from 2nd to 6th June 2022.

Highlights of the American Thoracic Society (ATS) 2022
Conference Proceedings, Published on: 28 Jun 2022

Listed below are the key abstracts presented at ATS 2022 conference, held at San Francisco, United States from 13th -18th May. The topics encompass respiratory diseases like asthma, chronic obstructive pulmonary disease, Idiopathic Pulmonary Fibrosis, hypersensitivity pneumonitis, and pulmonary hypertension.

Rizatriptan vs. other Triptans on Stringent Measures of Efficacy in Migraine Patients
Key Trials, Published on: 20 Jun 2022

The study demonstrated that 10 mg rizatriptan was more effective than oral sumatriptan, naratriptan and zolmitriptan in terms of pain-free response at 2 hours, symptom-free response at 2 hours, and 24-hour sustained pain-free response.

Non-inferiority of Avanafil to Sildenafil in Treatment of Erectile Dysfunction
Key Trials, Published on: 17 Jun 2022

The results of the study revealed that avanafil was superior to sildenafil in improving the International Index of Erectile Function - Erectile Function domain score at the end of 12 weeks of treatment. Avanafil demonstrated noninferiority/superiority in other efficacy parameters compared to sildenafil. Avanafil was associated with rapid onset of action leading to better clinical response.

ESC: Management of Hyperglycemia in Hospitalized Adult Patients in Non-critical Setting-An Update (2022)
Guidelines, Published on: 17 Jun 2022
Bone Marrow Transplant & Importance of Stem Cell Donation
Expert's Views, Published on: 16 Jun 2022

A bone marrow transplant is a medical treatment that replaces the patients bone marrow with healthy cells. The replacement cells can either come from self or from a donor.

Supportive Care in Blood Cancer and the Role of Physician
Expert's Views, Published on: 16 Jun 2022

The physician's role may include informing the patient of the diagnosis, helping with decisions about treatment, providing psychological support, treating intercurrent disease, continuing patient-appropriate preventive care, and recognizing and managing or co-managing complications of cancer and cancer therapies.

Myelodysplastic Syndrome
Expert's Views, Published on: 16 Jun 2022

A type of cancer in which the bone marrow does not make enough healthy blood cells (white blood cells, red blood cells, and platelets) and there are abnormal cells in the blood and/or bone marrow.

Transfusion Support in Haemato-Oncology Patients
Expert's Views, Published on: 16 Jun 2022

Transfusion medicine plays a vital role in the supportive care of patients receiving therapy for haematology, oncology and haematopoietic stem cell transplants.

Multiple Myeloma
Expert's Views, Published on: 16 Jun 2022

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. The disease can damage the bones, immune system, kidneys and red blood cells.

Myeloproliferative Neoplasms
Expert's Views, Published on: 16 Jun 2022

Myeloproliferative neoplasms are a group of diseases in which the bone marrow makes too many red blood cells, white blood cells, or platelets.

Chronic Lymphatic Leukaemia
Expert's Views, Published on: 16 Jun 2022

Chronic lymphocytic leukaemia is a type of cancer that involves white blood cells (called lymphocytes) in the bone marrow which mainly affects older adults and accounts for about one-third of all leukaemias.

Non-Hodgkin's Lymphoma
Expert's Views, Published on: 16 Jun 2022

Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body's germ-fighting immune system.

Chronic Myeloid Leukaemia
Expert's Views, Published on: 16 Jun 2022

Chronic myeloid leukaemia typically affects older adults - a slowly progressing and uncommon type of blood-cell cancer that begins in the bone marrow. It's caused by a chromosome mutation that occurs spontaneously.

Acute Lymphoblastic Leukaemia
Expert's Views, Published on: 16 Jun 2022

Acute lymphoblastic leukaemia is the most common childhood cancer. It is a type of blood cancer that develops from immature lymphocytes, a kind of white blood cell that’s key to immune system.

Blood Cancer & Diagnosis
Expert's Views, Published on: 16 Jun 2022

Blood cancers occur when abnormal blood cells start growing out of control, interrupting the function of normal blood cells, which fight off infection and produce new blood cells.

Amantadine for Management of Dyskinesias in Parkinson’s Disease
Key Trials, Published on: 16 Jun 2022

The study demonstrated that amantadine effectively controlled dyskinesias in majority of the study population. Patients’ response to amantadine was dependant on age of PD onset and use of dopamine agonist.

CHLAZIDOXY Trial: Single Dose of Azithromycin verses 7-day Course of Doxycycline for Anorectal C trachomatis Infection in Women with Concurrent Vaginal Infection
Key Trials, Published on: 15 Jun 2022

The CHLAZIDOXY trial compared doxycycline and azithromycin treatment for anorectal chlamydial infection in women. The results indicated that doxycycline is more effective than azithromycin for the treatment of anorectal infection concurrent with vaginal infection in women.

Strategies and Ideation to Keep Women in Pink of Health
eCMEs, Published on: 14 Jun 2022

In this talk, doctor gives an overview of the various strategies to keep women in pink of health by preventing and treating iron deficiency anaemia.

ADA/ACC: Management of HF in Prediabetes and Diabetes (2022)
Guidelines, Published on: 10 Jun 2022
Incidence and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma in Patients with Hematuria
Key Trials, Published on: 09 Jun 2022

In patients presenting with hematuria, male gender and smoking history are risk factors for bladder cancer, renal cell carcinoma (RCC) and upper tract urothelial cancer (UTUC), bladder cancer being the most common among the three. The incidence of RCC and UTUC in patients with nonvisible hematuria (NVH) was extremely low. This review will be beneficial to the global organizations in designing policies for appropriate investigation of hematuria.

Clinical Outcomes with Nasal Saline Irrigation in Children with AR using CARAT and MASK Tools
Key Trials, Published on: 07 Jun 2022

Add-on treatment using nasal irrigation with a sea-water solution supplemented with algae extracts resulted in improved symptom control with reduced medication use in children and adolescents with allergic rhinitis. CARAT questionnaires and MASK/Allergy diary could be useful tools to assess the clinical outcomes in real-life setting.

Efficacy of Teriparatide on Prior Use to Lumbar Fusion Surgery in Patients with Poor Bone Health
Key Trials, Published on: 31 May 2022

The present study assessed the two-year complication rates for patients who have poor bone health, with or without teriparatide pre-treatment before lumbar fusion procedures. The findings showed that use of teriparatide prior to lumbar fusion procedures reduced rate of complications.

Risk MACE or Cancers with Tofacitinib verses TNF Inhibitor in RA Patients
Key Trials, Published on: 30 May 2022

This study assessed the risk of cardiovascular disease and cancer with tofacitinib and TNF inhibitor in patients with rheumatoid arthritis. The study showed that   major adverse cardiovascular events (MACE) and cancers occurred more often with tofacitinib than with a TNF inhibitor.

Benefits of Pelvic Floor Muscle Training in Multiple Sclerosis Patients with LUTD
Key Trials, Published on: 25 May 2022

Pelvic floor muscle training resulted in significant reduction of urine leakage and neurogenic bladder symptoms, while increasing endurance and power of pelvic floor muscles in multiple sclerosis (MS) patients with lower urinary tract dysfunction (LUTD) as demonstrated by moderate and high-quality studies.

Preservative Free (PF) Therapy in Glaucoma
Slide Library, Published on: 24 May 2022

Preservatives in glaucoma medications are known to cause various ocular side effects including ocular surface disease (OSD), toxicity and inflammation especially in long-term users. Preservative-free (PF) eye drops answers an important medical need for preservative-sensitive glaucoma patients to avoid corneal damage, eye irritation, OSD, dry eye and other side effects. The current presentation gives a brief overview on the importance of preservative free therapy in glaucoma medical management.

Early Initiation of Rizatriptan to treat a Migraine Attack, Beneficial
Key Trials, Published on: 24 May 2022

TAME1 and TAME 2 studies demonstrated that early administration of rizatriptan following a migraine attack, while the symptoms were mild was beneficial.

NADIA Trial: Efficacy and Safety of Dolutegravir or Darunavir in Combination with Lamivudine plus either Zidovudine or Tenofovir for Second line HIV Treatment
Key Trials, Published on: 24 May 2022

NADIA trial assessed efficacy and safety of Dolutegravir or Darunavir in Combination with Lamivudine plus either Zidovudine or Tenofovir for 2nd line HIV Treatment. The 96-week results showed that dolutegravir plus two NRTIs produced durable viral suppression at 96 weeks but at greater risk of resistance in second-line therapy. Moreover, maintaining tenofovir was superior to switching to zidovudine for the outcome of viral suppression.

Functional Constipation and GERD Frequently Co-occur in Children
Key Trials, Published on: 20 May 2022

Functional constipation and GERD frequently co-occur in children, hence children with FC should also be assessed for GERD. Both the conditions should be considered simultaneously for therapeutic interventions.

Treatment with Casirivimab and Imdevimab Lowers Hospitalization Rates in High Risk Patients with Mild-to-Moderate COVID-19
Key Trials, Published on: 19 May 2022

The results of this real-world study demonstrated that treatment with casirivimab-imdevimab significantly lowered the rate of hospitalization among high-risk patients with mild to moderate COVID-19.

Hypertonic Saline Minimizes Structural Lung Damage in Children Aged 3-6 Years with Cystic Fibrosis
Key Trials, Published on: 19 May 2022

Inhaled hypertonic saline for 48 weeks improved the trajectories of structural airway changes as measured by chest CT scans as compared to isotonic saline in children aged 3–6 years with cystic fibrosis. This SHIP-CT study concluded that hypertonic saline is a safe and therapeutic option to minimize the structural lung damage in children aged 3-6 years with cystic fibrosis.

ESC: Integrated Care for Optimizing the Management of Stroke and Associated Heart Disease (2022)
Guidelines, Published on: 18 May 2022
PTC Trial: Need for Additional 5-day Course of β-lactam Treatment Among Patients Admitted to Hospital for CAP Clinically Stable After 3 Days of β-lactam Treatment
Key Trials, Published on: 17 May 2022

The Pneumonia Short Treatment (PTC) trial study assessed the short β-lactam treatment duration in patients admitted to non-critical care units with community-acquired pneumonia. The study showed that 3 days of β-lactam therapy was non-inferior to 8 days of treatment among study population.

DHHS: Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (2022)
Guidelines, Published on: 17 May 2022
Risk of T2DM Persists for Long After GDM Diagnosis
Key Trials, Published on: 13 May 2022

The study reaffirmed GDM to be a robust predictor for T2DM in later life, with the risk increasing substantially with each additionally affected pregnancy. Moreover, the risk of T2DM remained high even after 35 years of GDM, hence; regular screening for T2DM is essential for women with GDM even in their late life.

Amantadine may Improve Axial Symptoms in PD Patients with STN Stimulation
Key Trials, Published on: 12 May 2022

This is a first ever study to demonstrate the beneficial effects of amantadine in improving the axial symptoms in patients with Parkinson’s disease who undergo subthalamic nucleus deep brain stimulation.

Efficacy and Safety of Low-Dose BCG vs Standard-Dose BCG in NMIBC
Key Trials, Published on: 11 May 2022

Although low-dose BCG had higher recurrence rate than standard-dose BCG, tumor progression, cancer-specific survival, and overall survival were similar between the doses. The safety profile of low-dose BCG was better than the standard-dose as demonstrated by lesser incidence of adverse effects and lower withdrawal rate. Low-dose BCG may be a feasible alternative in the current scenario of BCG shortage.

Pandemic Adjusted Method for Asthma Diagnosis & Management with a Focus on Exacerbations
eCMEs, Published on: 10 May 2022

SABA overreliance is a major cause of concern globally and in India when it comes to asthma management. Increased SABA overusage has been directly related to poor clinical outcomes, increased risk of exacerbation and mortality. Asthma diagnosis, management and prevention of exacerbations has been especially challenging in light of the pandemic. Therefore, as a part of Cipla’s continuing effort in disseminating  knowledge on asthma management and eliminating SABA overreliance in India, we invite you for an expert forum on the 'Pandemic adjusted methods to diagnose and manage asthma with a focus on preventing exacerbations'. The expert talks will focus on the pandemic adjusted methods to manage asthma which will be followed by a panel round of experts discussing the practical considerations for asthma management during the pandemic, and the effective ways to prevent asthma exacerbation practiced both globally and in India.

Clinical Efficacy and Safety of r-FSH PFS Non-Inferior to r-FSH Pen for COH in IVF
Key Trials, Published on: 10 May 2022

Recombinant FSH (r-FSH) prefilled syringe (PFS) was clinically non-inferior to rFSH pen when used for controlled ovarian hyperstimulation following GnRH agonist long protocol in women undergoing assisted reproductive technologies. The efficacy and safety of rFSH PFS was comparable to that of rFSH pen.

Regular screening for Ocular Surface Changes, Essential in Diabetes Patients
Key Trials, Published on: 09 May 2022

Patients with diabetes have a high incidence of dry eye disease. OSDI score offers a valuable tool for examining dry eye. Diabetes patients should be screened for various ocular surface changes regularly.

Impact of Abnormal Ejaculation on Silodosin Treatment in Men with BPH
Key Trials, Published on: 06 May 2022

Although the incidence of abnormal ejaculation (AEj) was high in the patients treated with silodosin, not all patients with AEj desired to stop or change the medication. The patients were happy with the clinical efficacy of silodosin, and this was a significant predictor for the patients to stop or continue with the treatment. Pre-treatment ejaculatory status was an important indicator, and the rate of drug cessation demand was significantly higher in patients with pre-treatment high scores of ejaculatory functions.

Clinical Predictors and Long-term Impact of AKI on DKD Progression in Patients with T2DM
Key Trials, Published on: 05 May 2022

The study reaffirmed that acute kidney injury (AKI) was a powerful predictor of long-term renal complications and all-cause mortality in patients with type-2 diabetes mellitus. Elevated serum uric acid was associated with increased incidence of AKI and thus with progression of diabetic kidney disease.

COMBO-DN: Duloxetine and Pregabalin Combination vs. High-Dose Monotherapy in Patients with DPN who do not Respond to Standard-dose Monotherapy
Key Trials, Published on: 29 Apr 2022

The COMBO-DN study demonstrated for the first time that a combination of duloxetine 60 mg and pregabalin 300 mg, rather than high-dose monotherapy may be a clinical reasonable, safe, effective and well-tolerated option for patients with diabetic peripheral neuropathic pain who fail to respond to the standard-dose monotherapy with the individual drugs.

Efficacy and Safety of Pazopanib Monotherapy in Treatment-naive and cytokine-pre-treated Patients with Advanced and/or Metastatic RCC
Key Trials, Published on: 27 Apr 2022

This study investigated efficacy and safety of pazopanib monotherapy in treatment-naive and cytokine-pre-treated patients with advanced and/or Metastatic renal cell carcinoma.  Results showed that pazopanib was significantly effective and safe in this patient population.

Fluctuations in Central Foveal Thickness associated with Vision Outcomes in nAMD Patients Receiving Anti-VEGF Therapy
Key Trials, Published on: 26 Apr 2022

Fluctuations in retinal thickening while of anti-VEGF treatment may be associated with treatment response in patients with nAMD. Monitoring the fluctuations in retinal thickness during treatment may aid in tracking the treatment response of the patients.

IDSA: Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections (2022)
Guidelines, Published on: 22 Apr 2022
Effects of Prophylactic Administration of Rifaximin on Gut Microbiota in Cirrhotic Patients
Key Trials, Published on: 22 Apr 2022

Administration of rifaximin for 12 weeks was well tolerated and was associated with improved hyperammonemia and neurophysiological function in cirrhotic patients. The findings of this study demonstrated that rifaximin maintained the overall composition and diversity of gut microbiota, which may reduce the abundance of harmful bacteria and increase the abundance of probiotic bacteria. These changes may prevent HE by reducing the HE-related metabolic pathways. Prophylactic administration of rifaximin did not change the overall type and abundance of drug-resistant genes in the gut microbiota.

Montelukast Combined with Mometasone Furoate Offers Superior Clinical Outcomes in Children with Adenoid Hypertrophy
Key Trials, Published on: 20 Apr 2022

Combined therapy with oral montelukast and intranasal mometasone resulted in significant improvements with lesser recurrence in children with adenoid hypertrophy as compared to single therapy with intranasal mometasone alone.

AHA/ACC/HFSA: Management of Heart Failure (2022)
Guidelines, Published on: 19 Apr 2022
PALETTE Trial: Efficacy and Safety of Pazopanib with Placebo for Soft-tissue Sarcoma
Key Trials, Published on: 14 Apr 2022

The PALETTE Study investigated the effect of pazopanib on progression-free survival in patients with metastatic non-adipocytic soft-tissue sarcoma after failure of standard chemotherapy. The findings showed significant improvement in progression-free survival with pazopanib treatment compared to placebo.

Impact of Brivaracetam on the Anger Levels of Epilepsy Patients
Key Trials, Published on: 13 Apr 2022

Treatment with brivaracetam did not increase the anger level in patients with focal and generalised epilepsy. Brivaracetam could be used safely and effectively as an alternative in presence of a psychiatric background or in patients with a history of levetiracetam-related AEs.

RSSDI: Recommendations for Dyslipidemia Management in Diabetes Mellitus (2022)
Guidelines, Published on: 11 Apr 2022
Clinical Outcomes with Repeated Administration of Budesonide/Formoterol in Asthma
Key Trials, Published on: 07 Apr 2022

The comparative bronchodilator effects of repeated administration of salbutamol 200 µg and budesonide/formoterol 200/6 µg differed depending on the time of measurement in patients with asthma. Administration of salbutamol was associated with greater cardiovascular effects and more adverse events.

Levofloxacin and Doxycycline in Treatment of Vaginal Chlamydial Infection
Key Trials, Published on: 06 Apr 2022

This study compared the effect of doxycycline and levofloxacin for the treatment of vaginal chlamydial infection. The study found that both antibiotics showed similar effect on the eradication of vaginal chlamydial infection.

Tadalafil 5 mg Once Daily 12-Week Monotherapy Effective and Safe in Men with LUTS/BPH
Key Trials, Published on: 05 Apr 2022

Oral monotherapy with once daily 5 mg tadalafil was found to be effective, well tolerated and safe in men experiencing lower tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

Efficacy and Safety of Pazopanib and Sunitinib in Patients with Metastatic Renal-cell Carcinoma as First-line Treatment
Key Trials, Published on: 04 Apr 2022

The study compared the efficacy and safety of pazopanib and sunitinib in patients with metastatic renal-cell carcinoma as first-line treatment. Results showed noninferiority of progression-free survival with pazopanib versus sunitinib.

Excellent Efficacy of r-FSH PFS in CC-Resistant Anovulatory Infertile Women Including PCOS
Key Trials, Published on: 31 Mar 2022

rFSH prefilled syringe demonstrated excellent ovulation induction effects in anovulatory infertile women including PCOS patients classified as WHO group II and was proved to be non-inferior to rFSH Pen. The tolerability and safety profile of rFSH PFS was comparable to rFSH pen.

Treatment with Sacubitril/valsartan Associated with Improved Hemodynamic Status in Patients with HFrEF
Key Trials, Published on: 28 Mar 2022

According to the study, HFrEF patients treated with sacubitril/valsartan had improved hemodynamic status, as assessed by the changes in the echocardiographic parameters. Improved hemodynamic status was associated with decreased incidence of all-cause mortality and HF hospitalization in these patients.

Prediabetes Might Increase the Risk of Erectile Dysfunction in Younger Men
Key Trials, Published on: 25 Mar 2022

This meta-analysis concluded that prediabetes is associated with higher prevalence of erectile dysfunction, which may be independent of age and may be stronger in young men.

Casirivimab and Imdevimab Antibody Cocktail Clinically Beneficial in High Risk COVID-19 Patients
Key Trials, Published on: 25 Mar 2022

Casirivimab and Imdevimab antibody cocktail resulted in lesser requirement of mechanical ventilation and high-flow oxygen with no deaths as compared to the controls in symptomatic Covid-19 patients. The non-vaccinated patients who received this antibody cocktail did not require mechanical ventilation and those who were fully immunized seldom entailed high-flow oxygen. Casirivimab and Imdevimab treatment regimen is clinically beneficial for high risk COVID19 patients.

Trends in Antibiotic Prophylaxis for Post-operative Endophthalmitis after Cataract Surgery
Key Trials, Published on: 23 Mar 2022

This 2021 ASCRS survey demonstrated a steady increase in the use of intracameral antibiotic prophylaxis for post-operative endophthalmitis after cataract surgery. Moxifloxacin was the IC antibiotic that the cataract surgeons preferred.

AHA: Comprehensive Management of CV Risk Factors for Adults with Type-2 Diabetes (2022)
Guidelines, Published on: 22 Mar 2022
Maintenance ICS vs As-Needed ICS Treatment Regimens in Mild Asthma: Patient Perspectives
Key Trials, Published on: 22 Mar 2022

Factors relating to perceived asthma burden, disease knowledge, treatment complexity and treatment usefulness or safety were identified as the key patient perspectives on the implementation of preventer treatments for mild asthma. The as-needed budesonide-formoterol regimen was preferred to maintenance ICS treatment in mild asthma due to its simplicity and similar usage patterns. However, patient education is urgently needed to increase the disease knowledge and address implementation barriers.

Effectiveness of ZOL as a First-line Therapeutic Strategy After Percutaneous Kyphoplasty
Key Trials, Published on: 21 Mar 2022

The present study evaluated the efficacy of zoledronic acid (ZOL) administration against previously treated recompression vertebral fractures (RVF) and new vertebral fractures (NVF) in initial percutaneous kyphoplasty (PKP) patients with osteoporotic vertebral compression fractures (OVCF). The 3-year follow-up results showed that annual ZOL administration significantly lowers the risk of RVFs and NVFs, improving the clinical outcome of initial PKP in patients with OVCFs.

Sustained Antidyskinetic Effect of Amantadine in Levodopa-treated Patients with Advanced Parkinson’s Disease
Key Trials, Published on: 21 Mar 2022

The study demonstrates the sustained antidyskinetic effect of amantadine, extending well beyond one year of therapy, for the treatment of levodopa-induced dyskinesia in patients with advanced Parkinson’s disease.

Prophylaxis against Post-operative Endophthalmitis: The Role of Topical and Oral Moxifloxacin in Addition to Intracameral Moxifloxacin
Key Trials, Published on: 16 Mar 2022

This mathematical model-based study provides a valuable guide for the use of topical or oral moxifloxacin in addition to intracameral moxifloxacin to provide effective prophylaxis against post-operative endophthalmitis in patients undergoing cataract surgery.

Impact of Empagliflozin on Markers of Liver Steatosis and Fibrosis, and their Association with Cardiorenal Outcomes
Key Trials, Published on: 16 Mar 2022

According to the post hoc analysis of the EMPA-REG OUTCOME trial, empagliflozin treatment may improve steatosis risk in T2DM patients with pre-existing CVD. Treatment with empagliflozin also improved cardiorenal outcomes and mortality, independent of steatosis and fibrosis risk in the study population.

Tracking the Change in Beta-cell Function and Insulin Sensitivity in Newly diagnosed, Untreated T2DM Patients
Key Trials, Published on: 16 Mar 2022

The study reaffirmed that among newly diagnosed, untreated type-2 diabetes mellitus patients, changes in insulin sensitivity were evident from early stages. Beta-cell function continued to diminish with increasing glycemia in these patients.

GOLD: Global Strategy for Prevention, Diagnosis and Management of COPD (2022)
Guidelines, Published on: 15 Mar 2022
Efficacy and Safety of Rizatriptan 10 mg for the Treatment of Migraine Patients Switched from Non-triptan Treatment Regimen
Key Trials, Published on: 10 Mar 2022

This real-world study demonstrated that rizatriptan 10 mg was effective and safe for treating migraine attacks in patients who switched the treatment from non-triptan to triptan regimen.

Early Removal of Ureteric Stent Reduces UTIs in Kidney Transplant Recipients
Key Trials, Published on: 10 Mar 2022

The meta-analysis concluded that early ureteral stent removal, not later than 3 weeks, could significantly decrease the incidence of urinary tract infections without affecting incidence of major urological complications. The researchers of this study recommend 14 to 21 days as the optimal timing of ureteric stent removal in kidney transplant recipients.

Efficacy and Safety of r-FSH PFS Non-Inferior to r-FSH Pen in IVF
Key Trials, Published on: 08 Mar 2022

The efficacy and safety of rFSH in pre-filled syringe was non-inferior to r-FSH pen in ovulation induction in women undergoing assisted reproductive technology.

Clinical Efficacy and Safety of Purified-HMG is Comparable to HP-HMG in IVF
Key Trials, Published on: 08 Mar 2022

The clinical efficacy and safety of purified-HMG was non-inferior to highly purified HMG in women undergoing controlled ovarian hyperstimulation using assisted reproductive techniques.

RECOVERY Trial: Efficacy and Safety of Casirivimab and Imdevimab Combination in Hospitalized COVID-19 Patients
Key Trials, Published on: 08 Mar 2022

RECOVERY Trial evaluated efficacy and safety of casirivimab and imdevimab combination in hospitalized COVID-19 patients. The study showed that in patients with seronegative status at baseline, casirivimab and imdevimab was associated with a significant reduction in 28-day mortality compared with usual care alone.

Brivaracetam in Adults with Focal Seizures: Long-term Safety and Efficacy
Key Trials, Published on: 04 Mar 2022

Long-term treatment with brivaracetam with an individualized dose up to 200 mg/day was well-tolerated and effective in adult patients with focal epilepsy.

Treatment of Community-Acquired Pneumonia in Children: Short- vs. Standard-Course Outpatient Antibiotic Therapy
Key Trials, Published on: 04 Mar 2022

The study demonstrated that a short 5-day course of antibiotic was as effective as the standard 10-day course for treating children with non-severe community acquired pneumonia. The short course resulted in fewer adverse effects and lesser incidence of antibiotic resistant genes.

Can Hypochlorous Acid Nasal Spray be an Alternative to Saline Nasal Irrigation in CRS Patients Post-FESS?
Key Trials, Published on: 04 Mar 2022

The efficacy of HOCl nasal spray was similar to that of saline nasal irrigation in the patients with chronic rhinosinusitis who underwent functional endoscopic sinus surgery (FESS). HOCl nasal spray was convenient to use and could be an alternative to saline nasal irrigation in the post-FESS care.

Cardioprotective Effect of Oral Bisphosphonates
Key Trials, Published on: 04 Mar 2022

The present study determined the risk of incident cardiovascular disease associated with oral BP (oBP) use in oBP users and non-users. The findings indicated that real-world oBP users may gain some cardio-protective benefit from oBP. 

QUATUOR Trial: Efficacy and Safety of a 4-days-on and 3-days-off Maintenance Treatment Strategy for Adults with HIV-1
Key Trials, Published on: 03 Mar 2022

ANRS 170 QUATUOR trial is the first prospective multicentre randomised trial to investigate the efficacy and safety of a 4-days-on and 3-days-off antiretroviral treatment. The 48-week result showed that the intermittent triple-therapy regimen was non-inferior to the standard continuous triple-therapy regimen in maintaining virological suppression over 48 weeks.

Efficacy of Posterior Left Pericardiotomy in Reducing Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Key Trials, Published on: 01 Mar 2022

The present study assessed potential harms and benefits of posterior left pericardiotomy and test the hypothesis that posterior left pericardiotomy would reduce the incidence of atrial fibrillation after cardiac surgery. The study found that posterior left pericardiotomy at the time of cardiac surgery was associated with significant reduction in incidence postoperative atrial fibrillation.

Face Mask Reduces Nasal and Ocular Symptoms in Patients with Pollen Allergy During the Covid-19 Pandemic
Key Trials, Published on: 01 Mar 2022

The use of face masks was associated with decrease in both nasal and ocular allergic rhinitis symptoms in individuals with pollen allergy. The findings of this study suggests that the use of face masks would reduce the severity of allergic rhinitis symptoms and should be considered a preventive measure to minimize exposure to allergens in high-risk environments.

Overnight Switch from Levetiracetam to Brivaracetam, Safe and Well-tolerated
Key Trials, Published on: 23 Feb 2022

According to the study, abrupt overnight switch from levetiracetam to brivaracetam was safe and well-tolerated in patients with epilepsy. Reduction in neuropsychiatric adverse events may lead to increased treatment retention rates in such cases.

GELA Trial: CHOP plus Rituximab verses CHOP Alone in Elderly Patients with Diffuse Large-B-cell Lymphoma (2-yr Results)
Key Trials, Published on: 22 Feb 2022

The present study was conducted to compare CHOP chemotherapy plus rituximab with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. The results showed that CHOP plus rituximab was associated with significant clinical benefit and improved event-free and overall survival in patients as compared with standard CHOP alone.

Response to Obeticholic Acid using Non-invasive Tests in Patients with NASH - 18-Month Interim Analysis of REGENERATE Trial
Key Trials, Published on: 22 Feb 2022

REGENERATE Month 18 interim analysis demonstrated rapid and sustained improvements in various non-invasive tests (NITs) in patients treated with obeticholic acid (OCA). The antifibrotic effect of OCA demonstrated by liver histology were consistently observed in NITs. Dynamic changes in selected NITs separated histologic responders from non-responders. NITs might be valuable in evaluating histologic response to OCA therapy.

Patient Counselling Flipchart on Progesterone Deficiency
Patient Education, Published on: 17 Feb 2022

The flipchart will aid the doctor to counsel their patients regarding normal cycle, progesterone deficiency and the various complications that can arise due to the same, e.g. preterm birth, recurrent pregnancy loss, threatened abortion, etc.

Osteoporosis:Video
Patient Education, Published on: 17 Feb 2022

The public awareness video gives an overview of osteoporosis and its management in patient friendly visuals and language.

REGEN-COV Reduces Risk of Hospitalization and Shortens Time to Resolution of Symptoms in Symptomatic COVID-19 Patients
Key Trials, Published on: 16 Feb 2022

As per the results of this phase 3, administration of REGEN-COV decreased the risk of Covid-19–related hospitalization or death from any cause. REGEN-COV administration led to faster resolution of Covid-19 symptoms and more rapid decline of SARS-CoV-2 viral load than placebo.

CANTREAT-Extension Study: Long-term Efficacy of a Treat-and-Extend Regimen of Ranibizumab in Patients With nAMD
Key Trials, Published on: 15 Feb 2022

The 12-month extension of the CANTREAT study demonstrated that the clinical benefits of treat-&-extend regimen of ranibizumab was clinical beneficial for an extended period of 36 months for patients with neovascular age-related macular degeneration.

AIOS: Prevention of Intraocular Infections and Cluster Outbreaks after Cataract Surgery (2022)
Guidelines, Published on: 14 Feb 2022
Safety and Efficacy of Adjunctive Perampanel in Pediatric Patients with Inadequately Controlled FS or GTCS
Key Trials, Published on: 14 Feb 2022

The 311 Core study demonstrated adjunctive perampanel to be safe, well-tolerated and efficacious in children aged 4 to <12 years and affected with FS (with/without FBTCS) or GTCS.

AHA: Identifying Best Practices to Improve Evaluation and Management of In-Hospital Stroke (2022)
Guidelines, Published on: 10 Feb 2022
Global Longitudinal Strain: A Robust and Independent Prognostic Indicator in Patients with HFimpEF
Key Trials, Published on: 10 Feb 2022

Global longitudinal strain is a strong and independent predictor for future HF events and deteriorating cardiac function in patients with HFimpEF. It is therefore important to look for deterioration in patients with impaired GLS, despite having normalized LVEF.

Efficacy of r-FSH PFS Non-Inferior to r-FSH Pen in IVF-ET
Key Trials, Published on: 09 Feb 2022

Treatment with recombinant FSH (r-FSH) prefilled syringe (PFS) was well tolerated and efficacious in in-vitro fertilization-embryo transfer (IVF-ET) cycles. The efficacy of r-FSH PFS was non-inferior to r-FSH pen and could be a beneficial option for women undergoing assisted reproductive techniques.

Rectal Pessaries Effective as Vaginal Progesterone in Luteal Phase Support
Key Trials, Published on: 08 Feb 2022

Rectal administration of progesterone for luteal phase support was found to be effective and well tolerated as the vaginal preparations. Vaginal discharge was the most common side effect associated with vaginal capsules while constipation and flatulence were commonly reported in women using rectal pessaries of progesterone. The implantation and pregnancy outcomes were similar, regardless of the route of progesterone administration.

Mometasone Furoate Improves Symptoms and Reduces Adenoid Size in Children and Adolescents with Adenoid Hypertrophy
Key Trials, Published on: 02 Feb 2022

Mometasone furoate (MF) nasal spray was found to significantly improve the symptoms attributed to adenoid hypertrophy (AH) as well as reduce the adenoid size in children and adolescents. MF intranasal spray can be a good treatment option before adenoidectomy is considered.

Barijak (Barictinib) Monograph
Our Publications, Published on: 31 Jan 2022

Barictinib can be useful addition for treatment of Moderate to Severe Covid 19 patients in combination with Remdesivir. Barcitinib inhibits the intracellular signalling pathway of cytokines and prevents SARS-COV 2 entry into cell. In ACTT 2 trial Barictinib+ Remdesivir was superior to Remdesivir alone in reducing recovery time and accelerating improvement in clinical status among Covid 19 patients. Increased Platelet counts is a unique effect of Baricitinib and has been not observed with other JAK Inhibitors. IDSA guidelines recommends Barcitinib + Remdesivir in hospitalised severe Covid 19 patients on high flow oxygen/ Non Invasive ventilation, who cannot receive corticosteroids because of contraindication.

ARNI Superior to ACEI/ARB in reducing CV Outcomes in Patients with Acute Myocardial Infarction
Key Trials, Published on: 31 Jan 2022

The study demonstrated ARNI to be superior to ACE inhibitor or ARB for reducing long-term adverse cardiovascular outcomes in patients with acute MI.

Humidification - The Veterinary Horse of Embryology
eCMEs, Published on: 28 Jan 2022

The speaker elaborates on the different types of incubation techniques and talks about their benefits and risks, e.g. of dry versus humid incubators.

 

Quality Control in ICSI
eCMEs, Published on: 28 Jan 2022

In her talk, doctor focusses on quality control in ICSI - associated risks and measures to minimize them, factors that affect ICSI outcomes and indicators for quality in ART.

Debate on Conventional and Advanced Methods of Sperm Preparation
eCMEs, Published on: 28 Jan 2022

In this talk, the speakers debate about conventional versus advanced sperm preparation methods in ART, their advantages and disadvantages over years as well as what is the current acceptable sperm preparation method.

Quality Control in Embryo Transfer
eCMEs, Published on: 28 Jan 2022

In her talk, doctor firstly discusses the various components of total quality management, followed by variables in embryo transfer such as patient factors, errors, SOP, importance of consent and counselling, optimization and monitoring.

How AI & Machine Learning are Revolutionizing Quality Control in IVF
eCMEs, Published on: 28 Jan 2022

The speaker briefs about role of AI in quality control and assurance in IVF as well as clarifies the difference between digitization and AI.

Prevalence and Antifungal Sensitivity Patterns of Dermatophytosis Fungal Infection in India
Key Trials, Published on: 28 Jan 2022

The present Indian study assessed the prevalence of pathogenic dermatophytes, clinical types of dermatophyte fungal infection, and in vitro antifungal drug susceptibility testing against dermatophytes. The study identified T. rubrum as the most common, followed by T. mentagrophytes as an emerging/codominant fungal isolate in India.

Ten-year Outcomes of Standard CHOP Chemotherapy Regimen to CHOP Plus Rituximab in Patients with Diffuse large B-cell Lymphoma
Key Trials, Published on: 27 Jan 2022

The present study compares the 10-year efficacy and safety outcomes in diffuse large B-cell Lymphoma (DLBCL) patients treated with standard CHOP alone verses rituximab added to CHOP. The study showed that R-CHOP improved patient outcomes in elderly DLBCL patients with sustained beneficial effects.

ENCORE 1 Study: Efficacy and Safety of Reduced Dose EFV With Standard Dose EFV In Combination with TDF And FTC As First-Line Treatment for HIV Infection
Key Trials, Published on: 27 Jan 2022

ENCORE 1 study is the first randomized study comparison of a reduced dose of efavirenz in antiretroviral naive, HIV-infected adults. The 48 weeks result showed that reduced dose of 400 mg efavirenz was non-inferior to the standard 600 mg efavirenz dose in combination with tenofovir and emtricitabine as first-line treatment for HIV infection.

Superior Outcomes with Mini-PCNL than ESWL in Treatment of Non-Lower Pole, High-Density Renal Stones
Key Trials, Published on: 27 Jan 2022

Superior outcomes were demonstrated by mini-PCNL as compared to ESWL for treating 10-20 mm, high-density, non-lower pole renal stones. Mini-PCNL was associated with significantly higher stone free rate and shorter fluoroscopy and operative time. None of the patients undergoing mini-PCNL required retreatment and re-hospitalization.

A Critical Evaluation of Micronized Vaginal Progesterone to Prevent Miscarriage
Key Trials, Published on: 25 Jan 2022

Two large, high-quality, multicenter placebo-controlled trials evaluated effects of first-trimester use of micronized vaginal progesterone in women at risk of a miscarriage. Women who have had a past miscarriage and who experience bleeding in early pregnancy may benefit with micronized vaginal progesterone 400 mg twice daily started at the time of presentation with vaginal bleeding and continued to 16 completed weeks of gestation.

Evaluation of Vaginal NMP for Prevention of Preterm Labour
Key Trials, Published on: 25 Jan 2022

Progesterone supplement therapy has become the most widely used method of preventing preterm birth in patients with a history of preterm birth and/or short cervical length. In this prospective study, vaginal NMP 400 mg capsules significantly reduced the rate of preterm birth between 24-37 weeks of gestation in women with high risk factors for threatened preterm birth.

Rizatriptan vs. Ibuprofen for the Treatment of Acute Migraine
Key Trials, Published on: 25 Jan 2022

According to the study, rizatriptan 10 mg was superior to ibuprofen in relieving headache, associated symptoms and functional disability in patients with acute migraine attack.

Cipmolnu (Molnupiravir) Monograph
Our Publications, Published on: 20 Jan 2022

This monograph overviews in-vitro/clinical evidence for Molnupiravir efficacy, safety and positioning.

COPD Practice Updates
eCMEs, Published on: 19 Jan 2022

This PURVIEW is aimed at discussions on advanced diagnostic and prognostic tools available for COPD. The program also includes discussion on choosing right pharmacotherapy and Role of Pulmonary Rehabilitation at hospital and at home.

Better Functional Outcomes with the Novel Ultra-minimally Invasive Surgical Treatments in Men with BPH
Key Trials, Published on: 19 Jan 2022

The new ultra-minimally invasive surgical treatments (uMISTs) might offer fast and effective relief from lower urinary tract symptoms (LUTS) without negatively impacting the quality of life in men with benign prostatic hyperplasia (BPH). Steam injection, prostate artery embolization, intraprostatic injection of fexapotide triflutate, implantation of a prostatic urethral lift and the temporary implantable nitinol device (TIND) had a minimal impact on patients' sexual function with respect to baseline, especially with respect to preservation of ejaculation.

ORAL Standard Study: Clinical Efficacy of Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Key Trials, Published on: 18 Jan 2022

ORAL Standard study is a randomized, phase 3 clinical trial evaluating efficacy and safety of tofacitinib in patients with rheumatoid arthritis (RA). In this study ,tofacitinib demonstrated superior efficacy compared to placebo in RA patients receiving background methotrexate.

Spirometry Simplified
eCMEs, Published on: 18 Jan 2022

Spirometry has a pivotal role to play in diagnosis of Obstructive Airway Diseases. This webcast is aimed at giving all basic details of Spirometry including how to perform an interpret Spirometry as per ERS/ATS Guidelines 2019. The talks are followed by case study discussion and panel discussion from the experts.

Molnupiravir: Fact Sheet for Healthcare Givers and Recipients
Our Publications, Published on: 13 Jan 2022

This fact sheet contains the factual details about the drug molnupiravir, its restricted use under emergency situation, dosage, side effects etc. for healthcare givers and recipients.

Role of Viscosupplementation: Post Arthroscopic Surgery in Osteoarthritis Patients
Expert's Views, Published on: 13 Jan 2022

In this video, the speaker has discussed the role and selection criteria for viscosupplementation use post-arthroscopic surgery.

Oral Step: Efficacy and Safety of Tofacitinib with Methotrexate in Adult Patients with Active Moderate to Severe RA and An Inadequate Response to TNFi
Key Trials, Published on: 13 Jan 2022

ORAL Step study assessed effectiveness of tofacitinib with methotrexate in adult RA patients with inadequate response to tumour necrosis factor inhibitors (TNFi). Results showed that treatment with tofacitinib 5 or 10 mg twice a day along with background methotrexate resulted in rapid, significant, and clinically meaningful improvements in RA patients who were TNFi-IR compared to placebo.

Molnupiravir - FAQ Booklet
Our Publications, Published on: 12 Jan 2022

This document addresses frequently asked questions related to oral antiviral drug Molnupiravir in the treatment of Covid-19.

General Awareness on Hydroxychloroquine Tablets
Patient Education, Published on: 12 Jan 2022

This educational input provides patient counselling information as per prescribing information on Hydroxychloroquine tablets regarding its therapeutic usage, important precautions and possible side effects.

General Awareness on Methotrexate Tablets
Patient Education, Published on: 12 Jan 2022

This educational input provides patient counselling information as per prescribing information on methotrexate tablets regarding its therapeutic usage, important precautions and possible side effects.

General Awareness on Tofacitinib Tablets
Patient Education, Published on: 12 Jan 2022

This educational input provides patient counselling information as per prescribing information on Tofacitinib tablets regarding its therapeutic usage, important precautions and possible side effects.

General Awareness on Leflunomide Tablets
Patient Education, Published on: 12 Jan 2022

This educational input provides patient counselling information as per prescribing information on Leflunomide tablets regarding its therapeutic usage, important precautions and possible side effects.

IV Iron Sucrose Alone Seems Effective in Treatment of Postpartum Anemia
Key Trials, Published on: 12 Jan 2022

Oral iron supplementation after intravenous (IV) 500 mg iron sucrose treatment resulted in a marginal increase in the hemoglobin levels at 6 weeks after delivery in women with postpartum anemia. Addition of oral iron supplement did not improve the iron storage parameters or quality of life, thereby conferring no clinically significant benefits. IV iron sucrose 500 mg alone is effective in treating postpartum anemia.

Management of Heart Failure - Perks of Combination Therapy
Expert's Views, Published on: 06 Jan 2022

Dr Jagdish Hiremath talks about heart failure management.

Management of Heart Failure - Disadvantages of Combination Therapy
Expert's Views, Published on: 06 Jan 2022

Dr Jagdish Hiremath talks about heart failure management.

Management of Heart Failure - Effective Indication for Combination Therapy (Carvedilol & Ivabradine)
Expert's Views, Published on: 06 Jan 2022

Dr Jagdish Hiremath talks about heart failure management.

Management of Heart Failure - Beneficial Effects of Ivabradine Monotherapy
Expert's Views, Published on: 06 Jan 2022

Dr Jagdish Hiremath talks about heart failure management.

Management of Heart Failure - Phenomenal Effect of Ivabradine in HFrEF Patients
Expert's Views, Published on: 06 Jan 2022

Dr Jagdish Hiremath talks about heart failure management.

Management of Heart Failure - Challenges in Beta Blockers for HFrEF Patients
Expert's Views, Published on: 06 Jan 2022

Dr Jagdish Hiremath talks about heart failure management.

Management of Heart Failure - Clinical Advantages of Hindering SNS Pathway
Expert's Views, Published on: 06 Jan 2022

Dr Jagdish Hiremath talks about heart failure management.

Fundamental Principles in Heart Failure Management
Expert's Views, Published on: 06 Jan 2022

Dr Jagdish Hiremath talks about heart failure management.

Ipratropium Bromide Combined with Salbutamol Reduces Risk of Hospital Admission in Asthmatic Children and Adolescents
Key Trials, Published on: 06 Jan 2022

Treatment with ipratropium bromide and salbutamol reduced the risk of hospital admission and might improve clinical outcomes, especially in children and adolescents with severe and moderate to severe asthma exacerbation. Nevertheless, well-designed, double-blind RCTs with large sample size are needed for research to assess the efficacy of this combination in the treatment of asthmatic children and adolescents.

LIFT Alone Verses LIFT with the Adjunct Injection of PRP Treatment of Fistula-in-ano
Key Trials, Published on: 03 Jan 2022

The present study is a prospective randomized study comparing Ligation of the inter-sphincteric fistula tract (LIFT) alone versus LIFT with the adjunct injection of PRP (platelet-rich plasma). The data suggested that treatment with LIFT-PRP is feasible and safe and is associated with good healing rates in patients with trans sphincteric fistula.

REGEN-COV Prevents COVID-19 Infection in Previously Uninfected Household Contacts of Infected Subjects
Key Trials, Published on: 30 Dec 2021

A single subcutaneous REGEN-COV injection prevented symptomatic Covid-19 and asymptomatic SARS-CoV-2 infection in previously uninfected household contacts of infected persons. Administration of REGEN-COV resulted in shorter duration of symptoms and reduced the duration of high viral load, among the participants who became infected.

RSSDI: Consensus on Thyroid Dysfunction in Diabetes (2021)
Guidelines, Published on: 29 Dec 2021
Impact of Azithromycin on ARES in Children with HIV and Chronic Lung Disease
Key Trials, Published on: 28 Dec 2021

The present study is the post hoc analysis of BREATHE trial, The analysis aimed to explored the risk factors for acute respiratory exacerbations in children with HIV taking antiretroviral therapy and co-morbid chronic lung disease. The study found that presence of an abnormal respiratory rate at baseline and having a baseline CD4 count <200/mm3 were main risk factors in the study population.

Topical Cyclosporine 0.05% and Osmoprotective Lubricating Eye Drops: Role in the Management of DED and Inflammation
Key Trials, Published on: 24 Dec 2021

The study demonstrated that 6-month treatment with cyclosporine A 0.05% and osmoprotective lubricating eye drops was associated with reduced inflammation and improved ocular parameters in patients with dry eye disease.

AHA: Hypertension in Pregnancy (2021)
Guidelines, Published on: 23 Dec 2021
Switching to Tenofovir Alafenamide from Tenofovir Disoproxil Fumarate Might be Beneficial in Chronic HBV Patients
Key Trials, Published on: 21 Dec 2021

The results of this study revealed good viral suppression and ALT normalization after switching to tenofovir alafenamide (TAF) from tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B infection. The renal function stabilized after 48 weeks of TAF therapy. The body weight and body mass index which had decreased during TDF therapy, regained after switching to TAF.

Perampanel as First Add-on Therapy in Patients with Focal Epilepsy: Insights from 3-year Extension Study
Key Trials, Published on: 17 Dec 2021

This study demonstrated that treatment with low dose perampanel (≤4 mg/day) was effective and safe over a period of 3 years in patients with focal onset epilepsy.

Short-term Results of Lichtenstein Repair versus Desarda Repair in the Management of Inguinal Hernias Among Indian Adults
Key Trials, Published on: 15 Dec 2021

The present study compared the results of the Lichtenstein repair with the Desarda repair in the treatment of inguinal hernias. The study found that Desarda repair was associated with superior outcomes compared to Lichtenstein repair.

ACC/AHA/SCAI: Guidelines for Coronary Revascularization (2021)
Guidelines, Published on: 15 Dec 2021
Adjunctive Brivaracetam for the Treatment of Uncontrolled Partial-onset Seizures in Adults
Key Trials, Published on: 15 Dec 2021

The study demonstrated that adjunctive brivaracetam was effective, safe and well-tolerated in adult epilepsy patients with uncontrolled partial-onset sezures

Intravaginal Electrical Stimulation along with Bladder Training Improves Outcomes and Quality of Life in Women with Idiopathic OAB
Key Trials, Published on: 10 Dec 2021

Bladder training (BT) along with intravaginal electrical stimulation (IVES) significantly improved the clinical parameters as well as incontinence-related quality of life than BT alone in women with idiopathic overactive bladder.

Severe Asthma – Exploring the Role of Omalizumab
eCMEs, Published on: 08 Dec 2021

This webinar helps understand and simplify the diagnosis of severe asthma in your patients and explores the role of various biologics with a focus on Omalizumab in the management of severe asthma patients.

Efficacy and Safety of Dorzolamide-Timolol Combination vs. Brimonidine after ND:YAG Laser Capsulotomy for PCO
Key Trials, Published on: 08 Dec 2021

Amongst patients undergoing ND:YAG laser capsulotomy following a cataract surgery, brimonidine and dorzolamide+timolol produced similar reduction in IOP. A combination of Dorzolamide-timolol might be a better choice in patients at high risk of IOP attacks.

Efficacy and Safety of Preservative-free vs. Preservative-containing Brimonidine-Timolol Fixed Dose Combination in Patients with OAG
Key Trials, Published on: 08 Dec 2021

A preservative-free formulation of brimonidine-timolol fixed dose combination demonstrated an efficacy and safety profile that was similar to preservative containing formulation in OAG patients.

Long-Term Treatment with Omalizumab Safe and Effective in Chronic Rhinosinusitis with Nasal Polyps with Inadequate Response to Corticosteroids
Key Trials, Published on: 08 Dec 2021

Treatment with omalizumab for up to 1 year was found to be effective and safe in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) who demonstrate inadequate response to nasal corticosteroids. Omalizumab is a viable, longer-term alternative in patients with CRSwNP with inadequate response to nasal corticosteroids.

Opening a New Chapter in Asthma Control
eCMEs, Published on: 07 Dec 2021

This webinar explores the potential of fluticasone-formoterol combination for the management of asthma and the role of simpler inhaler devices in achieving optimal asthma control.

Better Outcomes with Saddle Block in HoLEP in the Treatment of BPH
Key Trials, Published on: 02 Dec 2021

Saddle block induced by the combination of 15 mg 0.5% bupivacaine and 50 μg fentanyl seems to be a preferrable option in HoLEP due to rapid sensory regression time and weaker postoperative motor blockade with stable hemodynamic changes. Saddle block was associated with more rapid onset and effective sensory block.

4- Week Vs 2 Weeks Course of Oral Amoxicillin–Clavulanate in Children with Suspected PBB
Key Trials, Published on: 26 Nov 2021

This is the first prospective randomised controlled trial to address the duration of antibiotic treatment for children with chronic wet cough suspected of having PBB. The study showed that 4-week course of amoxicillin–clavulanate improved symptom control during a 6-month follow-up with a significant 4-times increase in time to next wet cough exacerbation.

Long-Term Treatment with Bilastine is Safe and Effective in Japanese Patients with Allergic Rhinitis
Key Trials, Published on: 25 Nov 2021

Long-term treatment with bilastine was found to be effective, safe and well tolerated in Japanese patients with seasonal and perennial allergic rhinitis. The significant improvement in the symptoms was maintained for the duration of the study, with no loss of drug efficacy.

Acute Seizure Control in Pediatric Patients: Intranasal Midazolam vs. Intravenous/Rectal Benzodiazepines
Key Trials, Published on: 25 Nov 2021

Intranasal midazolam was as effective as intravenous/rectal benzodiazepines for aborting acute seizures in pediatric patients. The drug appears to be a promising agent in such cases due to its ease of administration.

Effect of Long-term Azithromycin Treatment on Airway Wall Thickness in Patients with SPA
Key Trials, Published on: 25 Nov 2021

The present study assessed the effect of long-term treatment with azithromycin on airways wall thickness in patients with severe persistent asthma (SPA). The study showed that eight months of treatment with azithromycin was associated with a marked increase in RB1 lumen radius and lumen area in patients with severe persistent asthma (SPA).

HFrEF Patients with Comorbidities, less likely to achieve NT-proBNP target: A Secondary Analysis of the GUIDE-IT
Key Trials, Published on: 22 Nov 2021

According to the secondary analysis of the GUIDE IT trial, patients with HFrEF and comorbidities such as AF, a lower BMI, or worse renal function are less likely to achieve a lower or target NT-proBNP.

Long-term Efficacy and Tolerability of Adjunctive Brivaracetam for the Treatment of FBTCS
Key Trials, Published on: 22 Nov 2021

This pooled-post hoc analysis demonstrated that adjunctive treatment with brivaracetam was associated with sustained, long-term reduction in the frequency of focal to bilateral tonic-clonic seizure in adult patients. The drug was generally well-tolerated and was associated with improved HQoL in the patients.

GAN Phase I: Global Trend in Burden of Asthma Symptoms in School Children
Key Trials, Published on: 17 Nov 2021

The GAN Phase I study provides standardized global estimates  and trend over three decades in the prevalence and severity of asthma symptoms in school children.

Adjunctive Perampanel Effective and Safe for the Treatment of Uncontrolled Partial-onset Seizures
Key Trials, Published on: 11 Nov 2021

The study demonstrated that adjunctive treatment with perampanel 4 mg/day and 8 mg/day was effective and safe in patients with uncontrolled partial-onset seizures, with/without secondary generalization.

EAS/ESVM: Lipid Lowering and Anti-thrombotic Therapy in Patients with PAD (2021)
Guidelines, Published on: 11 Nov 2021
BRIVAFIRST: Real-world Evidence on Adjunctive Treatment with Brivaracetam in Focal Epilepsy
Key Trials, Published on: 11 Nov 2021

The BRIVAFIRST study demonstrated that adjunctive brivaracetam treatment was effective and safe in patients with focal epilepsy, irrespective of the prior use of anti-seizure medication.

Cyproterone Acetate and Ethinyl Estradiol Combination Improves Hyperandrogenism in Females
Key Trials, Published on: 10 Nov 2021

Combination of cyproterone acetate and ethinyl estradiol was effective in reducing the hyperandrogenic symptoms in women. The menstrual cycles were normalised in 3 cycles. Acne and hirsutism completely resolved after 6 cycles of treatment. The treatment was well tolerated in all but one who had severe headache and nausea.

Patient Selection for Viscosupplementation in Osteoarthritis Patients
Expert's Views, Published on: 09 Nov 2021

In this video, the speaker has discussed about patient selection criteria for Viscosupplementation in Osteoarthritic patients.

EACS: Guidelines for the Management of People Living with HIV (PLWH) in Europe (2021)
Guidelines, Published on: 08 Nov 2021
AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR: Evaluation and Diagnosis of Chest Pain (2021)
Guidelines, Published on: 03 Nov 2021
AIOS/VRSI: Treatment Guidelines for Management of DME in India (2021)
Guidelines, Published on: 03 Nov 2021
Various Mediators Influence the Improvement in HF Outcomes with Empagliflozin: The EMPA-REG OUTCOME Analysis
Key Trials, Published on: 02 Nov 2021

This post hoc analysis of the EMPA-REG OUTCOME trial discusses various mediators that influence the empagliflozin-associated improvement in heart failure outcomes in patients with type-2 diabetes mellitus.

Sequencing Therapies After Progression on 1st Line in mRCC
Expert's Views, Published on: 02 Nov 2021

This talk explains about various novel therapies in the treatment of metastatic RCC, from Tyrosine Kinase inhibitor to immunotherapies and combinations.

Endoscopic and Clinical Effects of Nasal Irrigation with Thermal Water in Smokers with Non-Allergic Chronic Rhinitis
Key Trials, Published on: 29 Oct 2021

Nasal irrigations with sulfurous-arsenical-ferruginous thermal water resulted in reduction of nasal resistances, increase in the number of ciliated cells and a significant improvement in the endoscopic findings as compared to isotonic sodium chloride solution in smokers with nonallergic chronic rhinitis.

Interim Analysis of Randomized Phase 3 METEOR Trial – Cabzantinib vs Everolimus in Advanced Renal Cell Carcinoma
Key Trials, Published on: 28 Oct 2021

The present study reports the final overall survival results from the METEOR study that compared the efficacy and safety of cabozantinib versus everolimus in patients with advanced renal cell carcinoma. The findings showed that treatment with cabozantinib was associated with a significant increase in overall survival.

The Impact of Empagliflozin on Uric Acid Level and Gout Outcomes in Diabetes-The EMPA-REG OUTCOME Analysis
Key Trials, Published on: 26 Oct 2021

This analysis of the EMPA-REG OUTCOME trial demonstrated that empagliflozin treatment in T2DM patients was associated with reduced serum uric acid level and reduced risk of gout or prescription for antigout medication.

CELESTIAL: Cabozantinib vs. Placebo increases Overall Survival and Progression-free Survival in Patients with Advanced Hepatocellular Carcinoma
Key Trials, Published on: 25 Oct 2021

The CELESTIAL trial demonstrated that cabozantinib, compared with placebo improved the survival and progression-free survival in patients with advanced hepatocellular carcinoma.

CABOSUN Trial: Overall Survival and Progression Free Survival with Cabozantinib versus Sunitinib as Initial Therapy for Metastatic Renal Cell Carcinoma
Key Trials, Published on: 25 Oct 2021

CABOSUN trial assessed overall survival and progression free survival cabozantinib versus sunitinib as initial targeted therapy in patients with metastatic renal cell carcinoma (RCC). The study showed that cabozantinib treatment significantly prolonged progression free survival compared with sunitinib as initial systemic therapy for advanced RCC of poor or intermediate risk.

Impact of Glaucoma Medication on Dry Eye Syndrome and Quality of Life in Glaucoma Patients
Key Trials, Published on: 22 Oct 2021

Glaucoma medications may worsen eye dryness though to a limited extent. Clinicians must consider that these medications may limit near activity and social functioning in the patient, though they do not worsen the quality of life of the glaucoma patient.

Misoprostol – A Wonder Drug
Expert's Views, Published on: 21 Oct 2021

In his talk, doctor gives his expert comments on the various obstetrics & gynaecology conditions in which the efficacy & safety of misoprostol is well established.

Topical Dorzolamide 2% for the Treatment of Diabetic Cystoid Macular Edema
Key Trials, Published on: 21 Oct 2021

Topical dorzolamide 2% appears to be an effective, affordable and safe therapy for treating non-refractory diabetic cystoid macular edema.

Nasal Saline Irrigation Improves Clinical Nasal Symptoms in Children with Upper Respiratory Tract Infections
Key Trials, Published on: 21 Oct 2021

Saline nasal irrigation (SNI) was associated with improvement in clinical rhinological symptoms, and the long-term use reduced the incidence of upper respiratory tract infections (URTIs) and their complications. SNI was safe and well tolerated by children with acute URTIs. However, it did not result in an improvement in the respiratory symptoms.

Efficacy and Safety of Adjunctive Perampanel for the Treatment of Partial-onset Seizures
Key Trials, Published on: 19 Oct 2021

According to the findings of the study, adjunctive perampanel 8 mg and 12 mg were effective and safe for the treatment of partial onset seizure.

GE Junction Tumors: IO and Targeted Therapies, Where Do You Place Them
Expert's Views, Published on: 18 Oct 2021

This talk explains about various therapies in the management of GE junction Tumors; Immunotherapy in adjuvant and Metastatic Setting and Guidelines.

Updates in Lymphoma 2021
Expert's Views, Published on: 18 Oct 2021

This talk explains about recent updates in Lymphoma in the year 2021, focusing on CLL, MCL & Malt Lymphoma treatment.

Mitigating Adverse effects of Systemic Therapies in Metastatic Prostate Cancer
Expert's Views, Published on: 18 Oct 2021

This talk explains about various therapies in the treatment of prostate cancer and the side effects associated with the therapies. This session also helps to understand various guidelines in the management of adverse events, specifically improving the bone health; focusing on bisphosphonate and other therapies.

Maintenance Therapy in Ovarian Cancer: Are We Making Any Headway
Expert's Views, Published on: 18 Oct 2021

This talk explains about various novel therapies in the treatment of ovarian cancer; ranging from Chemotherapy, Systemic Therapy, PARP inhibitors, Monoclonal Antibodies, Genomics Testing and various future therapies.

Endometrial Cancer: Moving Towards Innovative Therapies
Expert's Views, Published on: 18 Oct 2021

This talk explains about various novel therapies in the treatment of Endometrial cancer ranging from Chemotherapy, Targeted therapies, Anti-angiogenic Agent, PARP inhibitors, Monoclonal Antibodies, Immunotherapy  and various future therapies.

Updates 2021: Metastatic Colorectal Cancer
Expert's Views, Published on: 18 Oct 2021

This talk explains about various updates in management of mCRC in 2021 focusing on HER2 directed therapies, immunotherapy, chemotherapy and combination therapies.

Non Clear Cell RCC: What’s New?
Expert's Views, Published on: 18 Oct 2021

This talk discusses various therapies, current and future, in the treatment of Non-Clear cell RCC.

Personalizing Therapy for Early HER2+ Breast Cancer and Future Directions
Expert's Views, Published on: 18 Oct 2021

This talk explains about various novel therapies (monoclonal antibodies, Tyrosine Kinase inhibitor and Antibody Drug Conjugate) in the treatment of early HER2+ breast cancer focusing on patient profile.

Multiple Myeloma: Recent Advances
Expert's Views, Published on: 18 Oct 2021

This session talks about novel therapies in Multiple Myeloma resulting in more options with impressive response rates.

ESCAT Guidelines for Molecular Profiling in Advance Solid Tumor
Expert's Views, Published on: 18 Oct 2021

This talk explains about ESCAT Guidelines that aim to prioritize cancer genomic abnormalities as marker to select patients for targeted therapies.

Follicular Lymphoma: Chemotherapy and Beyond
Expert's Views, Published on: 18 Oct 2021

This talk explains about various Current & Future therapies in the management of Follicular Lymphoma beyond Chemotherapy.

New Therapies Making Wave in mTNBC
Expert's Views, Published on: 18 Oct 2021

This talk explains about various novel therapies in the treatment of metastatic Triple negative breast cancer (chemotherapy , immunotherapy and Antibody Drug Conjugate and future therapies).

Evening Bronchodilation Improves Respiratory Mechanics and Inspiratory Neural Drive in COPD
Key Trials, Published on: 14 Oct 2021

There is significant deterioration in the respiratory mechanics at night in the COPD patients.Evening bronchodilator treatment was clinically beneficial in these patients and resulted in sustained overnight improvements in dynamic respiratory mechanics and inspiratory neural drive compared with placebo.

H. influenzae in Children with Acute Otitis Media: A Study on its Prevalence, Proportion of Capsulated Strains and Antibiotic Susceptibility
Key Trials, Published on: 13 Oct 2021

The study demonstrates a substantial prevalence of H. influenzae in children affected with acute otitis media. The study also provides data on overall up-to-date trend on antibiotic susceptibility of H. influenzae in children.

Prevalence and Determinants of Vitamin D Deficiency among under-5 Children Dwelling Slums of Mumbai, India
Key Trials, Published on: 12 Oct 2021

The study demonstrated that vitamin D deficiency (VDD) was prevalent in under-5 children, dwelling in slums in Mumbai, India. Sun-exposure, male gender, and calcium and vitamin D supplementations during infancy may be protective against VDD among under-five children.

Oral Natural Micronized Progesterone Sustained Release Formulations are Effective and Safe in IUI Cycles for Unexplained Infertility
Key Trials, Published on: 11 Oct 2021

Luteal phase supplementation with oral natural micronized progesterone sustained release formulations was effective and well tolerated and might be a good alternative to conventional formulations due to once-daily convenient dosing in women with unexplained infertility undergoing IUI.

SMART Effective in Treatment of Moderate to Severe Asthma – Quantitative Synthesis on Real-World Evidence
Key Trials, Published on: 08 Oct 2021

The results of this network meta-analysis of real-world evidence support the GINA recommendation that SMART should be considered as an ideal choice in the treatment of moderate to severe asthma, irrespective of the dose of ICS used in the formulation. SMART was associated with significant reduction in the risk of severe exacerbation in adults with moderate to severe asthma.

Hypertonic Saline Improves Nasal Symptoms and Ciliary Movement Compared to Isotonic Saline in Chronic Rhinosinusitis
Key Trials, Published on: 08 Oct 2021

Hypertonic saline nasal irrigation is associated with mild side effects and a superior clinical efficacy as compared to isotonic saline nasal irrigation in the treatment of chronic rhinosinusitis. Hypertonic saline nasal irrigation significantly improved the nasal symptoms and ciliary movement, but demonstrated no significant difference in imaging findings and smell improvement.

Navigating the Maze of Therapies in Metastatic HER2+ Breast Cancer
Expert's Views, Published on: 07 Oct 2021

This talk explains various novel therapies in the treatment of metastatic HER2+ breast cancer from monoclonal antibodies , Tyrosine Kinase inhibitor and Antibody Drug Conjugate and various future therapies.Dr Ashish Singh

Daily PrEP Verses on Demand PrEP Regimen Coverage CLAI for MSM
Key Trials, Published on: 05 Oct 2021

The present study determined the impacts of oral tenofovir disoproxil fumarate 300 mg/emtricitabine 200 mg (TDF/FTC) on demand verses daily PrEP   regimens on their coverage of condomless anal intercourse (CLAI) in men who have sex with men (MSM). The study showed that both daily and on-demand PrEP provided similar coverage of sex acts, which were tolerated and accepted by MSM.

EORTC-NCIC Trial: 5-Year Survival Outcomes with Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy Alone in Patients with Glioblastoma
Key Trials, Published on: 05 Oct 2021

This study presents the 5-year long-term results of EORTC-NCIC trial evaluating survival outcomes with radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone in patients with glioblastoma. The study showed that combined initial treatment for glioblastoma with temozolomide and radiotherapy improves survival compared with radiotherapy alone.

IAP & ISPGHAN: Recommendations for Diagnosis and Management of GERD in Children (2021)
Guidelines, Published on: 04 Oct 2021

Gastroesophageal reflux (GER) related symptoms are a major cause of parental concern and referrals at all ages. Here is an infographic on the recent ISPGHAN guidelines that has been framed to inform Indian pediatricians regarding current recommendations on diagnosis and management of gastro-esophageal reflux disease (GERD). 

ADA/EASD: The Management of Type-1 Diabetes in Adults - A Consensus Report (2021)
Guidelines, Published on: 04 Oct 2021
Significance of Secondary Resection and Efficacy of BCG Strains in Intermediate/High-Risk Non-Muscle-Invasive Bladder Cancer
Key Trials, Published on: 01 Oct 2021

BCG strains – TICE and RIVM were associated with better recurrence-free survival outcomes as compared to Connaught when administered with a maintenance protocol in intermediate-/high-risk non-muscle invasive bladder cancer patients (NMIBCs). The findings confirmed the importance of re-TUR in intermediate-/high-risk NMIBCs and is associated with longer progression-free survival and RFS outcomes. TICE had superior RFS outcomes than the other strains after stratifying for re-TUR.

Metabolically Healthy Obesity and its Association with Obesity-related Outcomes
Key Trials, Published on: 30 Sep 2021

Individuals with metabolically healthy obesity are at a substantially higher risk of obesity-related outcomes as compared with individuals with metabolically healthy non-obesity as well as those with metabolically unhealthy non-obesity. Weight management should therefore be recommended in obese individuals irrespective of their metabolic status.

Treatment Effect of Lamotrigine on Acute Bipolar Depression
Key Trials, Published on: 28 Sep 2021

The findings of this exploratory analysis suggested lamotrigine to be effective for treating the core symptoms of depression in patients with acute bipolar depression.

Efficacy of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in Reducing Risk of Vertical Transmission of HBV
Key Trials, Published on: 24 Sep 2021

Treatment with tenofovir alafenamide and tenofovir disoproxil fumarate for 24 weeks in women with high viral load, demonstrated similar efficacy in reducing the HBV DNA to levels associated with minimal transmission risk in infants who receive complete passive-active immunoprophylaxis.

ESC/EACTS: Management of Valvular Heart Disease-An Update (2021)
Guidelines, Published on: 22 Sep 2021
Tamsulosin More Effective than Tadalafil in Expulsion of Distal Ureteral Stones: Results from a Randomized Clinical Trial
Key Trials, Published on: 22 Sep 2021

Tamsulosin as medical expulsive therapy is more effective in reducing the stone expulsion time with lesser need for analgesics than tadalafil in the treatment of distal ureteral calculi.

Adjunctive Brivaracetam Effective and Well-tolerated in Patients with Uncontrolled Focal Seizures, Irrespective of Previous Antiseizure Medication Usage
Key Trials, Published on: 22 Sep 2021

This post hoc analysis demonstrated adjunctive BRV to be effective and generally well tolerated in adults with focal seizures, irrespective of the number of previous ASMs.

CARLOC-I (Carvedilol +Ivabradine) Monograph
Our Publications, Published on: 17 Sep 2021

Carvedilol/ivabradine have a proven chemical-pharmaceutical quality and are considered an approvable fixed-dose combination. Both carvedilol and ivabradine are well known, established substances, which are used as a combination in clinical practice. The clinical data on concomitant use are considered sufficient to support the fixed-dose combination in patients with CHF who are on a stable fixed dose regimen with both monocomponents. Combining ivabradine to carvedilol in patients with stable IHF or patients with systolic HF in sinus rhythm with heart rate >70 bpm is associated with better heart rate reduction, improvement of quality of life, and reduced rehospitalization.

Nasal Response to Allergen Challenge Post 1 Year of Discontinuation in Allergic Rhinitis
Key Trials, Published on: 17 Sep 2021

Sublingual grass pollen immunotherapy for 2 years did not result in any significant improvements in nasal response to allergen challenge after 1 year of discontinuation as compared to placebo in patients with moderate-to-severe seasonal allergic rhinitis.

ESC/EAPC: Guidelines on Cardiovascular Prevention in Clinical Practice (2021)
Guidelines, Published on: 16 Sep 2021
AHA: Guidance for Timely and Appropriate Referral of Patients with Advanced Heart Failure (2021)
Guidelines, Published on: 16 Sep 2021
Ronapreve (Casirivimab and Imdevimab) Monograph
Our Publications, Published on: 16 Sep 2021

Casirivimab and imdevimab are human, non-competing, high-affinity, IgG1 (immunoglobulin G1)-neutralising monoclonal antibodies produced by recombinant DNA technology and are to be administered together either intravenously or subcutaneously. Each antibody targets a different region of the S-proteins of SARS-CoV-2 and, hence, prevents interaction of the S-proteins with the ACE-2 receptors, leading to inhibition of infectivity of the host cells.

Understanding of Asthma Treatment Strategies from Physicians’ and Patients’ Perspectives
Key Trials, Published on: 14 Sep 2021

Most physicians focused on the prevention of asthma symptoms over exacerbations. ICS/formoterol was the preferred symptom reliever as per the GINA report. The survey findings demonstrated a lack of awareness and understanding of MART dosing among physicians. There is a need for improved education and strategies to implement GINA recommendations effectively in real-world clinical practice.

FIGARO-DKD: Impact of Finerenone on CV Outcomes in Patients with T2DM and CKD
Key Trials, Published on: 09 Sep 2021

The FIGARO-DKD trial demonstrated that as compared with placebo, treatment with finerenone improved the CV outcomes in patients with T2DM and CKD.

Psoriatic Arthritis: General Awareness
Patient Education, Published on: 08 Sep 2021

This patient education sheet provides information on Psoriatic arthritis disorder- its causes, risk factors, symptoms, complications, management and treatment options.

Exercises for Rheumatoid Arthritis
Patient Education, Published on: 08 Sep 2021

This input provides a manual guidance with instructions to perform various Hand exercises especially pertaining to small joints of hands and wrist for rheumatoid arthritis (RA) patients and highlights benefits of these exercises to improve fine movements and joint function of RA patients.

Exercises for Ankylosing Spondylitis
Patient Education, Published on: 08 Sep 2021

This input provides a manual guidance with steps and positions instructions to perform various types of Ankylosing spondylitis exercises, highlighting the importance and benefits of physiotherapy and exercises in AS which may aid patients to keep the spine strong and flexible, improve posture, and improve their muscle strength.

Ankylosing Spondylitis: General Awareness
Patient Education, Published on: 08 Sep 2021

This patient education sheet provides information on Ankylosing spondylitis disease- its causes, risk factors, symptoms, complications, management, and treatment options.

Fixed-Dose Combination of Timolol-Dorzolamide: Comparing the Efficacy and Safety of Thrice Daily vs. Twice Daily Regimen in POAG Patients
Key Trials, Published on: 07 Sep 2021

Amongst patients with POAG, a thrice-a day regimen of a fixed-dose combination of timolol/dorzolamide provided superior IOP reduction as compared with a twice-a day regimen, without any additional safety concerns.

PERMIT Study: Perampanel Effective and Well-tolerated in Patients with Focal Epilepsy
Key Trials, Published on: 06 Sep 2021

The permit study demonstrated long-term perampanel treatment to be effective and generally well tolerated in patients with focal epilepsy in everyday clinical practice.

SEHP: COVID-19 Safety Guidelines (2021)
Guidelines, Published on: 02 Sep 2021
Superiority of Fluticasone Propionate over Levocetirizine in Treatment of Allergic Rhinitis
Key Trials, Published on: 02 Sep 2021

Fluticasone nasal steroidal spray (FNSS) was associated with a rapid relief of clinical symptoms within 2 days as compared to 1 week with levocetirizine in patients with allergic rhinitis (AR). FNSS demonstrated a better safety profile than levocetirizine, making it a better choice in the treatment of AR.

BRAAVE Trial: Efficacy of Switching to STR of B/F/TAF vs Continuing on Regimen of 2 NRTIs and a Third Agent in Virologically Suppressed HIV Adults
Key Trials, Published on: 02 Sep 2021

BRAAVE study is the randomized phase 3 study evaluating efficacy and safety of   switching to fixed-dose combination of B/F/TAF vs continuing baseline regimen (SBR) in virologically suppressed adults. The study demonstrated that switching to B/F/TAF from a variety of baseline suppressive regimens was efficacious and safe.

Efficacy and Safety of Teriparatide in the Treatment of Nontraumatic Osteonecrosis of the Femoral Head
Key Trials, Published on: 02 Sep 2021

This study compared the pharmacological effects of teriparatide on collapse progression of nontraumatic osteonecrosis of femoral head (NOFH) and to compare these effects with alendronate. The study showed that the treatment with teriparatide resulted in lesser collapse progression of the femoral head than that by alendronate. 

Nebulizing Treatment with Hypertonic Saline Yielded Better Clinical Outcomes than Normal Saline in Children with Bronchiolitis
Key Trials, Published on: 02 Sep 2021

Nebulization with 3% hypertonic saline solution significantly reduced the severity of respiratory distress as well as the length of hospital stay and increased the time of sleep at night as compared with 0.9% saline solution among children with acute bronchiolitis. 

Significant Improvements in Hematological Parameters with IV Iron Sucrose Therapy in Pregnant Women with Moderate Anemia
Key Trials, Published on: 02 Sep 2021

Intravenous (IV) iron sucrose therapy significantly increased haemoglobin, serum ferritin and other haematological parameters in pregnant women with moderate anaemia. The side effects with IV iron sucrose therapy were negligible and can be a better alternative to intramuscular therapy due to injection related side effects.

Efficacy and Safety of Lenvatinib, Everolimus, or their Combination as Second-line Treatment in Patients with Metastatic Renal Cell Carcinoma
Key Trials, Published on: 30 Aug 2021

This study compared efficacy and safety of lenvatinib plus everolimus combination and single-agent lenvatinib with the standard dose of single-agent everolimus in patients with metastatic renal cell carcinoma who had disease progression after one previous VEGF-targeted therapy. The study demonstrated highest level of efficacy is associated with the combination regimen of lenvatinib plus everolimus, consisting of a contribution from each single agent.

Quality Control in Conventional IVF
eCMEs, Published on: 26 Aug 2021

In her talk, doctor shares data on various KPIs that set IVF lab benchmark.

Quality Control Standards in PGT: Time to Re-Check
eCMEs, Published on: 26 Aug 2021

In his talk, Doctor gives the KPIs around quality control in biopsy & PGT from an Embryologist’s perspective.

Quality Control Issues in Handling Culture Media
eCMEs, Published on: 26 Aug 2021

In his talk, doctor elaborates on the role of culture media that is at the centre of all ART procedures & related quality control factors.

ESI: Diagnosis and Management Considerations in Steroid-related Hyperglycemia in COVID-19 (2021)
Guidelines, Published on: 26 Aug 2021
Efficacy and Safety of Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip
Key Trials, Published on: 25 Aug 2021

The present study is the retrospective analyses evaluating efficacy of single dose zoledronic acid treatment in patients with transient osteoporosis of hip (TOH). Treatment with single-dose intravenous zoledronic acid was associated with early pain relief and complete reversal of TOH. None of the patients progressed to avascular necrosis at their last follow-up.

Nasal Irrigation with 0.9% Saline Effective and Safe as an Adjunct Therapy in Allergic Rhinitis
Key Trials, Published on: 25 Aug 2021

Nasal irrigation with 0.9% saline along with intranasal corticosteroid (INS) and antihistamine demonstrated greater improvements in the symptoms as compared to INS and antihistamine only in the patients with allergic rhinitis (AR). Along with efficacy, nasal saline irrigation is safe, cost effective and convenient to use, making it a potential adjunct therapy in the treatment of AR.

Imaging in Chest Diseases
eCMEs, Published on: 24 Aug 2021

Latest guidelines on imaging are now available for pulmonologists. This webcast is an attempt to provide guidance to the viewers on how to request and interpret HRCT reports. Moreover, advanced technologies in Imaging in chest diseases are discussed in length by the experts in this PURVIEW.

Novelty and Nuances of Inhaled Drug Delivery Systems
eCMEs, Published on: 24 Aug 2021

In Obstructive Airway Disease management – poor inhalation technique leads to poor clinical outcomes. This PURVIEW webcast entails guidance to viewers as to how to correct inhalation technique, how to choose the right inhalers and novel drug delivery systems available in Indian scenario.

Correlation Between Serum Vitamin D Levels and the Severity of Androgenetic Alopecia
Key Trials, Published on: 19 Aug 2021

This is case-control study compared serum vitamin D levels among males with androgenetic alopecia (AGA) and healthy controls. The mean serum 25-(OH)D level significantly differed between patients and controls. The severity of AGA showed a positive correlation with the serum vitamin D levels. 

Efficacy and Safety of Cefpodoxime in Treatment of URTI
Key Trials, Published on: 18 Aug 2021

The present study evaluated efficacy and safety of cefpodoxime empirical treatment in adult patients with acute upper respiratory tract infections. The study found that treatment with cefpodoxime was associated with high cure rates for acute maxillary sinusitis and acute tonsilopharyngitis and a favorable safety and tolerability profile.

Benefits of Vaginal Micronized Progesterone at Start of Luteal Phase in Recurrent Pregnancy Loss
Key Trials, Published on: 17 Aug 2021

Administration of vaginal micronized progesterone at the start of luteal phase improved the pregnancy success rates in a strictly defined cohort of women with recurrent pregnancy loss (RPL). The authors of this study recommend molecular analysis of luteal phase endometrium to identify the women who can be benefitted the most with vaginal progesterone given from the start of the luteal phase.

Long-term Efficacy and Safety of Adjunctive Lacosamide in Epilepsy Patients with Uncontrolled Focal Seizures
Key Trials, Published on: 17 Aug 2021

The study demonstrated that long-term adjunctive treatment (up to 36 months) with lacosamide was effective, safe and well-tolerated in epilepsy patients with uncontrolled focal seizures.

NEBUFLO Mesh Nebulizer
Device Demos, Published on: 17 Aug 2021
Dienogest in Endometriosis: Pre- & Post-operative Benefits
Expert's Views, Published on: 16 Aug 2021

In his talk, doctor provides his experience of medical therapy with dienogest in adolescent girls and reproductive age-group women with endometriosis.

NEBUFLO Mesh Nebulizer
Patient Education, Published on: 16 Aug 2021

NEBUFLO is an active mesh nebulizer that converts liquid medication into aerosol/mist that can easily be inhaled by patients. It is portable, easy to clean, and offers hassle free usage. It is a suitable option for patients with respiratory disorders on nebulization at home, hospital, clinics & nursing homes. NEBUFLO device package comes with main unit, medication cup, mouthpiece, face mask & adapter.

Comparative Efficacy of Gatifloxacin versus Ceftriaxone for Uncomplicated Enteric Fever
Key Trials, Published on: 13 Aug 2021

The present randomised controlled study compared efficacy of gatifloxacin and ceftriaxone in patients with uncomplicated enteric fever. The study found no difference in outcomes between patients receiving gatifloxacin and ceftriaxone.

Hyperandrogenism and Insulin Resistance in PCOS
Our Publications, Published on: 12 Aug 2021

PCOS is an endocrine disorder commonly presenting with irregular periods, hirsutism, infertility and also a link to metabolic abnormalities such as type 2 diabetes, insulin resistance and obesity. The booklet gives a brief on the disorder with focus on clinical efficacy of the COC containing cyproterone acetate & ethinylestradiol as well as the insulin sensitizing effects of inositols.

Biosimilarity Study for New Ranibizumab Biosimilar for Treating Neovascular (Wet) AMD
Key Trials, Published on: 10 Aug 2021

The efficacy, safety and immunogenicity profile of the biosimilar ranibizumab formulation was comparable with that of the innovator reference product. The biosimilar may thus be considered as a viable alternative for the innovator product for treating neovascular (wet) AMD.

Breastfeeding Awareness
Patient Education, Published on: 09 Aug 2021

This leaflet gives information about benefits of breastfeeding for mother and baby, optimal time and positions as well as importance of nutrition.

EMPA-REG OUTCOME: Significant CV benefits with Empagliflozin Evident within Weeks of Treatment Initiation
Key Trials, Published on: 06 Aug 2021

This post hoc analysis of the EMPA-REG OUTCOME trial demonstrated that amongst T2DM patients with established ASCVD, significant benefits of empagliflozin treatment in terms of reduced risk of HHF, CV death/HHF, and CV death were evident within weeks of treatment initiation and were sustained over a long-term.

As-needed Budesonide-Formoterol Effective and Safe in Adolescents with Mild Asthma: Pooled Analysis of SYGMA Studies
Key Trials, Published on: 05 Aug 2021

Reliever therapy with as-needed budesonide-formoterol (BUD-FORM) was superior to as-needed terbutaline and significantly reduced the rate of severe exacerbations and demonstrated similar efficacy to BUD maintenance in terms of symptom control and lung function in adolescents with mild asthma. As-needed BUD-FORM can be considered as an ideal alternative in adolescents with mild asthma, which can avoid daily maintenance treatment.

Subgroup Analysis of the POISE Trial Results based on Risk of Disease Progression in Primary Biliary Cholangitis
Key Trials, Published on: 05 Aug 2021

Long-term treatment with obeticholic acid (OCA) was effective and well tolerated and improved the levels of ALP, ALT, and AST, irrespective of baseline ALP and total bilirubin in patients with primary biliary cholangitis (PBC).

EULAR 2020 Updates in Rheumatology
Conference Proceedings, Published on: 04 Aug 2021

Highlights from EULAR virtual congress 2020 conference regarding latest advances and updates in the field of rheumatology.

Misoprostol More Effective and Safer than Oxytocin when Used for Cervical Ripening and Labor Induction
Key Trials, Published on: 03 Aug 2021

The findings of the study revealed that 25 µg of vaginal misoprostol at 4 hours intervals is safer and more effective cervical ripening and labor induction agent than oxytocin.

Efficacy and Safety of Adjunctive Perampanel in Indian Patients with Focal Seizures
Key Trials, Published on: 02 Aug 2021

The study demonstrated that adjunctive therapy with perampanel provided long-term seizure control in Indian patients. The efficacy and safety outcomes of perampanel remained similar for Indian and non-Indian patients.

AHS: Integrating New Migraine Treatments into Clinical Practice - An Update (2021)
Guidelines, Published on: 30 Jul 2021
Efficacy and Safety of Prostate-Specific Membrane Antigen-Targeted Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer
Key Trials, Published on: 30 Jul 2021

Prostate-specific membrane antigen (PSMA)-targeted endoradiotherapy/radioligand therapy (PRLT) with small-molecule, urea-based agents labeled with the β-particle–emitting radionuclide lutetium-177 (177Lu) is highly effective and safe in the treatment of castration-resistant prostate cancer (CRPC). PRLT was associated with relatively high number of prostate-specific antigen (PSA) responders coupled with low rate of severe toxicity. This systematic review and meta-analysis might be valuable to the clinicians who can balance the risks and benefits of this novel therapy in CRPC.

LOTUS Study: Head-to-Head Comparison of Long-Term Efficacy and Safety of Tafluprost, Travoprost, and Latanoprost in Patients with POAG or NTG
Key Trials, Published on: 28 Jul 2021

This study provides first head-to-head comparison on the efficacy and safety of three PGAs for treating patients with POAG or NTG. The study demonstrated tafluprost, travoprost and latanoprost to have similar efficacy and safety profile as a first-line treatment for glaucoma.

An Analysis of EDICT Study: Insulin Secretion Predicts the Need of Insulin Therapy in New-onset T2DM Patients with Poor Glycemic Control
Key Trials, Published on: 28 Jul 2021

According to this post hoc analysis of the EDICT study, insulin secretion predicts the need for insulin therapy at the time of T2DM diagnosis, irrespective of the antidiabetic treatment. A cut-off of 1.7 for CPEP120/CPEP0 may have a valuable role in individualizing glucose-lowering therapy in patients with new-onset T2DM and poor glycemic control.

GALACTIC-HF: The Therapeutic Benefits of Omecamtiv Mecarbil Increase with decreasing Ejection Fraction in HFrEF Patients
Key Trials, Published on: 28 Jul 2021

The subgroup analysis of the GALACTIC-HF trial demonstrates that the therapeutic benefits of omecamtiv mecarbil increase progressively with the decreasing EF in patients with HFrEF. Patients with more severe HF may thus derive greater clinical benefits from cardiac myosin activator therapy.

Afebrile Infants with Acute Otitis Media have Low Incidence of Invasive Bacterial Infections
Key Trials, Published on: 28 Jul 2021

Afebrile infants with acute otitis media (AOM) have a low incidence of invasive bacterial infections and adverse events. Outpatient management of such patients without diagnostic testing may thus be a feasible alternative.

Vaginal Misoprostol Reduces Pain and Force Needed for Cervical Dilatation before Hysteroscopy
Key Trials, Published on: 26 Jul 2021

Self-administered 400 microg of vaginal misoprostol 12 to 24 hours before hysteroscopy significantly reduced the force required to dilate the cervix and reduced the pain with no serious side effects. Misoprostol can be considered for cervical priming since its inexpensive, easy to use and safe.

Clinical Outcomes of Posterior Nasal Neurectomy and Pharyngeal Neurectomy in Allergic Rhinitis
Key Trials, Published on: 26 Jul 2021

Posterior nasal neurectomy (PNN) with or without pharyngeal neurectomy (PN) is safe and effective bringing about similar improvements in symptoms and quality of life in patients with allergic rhinitis (AR). Combined PNN and PN is a better surgical treatment option than PNN alone in AR patients with chronic coug

AAP: Evaluation and Management of Well-appearing Febrile Infants 8-60 Days Old (2021)
Guidelines, Published on: 23 Jul 2021
Long-term Efficacy and Safety of Alendronate in Adults with AVN
Key Trials, Published on: 22 Jul 2021

The present study is a systematic review evaluating long-term efficacy and safety of alendronate in adults with avascular osteonecrosis. The findings suggests alendronate use for adult AVN, partic­ularly with early stage and small necrotic size.

Demographic Subgroup Analysis of the POISE Trial Results: Long-Term Efficacy and Safety of Obeticholic Acid in Primary Biliary Cholangitis Patients
Key Trials, Published on: 21 Jul 2021

Long-term treatment with obeticholic acid (OCA) is associated with durable improvements in ALP, ALT, AST and GGT as well as stabilization of normal bilirubin in patients with primary biliary cholangitis (PBC), irrespective of age or sex.

The Effect of Physical and Chemical Factors in Embryo Culture
eCMEs, Published on: 20 Jul 2021

In his talk, doctor describes the embryo culture environment and their significance in IVF practice.

PANEL DISCUSSION: Fragmentation: A Broken Human Embryo, How to Minimize?
eCMEs, Published on: 20 Jul 2021

The group discusses embryo fragmentation, its pathophysiology & probable causes, scoring system and probable management.

Importance of Choo-(U)-sing - The Best Mineral Oil for Embryo Culture: Details to Consider
eCMEs, Published on: 20 Jul 2021

In his talk, the speaker gives an overview of embryo culture system and effects of OIL, the key component, on temperature, pH & osmolality, the differences between heavy & light oils, QC tests for oil toxicity screening & how can one minimize associated risks.

DEBATE: Humidified v/s Non-Humidified Embryo Incubation
eCMEs, Published on: 20 Jul 2021

The 2 experts give their views on which is the best method for embryo incubation, the advantages & disadvantages of each with relevant & supporting clinical data.

Oxygen: A Fresh Breath of Life or Toxin to the Embryo
eCMEs, Published on: 20 Jul 2021

In his talk, doctor aims to demonstrate physiologic concentrations of O2 for oocytes & embryos, O2 utilization by embryos & its role in embryo gene expression & metabolism, and, finally, human IVF in low v/s high O2.

BREVACTA Study: Long-term Efficacy and Safety of Subcutaneous Tocilizumab Every 2 Weeks in RA Patients with Inadequate Response to DMARDs
Key Trials, Published on: 20 Jul 2021

BREVACTA study evaluated long-term efficacy and safety of subcutaneous tocilizumab (TCZ-SC) every 2 weeks (q2w) over 2 years in patients with rheumatoid arthritis who have an inadequate response to disease-modifying antirheumatic drugs (DMARD). The study showed that efficacy and safety of TCZ-SC q2w were maintained over 96 weeks.

Clinical Representation & Red Flags: Cough
Expert's Views, Published on: 19 Jul 2021

Expert’s views on cough in children; common cause of cough, identification of cause of cough based on clinical representation, red flags & associated risk factors.

COMPASS: Rivaroxaban Plus Aspirin reduces the Death Risk vs. Aspirin alone in Patients with Chronic CAD and PAD
Key Trials, Published on: 16 Jul 2021

This sub-analysis of the COMPASS trial demonstrated that patients with chronic CAD or PAD treated with rivaroxaban-aspirin combination had a reduced risk of all-cause and CV-specific mortality as compared to those treated with aspirin alone.

Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations For A Public Health Approach (16 July 2021)
Guidelines, Published on: 16 Jul 2021
Case of Recent Hospitalisation for AMI
Expert's Views, Published on: 15 Jul 2021

Dr Arindam Pande talks about case of recent hospitalisation for AMI

Case of HTN with Discomfort & Fatigue
Expert's Views, Published on: 15 Jul 2021

Dr Arindam Pande talks about the case of patient having hypertension with discomfort & fatigue.

Case of Heart Failure with Reduced Ejection Fraction
Expert's Views, Published on: 15 Jul 2021

Dr Arindam Pande talks about case of patient having heart failure with reduced ejection fraction

Symptom Control and Quality of Life with As-Needed Fluticasone Furoate as Compared to Regular Use in Persistent Perennial Allergic Rhinitis
Key Trials, Published on: 15 Jul 2021

The efficacy of as-needed fluticasone furoate (FF) in terms of nasal symptoms and quality of life was similar to the regular use of FF in patients with moderate to severe persistent perennial allergic rhinitis. Although the cumulative dose of intranasal corticosteroid in the FF-as-needed group was half as compared to the FF-regular group, the symptom control was probably less sustained throughout the 6 weeks of treatment.

ICROP: Third Edition (2021)
Guidelines, Published on: 14 Jul 2021
Tips to Manage Fungal Infections
Patient Education, Published on: 13 Jul 2021

Information about general measures to manage fungal infections of the skin and nails, hygiene tips, how to prevent its spread.

Efficacy and Safety of Salvage Ureteroscopy after Previously Failed Shockwave Lithotripsy
Key Trials, Published on: 13 Jul 2021

The salvage ureteroscopy (URS) after previous unsuccessful shockwave lithotripsy (SWL) had similar stone free rates, duration of surgery and postoperative complications, demonstrating comparable efficacy and safety to primary URS.

Efficacy of Long-term Intermittent Azithromycin Therapy in Reducing the Frequency of Exacerbation in Severe COPD
Key Trials, Published on: 13 Jul 2021

This study evaluated efficacy of long-term intermittent azithromycin therapy in reducing the frequency of exacerbation in severe chronic obstructive pulmonary disease (COPD). Results showed that long-term intermittent azithromycin therapy was associated with significant reductions in acute exacerbations and was well tolerated.

Can Early-Life Indoor Microbial Diversity Increase the Risk of Allergic Rhinitis and Inhalant Atopy?
Key Trials, Published on: 13 Jul 2021

The findings of this study revealed that a higher indoor bacterial diversity in early life might lower the risk of allergic rhinitis later in childhood. This analysis demonstrates environment-dependent heterogeneity in the associations with inhalant atopy and suggests that specific constituents of the diversity might be relevant.

Efficacy and Safety of Topical Formulation of Minoxidil 5%+Finasteride 0.1% vs Minoxidil Alone in Adult Male Patients with Androgenetic Alopecia
Key Trials, Published on: 13 Jul 2021

The present study compared efficacy and safety of lipid based topical formulation of minoxidil and finasteride with minoxidil alone in patients with androgenetic alopecia. The study showed clinically significant improvement with combination in terms of hair growth as compared to minoxidil (5%) alone.

PEREAGAL Study: Efficacy and Safety of Perampanel as an Adjunctive to treat Focal-onset Seizures
Key Trials, Published on: 13 Jul 2021

Perampanel was an effective and safe add-on drug for treating patients with FOS, particularly those affected with FBTCS.

Efficacy and Safety of 3-day Azithromycin Treatment of Community Acquired Pneumonia in Patients with and Macrolide- Resistant Streptococcus pneumoniae Infection
Key Trials, Published on: 06 Jul 2021

This study evaluated efficacy and tolerability of a 3-day course of azithromycin in adults with mild to moderately severe community acquired pneumonia. The study showed that 3-day course of azithromycin is an effective first-line treatment for adults with mild to moderately severe community acquired pneumonia

As-needed Budesonide-Formoterol in Mild Asthma: Pooled Analysis of SYGMA Studies
Key Trials, Published on: 06 Jul 2021

Patients with mild asthma previously treated with short-acting β-agonists (SABA) alone and randomized to as-needed budesonide-formoterol had fewer severe exacerbations than those on twice daily budesonide. As-needed inhaled corticosteroid (ICS)-formoterol should be preferred to as-needed SABA alone in patients whose asthma is controlled on maintenance low-dose ICS. Both these low dose ICS therapies are associated with significant reduction in exacerbations and hence are safer than switching to SABA-only treatment.

Variable pH in Embryo Cultures
eCMEs, Published on: 06 Jul 2021

In his talk, doctor focusses on the importance of pH, various factors affecting pH, measuring right pH and what can happen if pH is wrong.

Role of Neuropeptides in Allergic Rhinoconjunctivitis, Allergic Rhinitis and Allergic Conjunctivitis
Key Trials, Published on: 05 Jul 2021

The neuropeptides especially the substance P (SP), vasoactive intestinal peptide (VIP) and calcitonin gene-related peptide (CGRP) play vital roles in the pathogenesis of allergic rhinoconjunctivitis (ARC). The nasal neurotransmitters and neuropeptides might have more important roles in allergic diseases than those of ocular origin.

SUMMACTA Trial: Long-term Efficacy and Safety of Subcutaneous Tocilizumab versus Intravenous Tocilizumab in Combination with Traditional DMARDs in Patients with RA
Key Trials, Published on: 02 Jul 2021

SUMMACTA Trial evaluated long-term efficacy and safety of subcutaneous tocilizumab versus intravenous TCZ, including switching formulations, in patients with rheumatoid arthritis (RA) and inadequate response to disease-modifying antirheumatic drugs. The study reported long term efficacy and sustained ACR responses with subcutaneous tocilizumab over 96 weeks.

Intravitreal Ranibizumab vs. Aflibercept for Wet AMD: The Impact of 3-yearTreat and Extend Protocol
Key Trials, Published on: 01 Jul 2021

This real-world study demonstrated that intravitreal ranibizumab injections improved the BCVA and CMT in patients with nAMD when administered using a treat and extend protocol for 3 years. The clinical benefits of ranibizumab were similar to that of intravitreal aflibercept.

HbA1c-A Marker of Subclinical Atherosclerosis in Asymptomatic Individuals
Key Trials, Published on: 01 Jul 2021

The study demonstrated that HbA1c levels are associated with SA. Routine use of HbA1c along with tradition CV risk factors can help in better identification of asymptomatic individuals at high risk of SA

Is Asthma a Premorbid Condition in Patients with Covid-19?
Key Trials, Published on: 30 Jun 2021

Asthma does not seem to be a potential premorbid condition in Covid-19 patients as per the findings of this systematic review. There is a possibility that the clinicians and researchers are not accurately describing the premorbid conditions in patients with COVID-19 and this could worsen the prognosis of Covid-19 patients.

Long-term Effectiveness and Tolerability of Perampanel in Epilepsy Patients
Key Trials, Published on: 28 Jun 2021

The study demonstrated perampanel to be effective and safe for adult and pediatric epilepsy patients. The effectiveness achieved at 12 months was maintained at 24 months and even at 36 and 48 months. 

Appropriate Usage of Colistin in Immunocompromised Patients – Current Scenario
Expert's Views, Published on: 24 Jun 2021

Dr. Sudipta talks on appropriate dosages for colistin, the last resort antibiotic in immunocompromised patients , in IV and nebulization and also highlights usage in current scenario.

Survival Outcomes with Darolutamide, Enzalutamide and Apalutamide in High-Risk Non-Metastatic Castration-Resistant Prostate Cancer
Key Trials, Published on: 24 Jun 2021

The current network meta-analysis (NMA) offers most mature and robust comparisons with respect to overall survival (OS) outcomes of treatment with darolutamide, enzalutamide and apalutamide in high-risk non-metastatic castration-resistant prostate cancer. Darolutamide demonstrated highest efficacy and safety as compared to the other 2 drugs. However, enzalutamide had the highest efficacy in patients with PSA-DT ≤ 6 months. Heterogeneity with respect to study design, maturity, cohort characteristics and follow-up duration should be considered in the interpretation of the current NMA.

Temperature Tolerance in Human Embryos
eCMEs, Published on: 24 Jun 2021

In her talk, doctor concentrates on temperature & temperature tolerance as a factor in the process of oocyte maturation, fertilization and embryo development. 

Osmolality: The Thirsty Human Embryo
eCMEs, Published on: 24 Jun 2021

In his talk, doctor briefs about the importance of osmolarity in IVF and the impact low or high osmolarity can have on the embryo.

The Prevalence of Atrial Fibrillation and its Treatment Vary Globally
Key Trials, Published on: 23 Jun 2021

The prevalence of AF varies widely across the global. Despite the high risk of stroke associated with AF, the use of antithrombotics is less common in countries with poorer income setting.

Safety and Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in People with HIV
Key Trials, Published on: 23 Jun 2021

The present study evaluated safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine in people with HIV (PLHIV) in a well characterised UK cohort. The study demonstrated that ChAdOx1 nCoV-19 vaccine given as prime-boost dosing given 4–6 weeks apart was well tolerated and produced equivalent immune responses in people living with HIV who are well controlled on ART compared with a similar adult population without HIV. These findings suggested that no dose adjustment is required in PLHIV on ART with CD4 counts >350 cells/µl.

Efficacy and Safety of Natural Micronized Progesterone Sustained Release Formulations in High-Risk Pregnancies
Key Trials, Published on: 18 Jun 2021

Long-term supplementation with oral natural micronized progesterone sustained release (NMP SR) formulations is effective and safe in high-risk pregnancies with risk factors for bad obstetric history or preterm birth. The preferred dose of NMP SR was 300 mg, initiated between 16 to 26 weeks and continued upto 34 weeks. Long-term supplementation with NMP SR was well tolerated with no adverse health outcomes.

NutriConnect – Signs & Symptoms during Pregnancy
Patient Education, Published on: 17 Jun 2021

This leaflet gives information about common signs and symptoms most women face during pregnancy, including, nausea, vomiting, acidity, constipation, dizziness, etc. and their management in a patient-friendly language.

NutriConnect – Self Care during Pregnancy
Patient Education, Published on: 17 Jun 2021

This leaflet gives information about what basic self-care one should follow and how, e.g. hygiene, sex, travel, work and weight gain in a patient-friendly language. 

NutriConnect – Nutrition during Pregnancy
Patient Education, Published on: 17 Jun 2021

This leaflet gives information about importance of nutrition and key nutrients before and during pregnancy as well as after delivery for the woman and her infant in a patient-friendly language.

NutriConnect – Medical Care during Pregnancy
Patient Education, Published on: 17 Jun 2021

This leaflet gives information about few health problems some women may experience during pregnancy, and few alert signs that call for immediate attention of the doctor, in a patient-friendly language. 

NutriConnect – Post-delivery Care
Patient Education, Published on: 16 Jun 2021

This leaflet gives information about key things to remember after delivery, such as breastfeeding, contraception, nutrition, exercise, follow-up visit and infant care.

NutriConnect – Exercise during Pregnancy
Patient Education, Published on: 16 Jun 2021

This leaflet gives information about benefits of, things-to-follow while and when to stop exercising during pregnancy. 

Cough and Types of Cough
Expert's Views, Published on: 16 Jun 2021

Expert views on cough in children; its types & assessment.

Efficacy of Laparoscopic Ureterolithotomy Might be Superior to Other Surgical Modalities in Treatment of Large Ureteric Stones
Key Trials, Published on: 16 Jun 2021

Laparoscopic ureterolithotomy (LUL) followed by percutaneous nephrolithotomy (PNL) demonstrated superior stone-free rates and lesser need for auxiliary procedures as compared to shock-wave lithotripsy (SWL) and ureteroscopy (URS) and seems to be the most effective surgical modality in the treatment of large upper ureteric stones.

AMBER and EMERALD Trial: 96-week Resistance Analysis of Once-daily Single Tablet Regimen of D/C/F/TAF in HIV-1 Adults Patients
Key Trials, Published on: 16 Jun 2021

The present study is a 96-week resistance analysis of AMBER and EMERALD trials, evaluating efficacy and safety of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in HIV -1 adults patients. The 96-week treatment with D/C/F/TAF once-daily single tablet regimen showed no treatment-emergent darunavir, primary PI or tenofovir RAMs were observed in the HIV-1 in   treatment-naïve and -experienced adults living with HIV-1.

CGM may Improve the Glycemic Control in T2DM Patients Treated with Basal Insulin
Key Trials, Published on: 15 Jun 2021

This study demonstrated that continuous glucose monitoring may improve glycemic control in type-2 diabetes mellitus patients treated with basal insulin without prandial insulin.

What are the Solutions to Tackle Forgetfulness in Clinical Practice?
Expert's Views, Published on: 14 Jun 2021

Dr Walke provides simple solutions such as printing pregnancy profile or format of pre-op investigations, flowcharts, etc. to tackle forgetfulness in clinical practice.

Why and How Should doctors Maintain Complete OPD Records of Every Patient with Themselves?
Expert's Views, Published on: 14 Jun 2021

Dr Walke talks about how maintaining OPD records can help in defending a case in favour of the doctor, if relevant.

From Medicolegal Point of View, Which Obstetric Emergencies are More Challenging and Why?
Expert's Views, Published on: 14 Jun 2021

Dr Walke talks about obstetric emergencies such as haemorrhage, amniotic fluid embolism, shoulder dystocia, birth injuries, sudden IUFD, etc. and the related medicolegal aspects.

Prolonging DAPT beyond 1 Year may be Effective and Safe in the ESC/EACT Guideline-endorsed High Thrombotic Risk Patients undergoing PCI
Key Trials, Published on: 14 Jun 2021

According to the findings of the study, prolonging DAPT beyond 1 year in ESC/EACTS guideline-endorsed high thrombotic risk patients, reduced the risk of MACCE without any increase in the risk of bleeding when compared with DAPT ≤1 year.

Effects of Smoking on Quality-of-life and Inflammatory Markers in Patients with Allergic Rhinitis
Key Trials, Published on: 14 Jun 2021

Smoking did not negatively impact the quality of life and atopic inflammatory markers in patients with allergic rhinitis (AR). The serum IL-33 levels were significantly lower in smokers as compared to non-smokers, which probably explains the lack of symptoms cautioning smokers of the harmful effects of smoking.

Effective Treatment of FC may Reduce the Burden of GERD in Children
Key Trials, Published on: 14 Jun 2021

The present study confirmed the frequent coexistence of GERD and FC in children. Appropriate treatment of FC may alleviate the symptoms of GERD in this patient population.

Preimplantation Genetic Screening in IVF – Centre Experience and What Data Says?
Expert's Views, Published on: 14 Jun 2021

Dr Patel provides efficacy and importance of PGT/PGS in IVF and shares her experience in conditions such as male factor, recurrent failure, miscarriage, advanced age, etc.

How does magnetic-activated cell sorting work to remove apoptotic spermatozoa?
Expert's Views, Published on: 14 Jun 2021

Dr Patel shares details of MACS, a technique routinely used in clinical immunology and haematology and its indications of use.

Case Report – Bone Marrow Derived Concentrate Injection in Uterine Artery of Spiral Arterioles For Thin Endometrium
Expert's Views, Published on: 14 Jun 2021

Dr Patel shares protocol of using PRP injection in case of refractory endometrium with a history of 3 failed IVF cycles 

What is the Role of Regenerative Medicine In Treatment Of Female Infertility?
Expert's Views, Published on: 14 Jun 2021

Dr Patel gives an inclusion and exclusion criteria as well as methods for ovarian rejuvenation, including her experience at the centre.

What Options Are Available to Improve IVF Success Rates in Poor Responders?
Expert's Views, Published on: 14 Jun 2021

Dr Patel gives options such as ACCUVIT protocol, changing the protocol, ovarian rejuvenation, donor eggs to treat poor responders.

What are Some Suggestions to Safeguard Oneself in Case of Instrumental Deliveries?
Expert's Views, Published on: 14 Jun 2021

Dr Walke provides suggestions such as taking consent, having a Neonatologist, documentation, etc. to safeguard oneself in case of instrumental deliveries.

What are Some Suggestions to Defend a Medicolegal Case of Obstetric Emergency?
Expert's Views, Published on: 14 Jun 2021

Dr Walke gives brief on how one can defend a medicolegal case of obstetric emergency by confirming stock of life saving drugs & their expiry, ensuring oxygen cylinder is full and equipment are checked, etc.

Effects of Indacaterol/Glycopyrronium on Lung Function and Cardiovascular Events in COPD – Results from a Meta-Analysis
Key Trials, Published on: 10 Jun 2021

Indacaterol/Glycopyrronium (IND/GLY) treatment was associated with lower incidence of acute exacerbations and slowed down the decline of FEV1. IND/GLY did not increase the incidence of adverse cardiovascular events and has an adequate safety profile.

Tenofovir Disoproxil Fumarate Therapy Might Increase Risks of Bone Loss and Renal Deficit as Compared to Entecavir in Patients with CHB
Key Trials, Published on: 09 Jun 2021

Treatment with tenofovir disoproxil fumarate (TDF) might be associated with increased risks of bone loss and renal deficits as compared to entecavir (ETV) in patients with chronic hepatitis B.

Exploring the Role of Salivary Pepsin A as a Marker for Gastroesophageal Reflux Episodes in Children undergoing Impedance Probe Monitoring
Key Trials, Published on: 08 Jun 2021

The study demonstrated that amongst children undergoing assessment for GER, presence of salivary pepsin A was associated with GER episodes even in presence of acid suppression.

Lamotrigine Safe and Effective as an Add-on Therapy for Treating Focal Epilepsy in Children and Adolescents
Key Trials, Published on: 08 Jun 2021

This systematic review and meta-analysis demonstrates lamotrigine to be safe and effective add-on therapy for treating focal epilepsy in children and adolescents.

Indacaterol/Glycopyrronium Superior to Salmeterol/Fluticasone in Current and Ex-Smoker Patients with COPD
Key Trials, Published on: 03 Jun 2021

Indacaterol/glycopyrronium (IND/GLY) demonstrated better efficacy with respect to lung function, health-related quality of life, dyspnea, rescue medication use and exacerbations in current smokers as well as ex-smokers as compared with salmeterol/fluticasone (SFC). The differences were generally more prominent in current smokers suggesting that smoking might decrease the effects of SFC.

AHA/ASA: Prevention of Stroke in Patients with Stroke and TIA (2021)
Guidelines, Published on: 03 Jun 2021
Comparative Efficacy of Procedure for Prolapse and Hemorrhoids vs Traditional Surgery for Outlet Obstructive Constipation
Key Trials, Published on: 02 Jun 2021

The present study compared the clinical efficacy of procedure for prolapse and hemorrhoids with traditional surgery for outlet obstructive constipation. The study results showed that procedure for prolapse and hemorrhoids is a better choice for treatment of outlet obstructive constipation caused by internal rectal prolapse with circumferential hemorrhoids when compared to the traditional surgery.

International Survey on GINA Strategy: ICS/Formoterol in Asthma Management
Key Trials, Published on: 02 Jun 2021

Most pulmonologists are up to date and understand the relevance of the changes in GINA reports from 2019 and are willing to include them in their clinical practice. Nevertheless, dissemination and implementation of GINA novel management strategy is still warranted.

Treatment with Mesalazine Improves Quality-of-Life Outcomes in Mild and Moderate Ulcerative Colitis
Key Trials, Published on: 02 Jun 2021

Treatment with delayed-release oral mesalazine resulted in significant clinical and statistical improvements in quality of life of patients with moderately and mildly active ulcerative colitis (UC) by 3 weeks, with further improvement at 6 weeks. Daily mesalazine dose did not predict QoL improvement. Patient’s clinical response to therapy was a predictor of improved QoL.

Large Volume Low Pressure Nasal Saline Combined with Fluticasone Propionate Effective in Pediatric Acute Rhinosinusitis
Key Trials, Published on: 27 May 2021

Large volume low pressure nasal saline irrigation (LVLP NSI) combined with fluticasone propionate (FP) was effective and could be a new line of therapy for the treatment of pediatric acute rhinosinusitis, either by itself or combined with standard therapy.

Global Initiative for Asthma (GINA) 2021 Update – Focus on Pediatric Asthma
Slide Library, Published on: 26 May 2021

Get to know recent updates in the Global Initiative for Asthma (GINA) 2021 guidelines for pediatric asthma, which has now recommended the use of formoterol/budesonide in children as maintenance and reliever therapy (MART)

Prophylactic Effect of Saccharomyces boulardii in the Prevention of Antibiotic-associated Diarrhoea
Key Trials, Published on: 26 May 2021

This study evaluated preventive effect of S. boulardii on antibiotic-associated diarrhoea development in patients with antibiotic-associated diarrhoea on antibiotic therapy. Results showed that Saccharomyces boulardii resulted in reduced antibiotic-associated diarrhoea in hospitalized patients.

GINA: Global Initiative for Asthma – Global Strategy for Asthma Management and Prevention: Guideline (2021)
Guidelines, Published on: 26 May 2021
High Pregnancy Rate with an Innovative Oral Formulation in the Treatment of Female Infertility – Indian Clinical Experience
Key Trials, Published on: 25 May 2021

A very high pregnancy rate of 71.1% was demonstrated by a novel formulation which could be a promising first-line oral treatment for female infertility.This innovative product contains standardized chasteberry extract, standardized green tea extract along with antioxidants, amino acids, vitamins and minerals.

Efficacy and Safety of Once Daily Fluticasone Propionate in Perennial Allergic Rhinitis
Key Trials, Published on: 21 May 2021

Fluticasone propionate aqueous nasal spray (FP ANS) 200 µg once daily in the morning is safe and effective therapy for perennial allergic rhinitis (AR). FP ANS 200 µg once daily is as effective as FP 100 µg twice daily or beclomethasone dipropionate 168 µg twice daily for the treatment of perennial AR.

Lacosamide-Effective and Safe for treating Children with Epilepsy
Key Trials, Published on: 20 May 2021

This study demonstrated lacosamide to be effective and safe in pediatric patients with epilepsy, resulting in substantial reduction in seizure frequency.

Sacral Neuromodulation Effective and Safe in Patients with Neurologic Lower Urinary Tract Dysfunctions
Key Trials, Published on: 19 May 2021

The findings of this meta-analysis demonstrate that permanent sacral neuromodulation (SNM) is not only beneficial in patients with various neurogenic lower urinary tract dysfunctions (nLUTDs) but also has high overall success rates, similar to idiopathic patients. SNM was found to be safe in such patients. However, prospective trials with more vigorous study designs and/or registries are warranted before definitive conclusions can be drawn.

NICE: Diagnosis and Management of Epilepsy (2021)
Guidelines, Published on: 19 May 2021
SGLT-2i as Compared with other Antidiabetic Drugs, does not Increase the Risk of Lower Limb Amputation in T2DM Patients
Key Trials, Published on: 18 May 2021

This large-scale study demonstrates no increased risk of lower limb amputation with SGLT-2i other antidiabetic drugs in T2DM patients. T2DM patients with PAD had an increased risk of amputation.

KDIGO: Management of Blood Pressure in CKD (2021)
Guidelines, Published on: 18 May 2021
OAC Treatment may be Clinically Beneficial in AF Patients with Concomitant Liver Disease
Key Trials, Published on: 17 May 2021

AF patients with concomitant LD have a high risk for major adverse events. Treatment with OAC in such patients is clinically beneficial.

CANVAS Program: Impact of Canagliflozin on CV and Renal Outcomes as per the Baseline Diuretic Use
Key Trials, Published on: 13 May 2021

This post hoc analysis of the CANVAS program demonstrated that T2DM patients using diuretics at baseline had greater reduction in the incidence of MACE when treated with canagliflozin.

Azithromycin plus Acetylcysteine for treating Chronic Otitis Media with Effusion in Children
Key Trials, Published on: 13 May 2021

The findings of the study suggest that the combination of an antibiotic and a bronchosecretolytic such as azithromycin and acetylcysteine may be useful in the treatment of chronic OME in pediatric patients.

Impact of Dorzolamide-Timolol vs. Brimonidine-Timolol on Retinal Vascular Autoregulation and Ocular Perfusion Pressure in Patients with POAG
Key Trials, Published on: 12 May 2021

The study demonstrated sOPP to be a determinant of RVD. Furthermore, treatment with D/T or B/T significantly improved RVA in POAG patients experiencing RVD while on timolol 0.5% alone.

Pharmacokinetics and Pharmacodynamics of Imipenem by Two-Step and Extended Infusions in Sepsis Patients
Key Trials, Published on: 12 May 2021

The pharmacokinetic/pharmacodynamic (PK/PD) parameters achieved in two-step and extended regimens of imipenem were comparable in the treatment of sepsis and septic shock.  A higher dose (1.0 g q8h) should be considered for target achievement at a minimum inhibitory concentration (MIC) of > 8 μg/ml.

 

Long-term Safety and Efficacy Data of Brivaracetam for the Treatment of Patients with Uncontrolled Epilepsy
Key Trials, Published on: 10 May 2021

This long-term study demonstrated safety and efficacy data of brivaracetam to be safe, effective and well-tolerated for treating focal or generalized onset seizures in patients with uncontrolled epilepsy.

Brivaracetam for treating Epilepsy: Real-world Data
Key Trials, Published on: 10 May 2021

This study provides real-world evidence on the efficacy and safety of brivaracetam in patients with different epilepsies.

Ensuring Pink of Health - Pre-pregnancy to Lactation
eCMEs, Published on: 06 May 2021

In his talk, doctor gives a perspective of iron deficiency anaemia burden in women, and especially the importance of nutrition, such as iron, folic acid, etc. from conception, through pregnancy, to lactation.

AHA: Adverse Pregnancy Outcomes and Cardiovascular Disease Risk (2021)
Guidelines, Published on: 06 May 2021
AHA: Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock (2021)
Guidelines, Published on: 06 May 2021
Benefits of Inhaled Budesonide in Early COVID-19 Infection: STOIC Study
Key Trials, Published on: 06 May 2021

This infographic summarises the key points of the STOIC study and outlines the benefits of administering inhaled budesonide in early COVID-19 infection.

 

Efficacy and Safety of Obeticholic Acid Therapy in Primary Biliary Cholangitis
Key Trials, Published on: 05 May 2021

The results obtained in the Poise trial on efficacy, safety and tolerability of obeticholic acid (OCA) can be reproduced in real-world conditions in patients with primary biliary cholangitis (PBC). Patients with cirrhosis had lower tolerability and might need optimization of pruritus control before starting OCA and during the treatment. OCA therapy might benefit patients with overlap PBC-autoimmune hepatitis (PBC-AIH), who demonstrated higher ALT reduction at 6 months compared with patients with pure PBC.

USPSTF: Screening for Hypertension in Adults (2021)
Guidelines, Published on: 05 May 2021
Prophylactic IC Moxifloxacin reduces the Incidence of Post-cataract Surgery Endophthalmitis: Results from an Indian Study
Key Trials, Published on: 04 May 2021

This Indian study demonstrated that prophylactic treatment with intracameral moxifloxacin reduced the incidence of post-cataract surgery endophthalmitis in rural Indian setting.

Biological Reconstruction Using Vascularized Fibula in Long Bone Tumours and Recalcitrant Osteomyelitis for Limb Salvage – Characteristics and Outcomes
eCMEs, Published on: 04 May 2021

In this video, the speaker has discussed cases relevant to long bone tumours.

Pathological Fractures- Common Presentation with Uncommon Disease
eCMEs, Published on: 04 May 2021

In this video, the speaker has discussed cases relevant to pathological fractures.

Metastasis - “The Wicked Weak Bone”
eCMEs, Published on: 04 May 2021

In this video, the speaker has discussed different theories of bone metastasis and associated complications along with relevant cases.

Osteoporotic Fractures – Case Presentations
eCMEs, Published on: 04 May 2021

In this video, the speakers have discussed the cases relevant to osteoporotic fractures.

All You Need to Know About Erlotinib
Patient Education, Published on: 03 May 2021

Erlotinib is a tyrosine kinase inhibitor indicated for Lung and Pancreatic cancer. This input describes Erlotinib administration & possible side effects.

Tips & Tricks in TKR
eCMEs, Published on: 03 May 2021

In this video, the speakers have discussed about patient selection for TKR, pre-operating planning, TKR in Valgus & Varus Knees, postoperative stiffness & patient dissatisfaction after TKR.

ANACO Study: Preoperative and Intraoperative Risk factors Contributing to AL and Postoperative Morbidity and Mortality After Colon Resection for Cancer
Key Trials, Published on: 30 Apr 2021

ANACO study identified preoperative and intraoperative risk factors contributing to anastomotic leak and postoperative morbidity and mortality after colon resection for cancer. The study found that preoperative nutritional status and the stapled technique were the risk factors were associated with clinically relevant anastomotic leak after elective right colectomy for cancer. Moreover, age of the patient, determines the risk of mortality, while the laparoscopic approach seems to reduce the postoperative morbidity.

Efficacy of Fractional Ablative Laser Followed by Immediate Topical 15% Vitamin C, 1.0% Vitamin E, and 0.5% Ferulic acid Serum in Patients Exhibiting Moderate Photodamage
Key Trials, Published on: 30 Apr 2021

The study evaluated the efficacy of a 15% Vitamin C, 1% Vitamin E, and 0.5% Ferulic acid serum in improving postoperative wound healing by evaluating the decrease in downtime and molecule markers, after the fractional ablative laser resurfacing procedure, in a photodamage split-face model .The study found that vitamin C, E, and ferulic acid correlated with the clinical effect of wound healing with a specific molecular mechanism of action. Moreover, it increased the clinical healing in patients during the initial days after the laser induced injury.

Efficacy of Fractional Ablative Laser Followed by Immediate Topical 15% Vitamin C, 1.0% Vitamin E, and 0.5% Ferulic acid Serum in Patients Exhibiting Moderate Photodamage
Key Trials, Published on: 30 Apr 2021

The study evaluated the efficacy of a 15% Vitamin C, 1% Vitamin E, and 0.5% Ferulic acid serum in improving postoperative wound healing by evaluating the decrease in downtime and molecule markers, after the fractional ablative laser resurfacing procedure, in a photodamage split-face model .The study found that vitamin C, E, and ferulic acid correlated with the clinical effect of wound healing with a specific molecular mechanism of action. Moreover, it increased the clinical healing in patients during the initial days after the laser induced injury.

CREDENCE: The Impact of Canagliflozin on HF and CV Death as per the Baseline Patient Characteristics
Key Trials, Published on: 29 Apr 2021

This sub-study of the CREDENCE trial demonstrates that the benefits of canagliflozin in terms of reduced risk of heart failure and cardiovascular death are consistent across broad range of patient subgroups.

Efficacy, Safety and Adherence to Treatment of Mupirocin verses Fusidic Acid in Primary Impetigo
Key Trials, Published on: 28 Apr 2021

This study compared efficacy and safety of 2% mupirocin ointment with   2% fusidic acid ointment in patient with primary impetigo. The study reported similar clinical success with mupirocin and fusidic acid in patients with primary impetigo.

Clinico-Epidemiological Pattern of Fungal Keratitis over Sixteen Years-The Indian Scenario
Key Trials, Published on: 28 Apr 2021

This large-scale and long-term Indian study provides valuable insights on the changing pattern of fungal species. The findings may improve the management of mycotic keratitis in India.

Gly/Form/Bud Triple Therapy Reduces All-Cause Mortality versus Dual Therapy in COPD: ETHOS Study
Key Trials, Published on: 27 Apr 2021

Triple therapy with budesonide/glycopyrrolate/formoterol fumarate (BGF) 320 resulted in reduction of all-cause mortality compared with glycopyrrolate/formoterol fumarate (GFF), in patients with moderate to severe COPD and a history of exacerbations. Triple therapy with BGF 320 lowered, but not significantly, the risk of death compared with budesonide/formoterol fumarate (BFF). There was no significant difference in the risk of death with triple therapy containing a lower dose of inhaled corticosteroid (BGF 160) versus the dual therapy comparators.

AHA: Obesity and Cardiovascular Diseases-A Scientific Statement (2021)
Guidelines, Published on: 27 Apr 2021
HERA Trial: Long-term Results of 1 year of Trastuzumab verses 2 years of Trastuzumab Treatment in HER2-positive Early Breast Cancer
Key Trials, Published on: 26 Apr 2021

HERA Trial compared the long-term outcomes of trastuzumab treatment for 1-year verses 2 -year in women with HER2-positive early breast cancer. The study showed that 1 year of adjuvant trastuzumab after chemotherapy for patients with HER2-positive early breast cancer significantly improved long-term disease-free survival.

Risk of Urosepsis in Patients Undergoing Ureteroscopy for Stone Disease
Key Trials, Published on: 26 Apr 2021

This meta-analysis demonstrated a 5% risk of postoperative urosepsis among patients undergoing ureteroscopy for treatment of stone disease. Older age, diabetes mellitus, ischemic heart disease, preoperative stent placement, a positive preoperative urine culture, and longer procedure time were independently associated with increased postoperative urosepsis risk. These findings will help the urologists with preoperative risk stratification before ureteroscopic procedures.

Current & Future Trends in Chronic Post-operative Pain Management
eCMEs, Published on: 26 Apr 2021

In this video, the speaker has discussed the approaches to reduce chronic postoperative pain in orthopedic surgeries.

Current & Future Trends in Acute Post-operative Pain Management
eCMEs, Published on: 26 Apr 2021

In this video, the speaker has discussed the approaches to reduce acute postoperative pain in orthopedic surgeries.In this video, the speaker has discussed the approaches to reduce acute postoperative pain in orthopedic surgeries.

Periprosthetic Fractures Around Knee & Hip (Case Presentation)
eCMEs, Published on: 26 Apr 2021

In this video, the speaker has discussed about the cases relevant to periprosthetic fractures around knee & Hip.

Lumbar Degenerative Disc Disease & Case Discussion
eCMEs, Published on: 26 Apr 2021

In this video, the speakers have discussed about all the aspects of lumbar degenerative disc disease such as symptoms, diagnosis, management, etc. with the help of relevant cases.

Gout Treatment- As Easy as it Seems?
eCMEs, Published on: 26 Apr 2021

In this video, the speakers have discussed about the various complications arising due to hyperuricemia focussing on renal and orthopaedic aspects.

Non-surgical Management of Young Osteoarthritic Knee
eCMEs, Published on: 26 Apr 2021

In this video, the speaker has discussed the evidences and recommendations relevant to Viscosupplementation and multimodal approach for osteoarthritis. 

Expectations of Doctors from Consumer Forum & Guidelines of Supreme Court While Handling the Medico-legal Cases
eCMEs, Published on: 26 Apr 2021

In this video, the speaker has discussed about expectations of a doctor from consumer forum and guidelines of supreme court while handling the medico-legal cases along with some relevant cases. 

Osteoprosis Treatment- When to Discontinue & Restart
eCMEs, Published on: 26 Apr 2021

In this video, the speaker has discussed about risks and benefits to be considered for osteoporosis treatment discontinuation and need of restart of therapy.

BRIVOLUTION Web Series: Episode 5 - Use of Brivaracetam (Case -based Approach)
eCMEs, Published on: 25 Apr 2021

Brivaracetam should be considered as an add-on therapy for partial epilepsy, uncontrolled on 2-3 antiepileptic drugs. And also, it should be use in patient with epilepsy having irritability, elderly diabetic & hypertensive with chronic renal failure. It is well tolerated with less behavioural side effects and minimal drug interaction. Provide effective seizure control and seizure freedom with improved quality of life in patients with partial epilepsy.

BRIVOLUTION Web Series: Episode 3 - Tackling Behavioral Issues with Anti-Epileptic Drugs
eCMEs, Published on: 25 Apr 2021

Brivaracetam has higher SV2A affinity and goes faster to brain. It has a good tolerability and safety and shows improvement in behavioral & psychiatric adverse events following the switch from levetiracetam to brivaracetam.

BRIVOLUTION Web Series: Episode 2 - International Clinicians Perspective on Brivaracetam
eCMEs, Published on: 25 Apr 2021

Brivaracetam has higher SV2A affinity and goes faster to brain. It has a good tolerability and retention rate 60-70% after 6 months. Improvement in psychobehavioral adverse events following the switch from levetiracetam to brivaracetam in about 60% cases. Provide effective seizure control and seizure freedom.

AIIMS/ ICMR-COVID-19 National Task Force/Joint Monitoring Group Ministry of Health & Family Welfare, Government of India: Clinical Guidance for Management of Adult COVID-19 Patients (22nd April 2021)
Guidelines, Published on: 23 Apr 2021

The Union health ministry on 22nd April 2021 issued a revised “Clinical Guidance for Management of Adult COVID-19 Patients”. This guideline issued by AIIMS, ICMR-COVID-19 National Task Force and the Joint Monitoring Group (DGHS) under the ministry discusses preventions and cures for all kinds of COVID-19 patients - mild, moderate and severe. It also advises on the usage of drugs which remain in high demand amid the COVID-19 pandemic.

ToGA Trial: Efficacy and Safety of Trastuzumab Added to Chemotherapy for First-line Treatment of Advanced Gastric or Gastro-oesophageal Junction Cancers with Overexpression of HER2
Key Trials, Published on: 23 Apr 2021

ToGA trial evaluated efficacy and safety of trastuzumab added to chemotherapy for first-line treatment of advanced gastric or gastro-oesophageal junction cancers with overexpression of HER2. The study showed that addition of trastuzumab to chemotherapy significantly improved overall survival compared with chemotherapy alone.

Rizatriptan-Effective and Safe for Treating Acute Migraine Attacks in Patients treated with Topiramate for Migraine Prophylaxis
Key Trials, Published on: 21 Apr 2021

The study demonstrated rizatriptan to be effective and safe treatment of acute migraine attacks in patients receiving prophylactic treatment with topiramate.

Montelukast Safe and Effective in Patients with Asthma and Allergic Rhinitis
Key Trials, Published on: 21 Apr 2021

Montelukast 10 mg is a safe and effective systemic treatment of both upper and lower airways in patients with both asthma and allergic rhinitis in a real-life setting.

BRIVOLUTION Web Series: Episode 1 - Indian Perspective on Brivaracetam
eCMEs, Published on: 21 Apr 2021

Brivaracetam should be considered as an add-on therapy for partial epilepsy, uncontrolled on 2-3 antiepileptic drugs. It is not associated with serious systemic adverse effects, well tolerated with less behavioural side effects and minimal drug interaction. Provide effective seizure control and seizure freedom with improved quality of life in patients with partial epilepsy.

 

CDC: Sexually Transmitted Infections Treatment Guidelines (2021)
Guidelines, Published on: 20 Apr 2021
Management of Open Fractures
eCMEs, Published on: 17 Apr 2021

In this video, the speaker has discussed about management of open fractures and relevant cases.

How Do You Solve the Problems of Intertrochanteric Fractures (Case Presentation)?
eCMEs, Published on: 17 Apr 2021

In this video, the speaker has discussed a case on PFN intertan for comminuted intertrochanteric fracture of femur.

Patient Presenting with Traumatic Vertebral Burst Fracture (Case Presentation)
eCMEs, Published on: 17 Apr 2021

In this video, the speaker has discussed a case on traumatic paraplegia with sphincter involvement.

TKA in Severe Deformities
eCMEs, Published on: 17 Apr 2021

In this video, the speaker has discussed about complications during TKA due to severe deformities and relevant cases.

After the Storm: Post-CoVID Complications
eCMEs, Published on: 12 Apr 2021

More than a crore of patients have recovered in India after new CoVID-19 infection. After recovery many complications in and outside lung are observed. This webcast is dedicated to an expert talks on how to tackle post CoVID complications.

 

Utility of C-Reactive Protein Based Protocol in the Duration of Antibiotic Therapy in Critically Ill Patients
Key Trials, Published on: 12 Apr 2021

A protocol based on daily monitoring of C-reactive protein levels may allow early interruption of antibiotic therapy in a higher proportion of critically ill patients, without an effect on total antibiotic consumption. However, more studies are warranted to assess the clinical and microbiological relevance of this finding.

 

AAN/PF: Dopaminergic Therapy for Motor Symptoms in Early Parkinson’s Disease (2021)
Guidelines, Published on: 11 Apr 2021
AAN: Oral and Topical Treatment of Painful Diabetic Polyneuropathy-Update Summary (2021)
Guidelines, Published on: 11 Apr 2021
AAN: Oral and Topical Treatment of Painful Diabetic Polyneuropathy-Update Summary (2021)
Guidelines, Published on: 11 Apr 2021
Tenofovir Alafenamide Fumarate Might be a Feasible Alternative in Chronic HBV Infected Patients Treated with Other Antiviral Drugs
Key Trials, Published on: 08 Apr 2021

Treatment with tenofovir alafenamide fumarate (TAF) was a feasible, well-tolerated, and safe alternative in chronic hepatitis B virus infected patients who are treated with tenofovir disoproxil fumarate, entecavir, lamivudine and adefovir. TAF was effective in maintaining significant viral suppression and higher alanine aminotransferase (ALT) and aspartate aminotransferase (AST) normalization rates 6 months after switching to TAF.

 

Safety Profile of As-needed Budesonide-Formoterol Comparable to Daily Budesonide in Mild Asthma
Key Trials, Published on: 08 Apr 2021

Safety analysis of SYGMA 1 and SGYMA 2 studies demonstrated that as-needed budesonide-formoterol anti-inflammatory reliever therapy was well-tolerated in patients with mild asthma with no new safety concerns. Budesonide-formoterol has a similar safety profile to that of daily budesonide.

Effects of Probiotic, Antibiotic or Combination on Intestinal Microbiota in Healthy Humans
Key Trials, Published on: 07 Apr 2021

The present randomized controlled trial conducted in healthy volunteers examined the effects of the probiotic Saccharomyces boulardii CNCM I-745 (SB), the antibiotic amoxicillin-clavulanate (AC) and the combination on the composition of healthy subjects’ microbiota and gut-related side effects associated with a commonly used antibiotic AC. The study showed that that antibiotic therapy with AC led to substantial alterations of the microbiota of healthy subjects.

 

Efficacy of AED in Children (Dr. V. Senthilkumar)
Expert's Views, Published on: 07 Apr 2021

Choice of an AED for the treatment of epilepsy in children depends on various aspects including efficacy, safety, impact on behavior and learning, and existing co-morbidities. Levetiracetam is an effective adjunctive therapy in treatment of childhood epilepsy and well tolerated with minimal side effects.

Optimizing Epilepsy Management (Dr. V. Senthilkumar)
Expert's Views, Published on: 07 Apr 2021

Management of epilepsy depends on various factors including comorbidity, type of seizure and concomitant medication. Proper diagnosis and management lead to improvement in 2/3rd of the epilepsy patients. Proper diagnosis includes identification of true seizure, identifying type of seizure and syndrome associated with it.

EMPA-REG OUTCOME: The Initial ‘eGFR Dip’ due to Empagliflozin does not affect its CV and Renal Benefits in T2DM Patients
Key Trials, Published on: 06 Apr 2021

This post hoc analysis of the EMPA REG OUTCOME trial demonstrated that although, SGLT-2 inhibitors are associated with an initial dip in eGFR in T2DM patients, this initial dip dose not impact the CV and renal benefits of SGLT-2 inhibitor treatment.

STAMPEDE Trial: 5 Year Follow-up Analysis of Bariatric Surgery and its Effects on Diabetes-related End-organ Disease
Key Trials, Published on: 05 Apr 2021

The present study is 5-year follow-up analysis of STAMPEDE Trial that studied the outcomes of bariatric surgery effects on diabetes – related endorgan disease. The study showed that bariatric surgery was superior to intensive medical therapy in terms of glycemic control, weight reduction, medication reduction, improvement in lipid levels, and quality of life.

 

As-Needed Budesonide-Formoterol Reduces Risk of Severe Exacerbation - Post hoc Analysis of SGYMA 1 Study
Key Trials, Published on: 05 Apr 2021

In mild asthma, even a single day with increased SABA use is an indicator for increased short-term risk of severe exacerbation. As-needed budesonide-formoterol is associated with a reduction in the short-term risk of severe exacerbations after a single day of higher use (more than two as-needed inhalations), even when overall use is infrequent. The frequency of exacerbations and subsequent risk of sever exacerbations and the need for oral corticosteroids is reduced with as-needed budesonide-formoterol as compared to as-needed SABA.

 

Managing Elderly Patients with Epilepsy (Dr. Neethi Arasu)
Expert's Views, Published on: 03 Apr 2021

Epilepsy occurs due to abnormal firing of neuron. In elderly it is associated with significant morbidity and mortality. Treatment in elderly is challenging as they are on multiple drugs. Hence the monotherapy AED treatment is recommended at low dose with drug having minimal drug interactions.

 

Safety Concerns of Current ART: Indian Perspective
eCMEs, Published on: 31 Mar 2021

Multiple New targets has been identified and targeted to disrupt the HIV-life cycle. Dolutegravir based regimens are currently the preferred first line ART in WHO guidelines. Cardiovascular, Renal, Diabetes, Neurocognitive effects, Cancers, and Liver disorders are the Non-AIDS causes of morbidity/mortality in India.

 

Better Symptom Relief with Fluticasone + Azelastine Nasal Spray than Fluticasone Alone in Persistent Allergic Rhinitis
Key Trials, Published on: 30 Mar 2021

The efficacy of both fluticasone propionate + azelastine nasal spray and fluticasone propionate nasal spray were comparable in relieving symptoms in patients with persistent allergic rhinitis. Fluticasone propionate and azelastine nasal spray resulted in significant reduction of symptoms such as nasal obstruction, nasal discharge and nasal itching when compared with fluticasone propionate alone.

 

Clinical Outcomes of Amoxicillin–Clavulanate for 5 Days Verses 10 Days in Children with Acute Otitis Media
Key Trials, Published on: 30 Mar 2021

This noninferiority trial evaluated whether antimicrobial treatment with amoxicillin–clavulanate for 5 days rather than using the standard 10-day regimen would result in   similar outcomes and reduce the risk of antimicrobial resistance among children with acute otitis media. The study showed that reduced duration treatment for 5 days was less effective than standard-duration treatment for 10 days in children 6 to 23 months of age with acute otitis media.

 

Clinical Outcomes of Amoxicillin–Clavulanate for 5 Days Verses 10 Days in Children with Acute Otitis Media
Key Trials, Published on: 30 Mar 2021

This noninferiority trial evaluated whether antimicrobial treatment with amoxicillin–clavulanate for 5 days rather than using the standard 10-day regimen would result in   similar outcomes and reduce the risk of antimicrobial resistance among children with acute otitis media. The study showed that reduced duration treatment for 5 days was less effective than standard-duration treatment for 10 days in children 6 to 23 months of age with acute otitis media.

 

ASCO: Management of Dyspnea in Advanced Cancer (2021)
Guidelines, Published on: 24 Mar 2021
EHA-ESMO : Multiple Myeloma: Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up (2021)
Guidelines, Published on: 24 Mar 2021
ESMO : Updated Treatment Recommendations for Hepatocellular Carcinoma (HCC) (2021)
Guidelines, Published on: 24 Mar 2021
ASCO : Chemotherapy in Combination with Radiotherapy for Definitive-intent Treatment of Stage II to IVA Nasopharyngeal Carcinoma (2021)
Guidelines, Published on: 24 Mar 2021
ASCO: Initial Management of Non-Castrate Advanced, Recurrent or Metastatic Prostate Cancer (2021)
Guidelines, Published on: 24 Mar 2021
Combined Effect of Levetiracetam and Lacosamide in Patients with Epilepsy
Key Trials, Published on: 24 Mar 2021

The study showed that combination of levetiracetam and lacosamide not only enhanced the therapeutic effectiveness for treating patients with partial refractory seizures, but also had improved retention rate and quality of life over a period of 6 months.

 

48-week Efficacy and Safety of Switching to Bictegravir/ Emtricitabine/Tenofovir alafenamide in Virologically Suppressed People Living with HIV aged > 65 years
Key Trials, Published on: 24 Mar 2021

The presents study evaluated efficacy and safety of switching older people with HIV to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF). The 48 weeks results showed that switching to B/F/TAF was effective and well tolerated through 48 weeks in virologically suppressed adults aged > 65 years

 

Luteal Phase Support in Assisted Reproductive Techniques: Findings from a Worldwide Web-based Survey
Key Trials, Published on: 24 Mar 2021

The results of the survey demonstrated vaginal administration as the preferred route for luteal phase support (LPS). The emerging use of the oral route confirms the expected shift in clinical practice as a result of recent evidence showing a reassuring safety score of oral progestins. There is a trend towards extended LPS in ART cycles with fresh embryo transfer despite the lack of evidence supporting the continuation of luteal support until 12 weeks' gestation, highlighting the difference between evidence-based medicine and real-life practices.  

 

The ARIC Study: Prevalence and Prognosis of Mitral Regurgitation in ADHF Patients
Key Trials, Published on: 23 Mar 2021

Patients hospitalized with ADHF are burdened with higher prevalence of MR. higher severity of MR was associated with an increased risk of 1-year mortality, particularly in patients with LVEF <50%

 

Overview of Escitalopram (Dr. Umang Kochhar)
Expert's Views, Published on: 23 Mar 2021

Escitalopram belongs to class of selective serotonin reuptake inhibitors. It is effective at lower dose compared to citalopram. Also,  has good efficacy which significantly improves the depressive symptoms with minimal drug interaction and better tolerability profile.

 

Novel Antibiotic Adjuvant Entity Might Be an Effective Empirical Therapy for Treating Nosocomial Infections
Key Trials, Published on: 21 Mar 2021

It can be concluded that the use of CSE 1034 of ceftriaxone, sulbactam, and ethylenediaminetetraacetic acid is an effective option for the treatment of MDR nosocomial infections including pneumonia and cUTI.

Treating Benzodiazepine Refractory Convulsive Status Epilepticus in Children: Levetiracetam vs. Fosphenytoin
Key Trials, Published on: 19 Mar 2021

This Indian study demonstrated levetiracetam to be an effective alternative to fosphenytoin for treating pediatric patients affected with benzodiazepine resistant status epilepticus.

Comparison of Omalizumab Biosimilar and Innovator in Moderate to Severe Persistent Asthma
Key Trials, Published on: 19 Mar 2021

There were no clinically meaningful differences in the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity between the first global biosimilar omalizumab and reference product. Omalizumab biosimilar might be a good alternative to reference product in patients with moderate to severe persistent asthma.

Fexofenadine Hydrochloride Effective in Ragweed-Induced Air Pollution-Aggravated Allergic Rhinitis
Key Trials, Published on: 19 Mar 2021

The ragweed-induced seasonal allergic symptoms were significantly aggravated by diesel exhaust particles (DEP). Fexofenadine HCl was well tolerated and effective in alleviating pollen-induced, air pollution-aggravated allergic rhinitis symptoms.

Local Salvage Therapies in Radiation Recurrent Prostate Cancer – Are they Beneficial?
Key Trials, Published on: 18 Mar 2021

Local salvage therapies after radiation recurrent prostate cancer (PCa) negatively impact the continence, lower urinary tract symptoms and sexual functions. Despite these adverse consequences, there are oncological benefits associated with use of local salvage therapy post radiation failure in select patients. The decision to use local salvage therapies should be made with the informed patient in a shared decision working process.

 

Zinc Supplementation Associated with Improved Treatment Outcomes in Children Hospitalized with Pneumonia
Key Trials, Published on: 15 Mar 2021

This first-of-its-kind study demonstrated the clinical benefits of zinc supplementation in children hospitalized for pneumonia. The findings suggest that zinc supplement be initiated in such patients irrespective of baseline zinc status.

 

Introduction to Heart Failure
eCMEs, Published on: 12 Mar 2021

Heart failure is a life - threatening disease. Incidence and prevalence rates of heart failure are rising due to population, epidemiological and health transitions. A significant proportion of this burden may be preventable with better screening, early identification and treatment of major risk factors.

 

Recombinant FSH and Urinary HMG - Optimizing their Use in COH Protocols
eCMEs, Published on: 11 Mar 2021

In his talk, the doctor shares clinical insights and published data on urinary and recombinant gonadotropins in IVF to help make individualized choices easier.

 

AHA: Management of Central Retinal Artery Occlusion (2021)
Guidelines, Published on: 11 Mar 2021
Improvements in APRI and GLOBE Score in Primary Biliary Cholangitis Patients with Obeticholic Acid
Key Trials, Published on: 11 Mar 2021

AST -to-platelet ratio index (APRI) and GLOBE score are useful in predicting the risk of liver-related complications in primary biliary cholangitis (PBC). Treatment with obeticholic acid reduces the risk of liver-related complications in patients with PBC.

 

The Golden Knee
eCMEs, Published on: 10 Mar 2021

In this video, the speaker has discussed diagnosis of metal allergy in patients undergoing joint replacement surgery and role of golden knee in the same.

SOE/IMI: Management of Myopia-An Update (2021)
Guidelines, Published on: 10 Mar 2021
Treating Functional Constipation in Children: PEG 3350 vs. Lactulose
Key Trials, Published on: 10 Mar 2021

The study demonstrated PEG 3350 to be better than lactulose for treating functional constipation in pediatric patients, including those aged below 2 years

 

Overuse of Short Acting β2-Agonists in Asthma in European Countries – Findings from SABINA Program
Key Trials, Published on: 10 Mar 2021

The analysis of this study from the SABINA program demonstrated that a significant proportion of asthmatic patients use at least three SABA canisters per year across Europe, despite the different healthcare and reimbursement policies of each country.

 

Treatment Response to Azithromycin Verses Ciprofloxacin in Uncomplicated Salmonella Typhi Infection
Key Trials, Published on: 09 Mar 2021

The present study evaluated treatment responses to ciprofloxacin and azithromycin following challenge with a fully sensitive strain of S. Typhi in healthy volunteers. The study showed that azithromycin effectively treated typhoid fever, however longer durations of bacteraemia and fever clearance times were observed when compared with ciprofloxacin treatment.

 

Safety and Efficacy of Mirabegron Compared to Antimuscarinics in Older Subjects with Overactive Bladder
Key Trials, Published on: 09 Mar 2021

The efficacy of mirabegron was similar to that of antimuscarinics among older adults with overactive bladder. Mirabegron had a favorable safety profile and the safety outcomes typically associated with anticholinergic burden, were less frequently observed in patients treated with mirabegron.

 

PROVE HF: Impact of Sacubitril/valsartan on Atrial Natriuretic Peptide in Patients with HFrEF
Key Trials, Published on: 04 Mar 2021

Amongst patients with HFrEF, sacubitril/valsartan treatment improved the ANP levels. Improvement in ANP levels in turn was associated with improved cardiac remodelling.

 

Role of MRA in CV protection
Expert's Views, Published on: 04 Mar 2021

Dr Aziz Khan talks about the role of MRA in cardiovascular protection

 

Case with long standing HTN diagnosed as HFpEF
Expert's Views, Published on: 04 Mar 2021

Dr Aziz Khan talks about the case with long standing hypertension diagnosed as HFpEF.

 

ACVIP: Recommended Immunization Schedule and Update on Immunization for Children Aged 0 Through 18 Years (2020-21)
Guidelines, Published on: 04 Mar 2021
The EPIC-Potsdam Study: Association of BMI and BMI Changes with Micro-and Macro-vascular Complications in T2DM
Key Trials, Published on: 04 Mar 2021

The study demonstrated a positive linear association between pre-diagnosis BMI and microvascular complications in patients with T2DM. The study further highlighted the importance of weight loss for lowering the risk of microvascular complications.

PRIDE: A Practical Guide on the Use of Inhaler Devices for Asthma and COPD (March 2021) by PURE Foundation
Guidelines, Published on: 04 Mar 2021
AAP: Recommendations for Preventive Pediatric Health (2021)
Guidelines, Published on: 04 Mar 2021
IHS: Health Technology Assessment for the Acute and Preventive Treatment of Migraine (2021)
Guidelines, Published on: 04 Mar 2021
NICE/BTS/SIGN: British Guideline on the Management of Asthma (2021)
Guidelines, Published on: 04 Mar 2021
Efficacy and Safety of Amoxicillin/Clavulanic Acid Compared to Clindamycin in Odontogenic Infections
Key Trials, Published on: 03 Mar 2021

The present study evaluated efficacy, safety, and tolerability of amoxicillin/clavulanic acid (875 mg/125 mg) and clindamycin (150mg) in the treatment of acute odontogenic infection with or without abscess. The study showed that amoxicillin/clavulanic acid administered twice daily for 5–7 days was found to be noninferior or “comparable” to clindamycin administered four times daily.

 

Overall Survival Outcomes with Lenvatinib versus Sorafenib as a First-line Treatment for Unresectable Hepatocellular Carcinoma
Key Trials, Published on: 03 Mar 2021

This is a phase 3 randomised, open-label, non-inferiority study comparing the efficacy and safety of lenvatinib versus sorafenib as a first-line treatment for unresectable hepatocellular carcinoma. The study showed that lenvatinib was non-inferior to sorafenib in terms of overall survival in untreated advanced hepatocellular carcinoma.

 

IDSA: Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections - Version 2 (2021)
Guidelines, Published on: 03 Mar 2021
NICE: Diagnosis, Monitoring and Chronic Asthma Management-An Update (2021)
Guidelines, Published on: 03 Mar 2021
AAO: Cataract in the Adult Eye-Preferred Practice Patterns (2021)
Guidelines, Published on: 03 Mar 2021
ADA/EASD: The Management of Type-1 Diabetes in Adults - A Consensus Report (2021)
Guidelines, Published on: 28 Feb 2021
ADA: Standard of Medical Care in Diabetes (2021)
Guidelines, Published on: 28 Feb 2021
Association Between Anaesthesia Depth and POCD Incidence at 7 days and 3 months Following Abdominal Surgery in Elderly Patients
Key Trials, Published on: 26 Feb 2021

This randomized controlled study evaluated the association between depth of anaesthesia and postoperative cognitive dysfunction  (POCD)  in elderly patients undergoing abdominal surgery . The study found that compared to light anaesthesia , deep anaesthesia under total intravenous anaesthesia was associated with a reduced incidence of short‐term POCD and decreased release of inflammatory cytokines in elderly patients undergoing abdominal surgery .

 

ALLHAT Study: Worsening of Kidney Function-A Major Contributor of HF Risk in Hypertensives
Key Trials, Published on: 26 Feb 2021

Worsening of kidney function is a major contributor towards the risk of HF in patients with hypertension. Choosing an antihypertensive that would prevent eGFR decline would cut down the risk of HF in such patients.

 

Efficacy of Early Azithromycin Administration in Prevention of Severe LRTI in Children
Key Trials, Published on: 25 Feb 2021

The present study evaluated early administration of azithromycin, started prior to the onset of severe lower respiratory tract illness (LRTI) symptoms, prevent the progression of these episodes in preschool children with severe intermittent wheezing in the context of RTIs. The study found that azithromycin started at the earliest signs of an RTI was effective in significantly reducing the risk of experiencing progression to severe LRTI along with reducing symptom severity during episodes of severe LRTI.

 

Impact of Oxcarbazepine and Levetiracetam Monotherapy on Intellectual and Cognitive Development in Children with BECTS
Key Trials, Published on: 25 Feb 2021

The study demonstrated oxcarbazepine and levetiracetam monotherapy to be effective in reducing seizure frequency in children with BECTS, though the former was more efficacious than the later. Oxcarbazepine also exhibited improvement in certain cognitive and intellectual parameters of the children.

Fluticasone + Azelastine Nasal Spray Provides Significant Symptom Relief in Allergic Rhinitis
Key Trials, Published on: 24 Feb 2021

The fluticasone propionate and azelastine hydrochloride combination nasal spray was clinically more effective in suppressing allergic rhinitis (AR) symptoms as compared to fluticasone alone.

 

Time in Range Inversely associated with All-cause and Cardiovascular Mortality in Patients with Type 2 Diabetes Mellitus
Key Trials, Published on: 23 Feb 2021

Lower TIR was associated with an increased risk of all-cause and CV mortality among patients with T2DM. TIR thus appears to be valid measure of glycemic control that may also serve as an indicator of adverse clinical outcomes in T2DM patients.

 

Management of Young Osteoarthritic Knee- Role of Viscosupplementation
eCMEs, Published on: 23 Feb 2021

In this video, the speaker has discussed role of Viscosupplementation in management of young osteoarthritis.

Diagnosis of Atypical Pneumonia
Expert's Views, Published on: 23 Feb 2021

Sometime, is becomes difficult to diagnose and treat the patients with atypical pneumonia. This session will talk on different methods and investigation to diagnose a case of atypical pneumonia.

 

How to Evaluate Patient Prognosis in Pneumonia?
Expert's Views, Published on: 23 Feb 2021

This session will help to understand, how to evaluate the prognosis of CAP patients in order to avoid further consequences and if needed change the treatment strategy.

 

Treatment of CAP
Expert's Views, Published on: 23 Feb 2021

Due to advancement in the medical science, we have many treatment modalities to treat the patient of CAP. This session will throw a light on various treatment strategies in order to cure the patients with CAP

 

Diagnosis of Pneumonia
Expert's Views, Published on: 23 Feb 2021

The diagnosis of CAP is mainly based on clinical findings and investigations to channelize the treatment protocol. This session will discuss various aspects of diagnosing a case of CAP.

 

Clinical manifestation of Pneumonia
Expert's Views, Published on: 23 Feb 2021

The patient of CAP comes with different signs and symptoms and many times it becomes difficult to curtailed down to one specific disease. This session will give insights on clinical manifestation of CAP.

 

Microbiology of Sputum in CAP
Expert's Views, Published on: 23 Feb 2021

There are different microorganisms which are causative for the development of CAP. This session will talk on such pathological organisms.

 

Definition, Epidemiology and Risk Factors of Pneumonia.
Expert's Views, Published on: 23 Feb 2021

This session will throw a light on prevalence of pneumonia in the community along with risk factors for the development of pneumonia

 

How to Investigate Patients of Respiratory Symptoms?
Expert's Views, Published on: 23 Feb 2021

This session will help to understand about various investigations needed  in order to diagnose different respiratory ailments.

IV Colistin vs. Combination of IV plus Inhaled Colistin in Critically Ill Children with MDR GNB-associated VAP
Key Trials, Published on: 17 Feb 2021

Amongst critically ill pediatric patients with MDR GNB-associated VAP, treatment with inhaled plus IV colistin yielded clinical and microbiological outcomes similar to that of colistin IV alone. Nevertheless, the former resulted in a shorter time to bacterial eradication.

 

BHIVA: Management of Tuberculosis in Adults Living with HIV (2021)
Guidelines, Published on: 17 Feb 2021
Safe and Effective Comprehensive Oral Therapy for Management of PCOS – An Indian Experience
Key Trials, Published on: 17 Feb 2021

The fixed-dose combination of myoinositol 550 mg, D-chiro-inositol 13.8 mg, L-methyl folate 0.1 mg, vitamin D3 400 IU and chromium picolinate 100 mcg as orange-flavoured chewable tablets, demonstrated a high ovulation and conception rate in PCOS women. The study product demonstrated significant decreases in serum testosterone and hirsutism, reduction in body mass index and increase in serum progesterone levels. This study product was well tolerated and could be considered as a promising first-line comprehensive oral management therapy for PCOS.

 

ORAL STRATEGY Study: Comparative Efficacy of Tofacitinib Monotherapy versus Tofacitinib in Combination with MTX in RA Patients with a Previous Inadequate Response to MTX
Key Trials, Published on: 16 Feb 2021

This is the first head-to-head non-inferiority comparison of tofacitinib monotherapy versus tofacitinib in combination with methotrexate in rheumatoid arthritis patients with a previous inadequate response to methotrexate. The study found that tofacitinib plus methotrexate was non-inferior to adalimumab plus methotrexate.

Long-Term Treatment with Rifaximin Reduces Rate of Hospitalization in Recurrent Hepatic Encephalopathy
Key Trials, Published on: 16 Feb 2021

Long-term treatment (≥24 months) with rifaximin 550 mg, twice daily was associated with reduced risk of hospitalizations in patients in remission from recurrent hepatic encephalopathy. Treatment with rifaximin for 24 months or longer was well tolerated and did not increase the rate of adverse events.

Managing Depression and Anxiety (Dr. Pradeep Yadav)
Expert's Views, Published on: 10 Feb 2021

Depression and anxiety disorder commonly occur together, and they have high severity of illness and significantly impair work functioning and quality of life. Generally, escitalopram, desvenlafaxine, sertraline are commonly utilized to manage depression and anxiety.

Optimizing Epilepsy Care with Appropriate AED Selection (Dr. V Neethi Arasu)
Expert's Views, Published on: 10 Feb 2021

Antiepileptic drugs are the mainstay treatment of epilepsy. Management of epilepsy depends on various factors including comorbidity, type of seizure and concomitant medication. Levetiracetam is a novel AED with wide safety profile is effective in diverse epilepsy. Lamotrigine is also commonly used AED because of better tolerability profile in partial and generalized epilepsy.

Managing Epilepsy in Women (Dr. Veena Kalra)
Expert's Views, Published on: 10 Feb 2021

AED used to treat women with epilepsy should have following criteria including it should be effective, should be broad spectrum and used in wide range of epilepsy, it should not interfere with hormonal balance and not induce ovarian changes. Most Commonly used drug in WWE is lamotrigine because of better tolerability and safety profile.

Efficacy of AED In Children (Dr. Vineet Bhushan Gupta)
Expert's Views, Published on: 10 Feb 2021

Levetiracetam is widely used in the treatment of several types of epilepsy. In children, LEV is approved for use of adjunct treatment for partial epilepsy and generalized tonic clonic. LEV has become an attractive choice because of its lack of hepatic metabolism, minimal drug interactions, activity against several seizure types.

Efficacy, Tolerability and Safety of Levetiracetam Monotherapy in Pediatric Epilepsy Patients
Key Trials, Published on: 10 Feb 2021

This study demonstrates levetiracetam monotherapy to be effective, tolerable and safe option for treating pediatric patients with focal and generalized seizures.

 

Gly/Form/Bud Triple Therapy is Clinically Beneficial in Patients with Moderate to Very Severe COPD
Key Trials, Published on: 10 Feb 2021

BGF MDI was efficacious, well tolerated, and could be a more appropriate treatment than the corresponding dual therapies for symptomatic patients with moderate to very severe COPD, irrespective of exacerbation history.

 

Results from Worldwide Survey on Luteal Phase Support in Assisted Reproductive Techniques
Key Trials, Published on: 10 Feb 2021

The results of this worldwide survey are encouraging as there is a clear shift towards a more unified and evidence-based clinical approach to LPS in IVF cycles, as compared to the earlier survey done in 2009. Although there is no firm evidence supporting the continuation of LPS after the demonstration of fetal heart-beat on ultrasound, this seems to be common practice to continue LPS for upto 10 weeks of gestation by the majority of assisted reproduction centres across the world.  

 

ASTRO : Guideline on Radiation Therapy for Rectal Cancer (2021)
Guidelines, Published on: 09 Feb 2021
ASCO : Initial Management of Non-Castrate Advanced, Recurrent or Metastatic Prostate Cancer (2021)
Guidelines, Published on: 09 Feb 2021
EMPA-REG OUTCOME: Impact of Empagliflozin on CV Outcomes as per Baseline LDL-C Levels
Key Trials, Published on: 09 Feb 2021

This post hoc analysis of the EMPA REG OUTCOME demonstrated consistent cardiovascular benefits of empagliflozin, independent of baseline LDL-C levels.

Is Electromyographic Biofeedback Plus Pelvic Floor Muscle Training Beneficial in Women with Urinary Incontinence?
Key Trials, Published on: 09 Feb 2021

This study did not demonstrate any clinically significant benefits in the severity of urinary incontinence at 24 months between women randomized to electromyographic biofeedback pelvic floor muscle training (PFMT) or to PFMT alone. Routine use of electromyographic biofeedback with PFMT for women with stress or mixed urinary incontinence should not be recommended as it did not confer any additional benefit.

Efficacy and Safety of Lenvatinib in Patients with Iodine 131-refractory Thyroid Cancer
Key Trials, Published on: 05 Feb 2021

The present study evaluated progression-free survival among patients with iodine-131–refractory thyroid cancer who received lenvatinib as compared with those who received placebo. The study showed significant improvements in progression-free survival and the response rate among patients receiving lenvatinib.

 

A Breath of Fresh Air in OAD: New Frontiers in Preventing Exacerbations in OAD
eCMEs, Published on: 05 Feb 2021

This symposium focuses on exacerbation prevention as an important goal in obstructive airways disease management, with a reality check on the burden of OADs in India and how these can be overcome with novel therapeutic options.

 

Managing Epilepsy in Adults: Tips & Tricks (Dr. Supreeth CS)
Expert's Views, Published on: 05 Feb 2021

Epilepsy is a group of disorder characterized by two or more unprovoked seizures. Levetiracetam is a newer AED with wide safety margin and minimal interactions with other antiepileptics. Also, it increases the rates of seizure freedom, has significant higher retention rate and is generally well tolerated compared to traditional AED.

Managing Depression and Anxiety (Dr. Tanu Singh)
Expert's Views, Published on: 05 Feb 2021

Major depressive disorder is severe mood disorder associated with significant morbidity and mortality. SSRIs are commonly utilized to manage depression and anxiety. Escitalopram as an antidepressant has good efficacy which significantly improves the depressive symptoms with minimal drug interaction with better tolerability profile.

Benefits of Triptan On QOL (Dr. Varghese Pallan)
Expert's Views, Published on: 05 Feb 2021

Migraine is a chronic neurological disorder, typical symptoms includes throbbing or pulsatile headache with moderate to severe pain that intensifies with movement or physical activity. Rizatriptan is commonly used in treatment of migraine and is associated with a higher degree of patient satisfaction than other migraine-specific agents, with rapid pain relief, ease and tolerability being important reasons for patient preference. The treatment also results in overall improvement in Quality of life.

Optimizing Depression Management (Dr Subhendu Dhar)
Expert's Views, Published on: 05 Feb 2021

Major depressive disorder is severe mood disorder with symptoms of low mood, less self-esteem, weight changes and is associated with significant morbidity and mortality. Escitalopram as an antidepressant has good efficacy which significantly improves the depressive symptoms with minimal drug interaction and good tolerability profile.

An Important AED to Optimize Epilepsy Management (Dr. Rajender Singla)
Expert's Views, Published on: 05 Feb 2021

Lacosamide enhances the slow inactivation of voltage-gated sodium channels resulting in the stabilization of hyperexcitable neuronal membranes. Add on lacosamide provides effective seizure control and is generally well tolerated when used as a first add on therapy across a broad age range of AEDs.

Optimizing Epilepsy Care with Appropriate AED Selection (Dr. Souvagya Panigrahi)
Expert's Views, Published on: 05 Feb 2021

Antiepileptic drugs are the mainstay treatment of epilepsy. Levetiracetam is a novel AED with wide safety profile and minimal drug interactions. Also, it has significantly higher retention rate and better seizure control compared to traditional AED.

Epilepsy Management (Dr. Sisir Das)
Expert's Views, Published on: 05 Feb 2021

Levetiracetam is a newer AED with wide safety margin and minimal interactions with other antiepileptics. It increases the rates of seizure freedom and is generally well tolerated. Also, has significantly higher retention rate and better seizure control compared to traditional AED.

Managing Epilepsy in Adults: Tips & Tricks (Dr. Shaji KR)
Expert's Views, Published on: 05 Feb 2021

Epilepsy is common neurological disorder and the most common cause includes brain pathology ex: tumour, stroke, haemorrhage or infection or metabolic disorder. AED are the mainstay of epilepsy management. Commonly used drugs include levetiracetam, phenobarbitone, lamotrigine. Levetiracetam is effective in diverse epilepsies, and the evidence shows that it increases the rates of seizure freedom and well tolerated without major adverse effects.

 

Optimizing Management in Epilepsy (Dr. Rajesh Kumar Singh)
Expert's Views, Published on: 04 Feb 2021

Lacosamide enhances the slow inactivation of voltage-gated sodium channels resulting in the stabilization of hyperexcitable neuronal membranes. Add on lacosamide provides effective seizure control and is generally well tolerated when used as a first add on therapy across a broad age range of AEDs.

Optimizing Epilepsy Care with Appropriate AED Selection (Dr. Ravindra Patil)
Expert's Views, Published on: 04 Feb 2021

Management of epilepsy depends on various factors including comorbidity, type of seizure and concomitant medication. Levetiracetam is effective in diverse epilepsies, and the evidence shows that it increases the rates of seizure freedom and well tolerated without major adverse effects. Also, has significantly higher retention rate and better seizure control compared to traditional AED.

Optimizing Epilepsy Care (Dr. Piyush Barlota)
Expert's Views, Published on: 04 Feb 2021

Epilepsy is common neurological disorder associated with unprovoked seizure. Antiepileptic drugs are the mainstay treatment of epilepsy. Lacosamide enhances the slow inactivation of voltage-gated sodium channels resulting in the stabilization of hyperexcitable neuronal membranes. Add on lacosamide provides effective seizure control and is generally well tolerated

Choosing an Appropriate Monotherapy to Optimize Epilepsy Care (Dr. Neeraj Baheti)
Expert's Views, Published on: 04 Feb 2021

Lacosamide is a third generation AED which enhances the slow inactivation of voltage-gated sodium channels resulting in the stabilization of hyperexcitable neuronal membranes. Add on lacosamide provides effective seizure control, minimal drug interaction and is generally well tolerated.

Optimizing Epilepsy Care with Appropriate AED Selection (Dr. Kumar NM)
Expert's Views, Published on: 04 Feb 2021

Epilepsy is a group of disorder characterized by two or more unprovoked seizures. Levetiracetam, carbamazepine and lamotrigine are commonly used in pregnant women with epilepsy because of its minimal effect on fetus and minimal fetal malformations compared to other AEDs.

Managing Depression and Comorbid Anxiety (Dr. Jyotirmoy Das)
Expert's Views, Published on: 04 Feb 2021

Depression and anxiety disorder commonly occur together, and they have high severity of illness and significantly impair work functioning and quality of life. The major cause of depression and anxiety is low level of serotonin. Generally, SSRI such as escitalopram, desvenlafaxine are commonly used to manage depression and anxiety.

Managing Depression with Comorbid Hypertension (Dr. Lokesh Babu)
Expert's Views, Published on: 04 Feb 2021

Depression is a severe mood disorder associated with significant morbidity and mortality. Worldwide, 17% of people are likely to experience major depression during their lifetime; especially prevalent in patients with cardiovascular disorders. Treatment with escitalopram decreases heart rate, improve sleep quality, and decrease blood pressure and is an effective option in patients with depression and comorbid hypertension.

Epilepsy Management (Dr. RV Narayana)
Expert's Views, Published on: 04 Feb 2021

Epilepsy is a neurological disorder characterized by unprovoked seizures. The causes of epilepsy includes injuries, infections metabolic disorder, stroke or traumatic brain injury. Commonly used AED in practice are phenobarbitone, levetiracetam, lamotrigine and lacosamide.

Tailoring Contraceptive Choices for Women
eCMEs, Published on: 03 Feb 2021

The doctor talks about various modes of contraception currently available in India and the importance of tailoring these options, based on woman’s profile, context and method profile, to improve the chances of adherence.  

 

Abortion Law and its Practice in India
eCMEs, Published on: 03 Feb 2021

The doctor sheds light on some alarming statistics related to abortion and what the IPC, MTP and POCSO act mention in their rules and regulations regarding the same.

 

Sacubitril/Valsartan Treatment in Patients with HFrEF with and without Diabetes-Impact on Reverse Cardiac Remodeling
Key Trials, Published on: 03 Feb 2021

This post hoc analysis of PROVE-HF study demonstrated benefits of sacubitril/valsartan in terms of reverse cardiac remodelling and improved NT-proBNP and health status in patients with heart failure and reduced ejection fraction. Benefits of treatment were consistent in patients with and without diabetes.

Optimizing Epilepsy Care with Appropriate AED Selection (Dr. Uday Bhaumik)
Expert's Views, Published on: 03 Feb 2021

Epilepsy is a group of disorder characterized by two or more unprovoked seizures. Levetiracetam is a novel AED with wide safety margin and minimal interactions with other antiepileptics. It increases the rates of seizure freedom and is generally well tolerated. It also has significantly higher retention rate and better seizure control compared to traditional AED.

Optimizing Epilepsy Care with Appropriate AED Selection (Dr. Tarun Mathur)
Expert's Views, Published on: 03 Feb 2021

Epilepsy is a group of disorder characterized by two or more unprovoked seizures. Levetiracetam is a novel AED with wide safety margin and minimal interactions with other antiepileptics. It increases the rates of seizure freedom and is generally well tolerated. It also has significantly higher retention rate and better seizure control compared to traditional AED.

Managing Women with Epilepsy (Dr. Ghanata Srinivas)
Expert's Views, Published on: 03 Feb 2021

Epilepsy is a group of disorder characterized by unprovoked seizures. Lamotrigine is an important AED in treatment of epilepsy as it has broad efficacy, long term effectiveness, well tolerable and favourable pharmacokinetics properties. It is commonly used AED in pregnant women because of its minimal effect on foetus and minimal foetal malformations compared to other AEDs

Managing Depression and Anxiety (Dr. Pawan Adatia)
Expert's Views, Published on: 01 Feb 2021

Depression and anxiety are common comorbid condition, with 35-60% of patients with depression having an anxiety disorder. They have high severity of illness and significantly impair work functioning and quality of life. Escitalopram, desvenlafaxine, sertraline are commonly utilized to manage depression and anxiety.

Efficacy and Safety of AED in Bipolar Disorder (Dr. Mayur Muthe)
Expert's Views, Published on: 01 Feb 2021

Bipolar disorder is a chronic mental disorder with repetitive cycles of mania/hypomania as well as depressive episodes. Lamotrigine is an effective option for the management of bipolar disorder, most significantly for its role in the prophylaxis of mood episodes and it is relatively safe and effective option for maintenance treatment in women with bipolar disorder and also effective in long term therapy.

 

Benefits of Early Use of Triptans (Dr. Vikas Bhardwaj)
Expert's Views, Published on: 01 Feb 2021

Rizatriptan shows the quickest onset of action, with high efficacy levels at two hours. Also, its efficacy is improved with early use during migraine attacks. It is associated with a higher degree of patient satisfaction than other migraine-specific agents, with rapid pain relief, ease and tolerability being important reasons for patient preference.

Management of Hyperandrogenism in PCOS
eCMEs, Published on: 01 Feb 2021

In his talk, the doctor briefs on the hyperperandrogenism aspect of PCOS, and the established efficacy of OCPs in its management.

 

Significantly Low Serum Ferritin and Vitamin D Levels in Patients with Diffuse Hair Loss
Key Trials, Published on: 01 Feb 2021

The present study evaluated serum levels of ferritin, folate, vitamin B12, zinc, thyroid-stimulating hormone and vitamin D in patients complaining of diffuse hair loss. The study found that serum ferritin and vitamin D levels in patients with diffuse hair loss were significantly low compared to healthy individuals.

 

PROVE HF: Impact of Sacubitril/Valsartan Initiation on Health Status in Patients with HFrEF
Key Trials, Published on: 01 Feb 2021

This secondary analysis of the PROVE HF trial demonstrated that initiation of sacubitril/valsartan treatment in HFrEF patients was associated with a rapid improvement of the KCCQ-23 scores; which in turn correlated with NT-proBNP levels.

 

Benefits of Adding Leukotriene Receptor Antagonist to Anti-Histamine in Allergic Rhinitis
Key Trials, Published on: 01 Feb 2021

The antihistamine-leukotriene receptor antagonist (AH-LTRA) combination therapy resulted in greater beneficial effects on composite nasal symptoms, rhinorrhea, and sneezing compared to AH alone in patients with allergic rhinitis (AR). Patients with perennial AR were most responsive to AH-LTRA.

 

Nasal Saline Irrigation Safe and Effective in Children with Allergic Rhinitis and Asthma
Key Trials, Published on: 01 Feb 2021

Bronchial hyperresponsiveness, asthma control status and quality of life improved after 12 weeks treatment with nasal saline irrigation (NSI) in children with allergic rhinitis and asthma. NSI seems to be a promising adjunctive option as it is a safe, simple and effective procedure.

 

Intravenous Colistin Effective and Safe in Very Low Birth Weight Preterm Infants
Key Trials, Published on: 01 Feb 2021

Colistin appeared to be effective and safe in very low birth weight infants affected with methicillin-drug resistant gram negative bacteria. Such patients may require close monitoring of renal function and electrolytes while on colistin treatment.

 

Efficacy and Safety of Gly/Form/Bud Triple Therapy versus Dual Therapy in COPD
Key Trials, Published on: 27 Jan 2021

Triple therapy with budesonide, glycopyrrolate, and formoterol was associated with a lower rate of moderate or severe COPD exacerbations and better health-related quality of life than dual therapy with glycopyrrolate–formoterol or budesonide–formoterol. 

 

Optimizing Epilepsy Care (Dr. Sunil Kumar Patra)
Expert's Views, Published on: 27 Jan 2021

Levetiracetam is a novel AED with wide safety margin and minimal interactions with other antiepileptics. It is effective in diverse epilepsies, and the evidence shows that it increases the rates of seizure freedom and well tolerated without major adverse effects.

Latest Updates in Neurosurgery (Dr. Kapil Jain)
Expert's Views, Published on: 27 Jan 2021

Radiosurgery is precisely focused radiation beams to treat tumors and other problems in the brain, spine and other parts of the body and reduces side effects also. Laser interstitial thermal therapy is an adjuvant treatment for intracranial lesions that are treatment refractory or in deep or eloquent brain.

Managing Depression (Dr. Juzer Ali)
Expert's Views, Published on: 27 Jan 2021

Depression is major mood disorder with low mood, insomnia/hypersomnia, loss of energy, weight loss lasting for more than 2 weeks. Physical, psychotherapy and pharmacotherapy are three major categories of management of depression. SSRI and SNRI are mainstay of depression management.

Migraine Management (Dr. Jeeban Pratik Khatua)
Expert's Views, Published on: 27 Jan 2021

Migraine is common neurological disorder occurring in different phases including prodrome, aura, headache and postdrome phase. Triptans is 5HT 1B/1D receptor agonist which causes cerebral vasoconstriction and reduces pain which can be given by nasal, oral and subcutaneous route. Rizatriptan and Zolmitriptan shows the quickest onset of action, with high efficacy levels at two hours

Managing Depression and Anxiety (Dr. Ganesh Prasad Mudraje)
Expert's Views, Published on: 27 Jan 2021

Depression and anxiety are common comorbid condition, with 35-60% of patients with depression having an anxiety disorder. Escitalopram monotherapy and in combination with clonazepam has good antidepressant effect which significantly improves depressive symptoms and has good tolerability profile in managing depression patients with comorbid anxiety

Managing Depression and Anxiety (Dr. PK Srivastava)
Expert's Views, Published on: 27 Jan 2021

Depression and anxiety disorder commonly occur together, and they have high severity of illness and significantly impair work functioning and quality of life. Generally, escitalopram, desvenlafaxine, sertraline are commonly utilized to manage depression and anxiety

Epilepsy Management (Dr. Sumanto Chatterjee)
Expert's Views, Published on: 27 Jan 2021

Epilepsy is neurological disorder characterized by unprovoked seizure and are divided into focal and generalized epilepsy. It significantly reduces the quality of life. Patients with status epilepticus are primarily treated with benzodiazepine, post that treated with phenytoin, fosphenytoin, levetiracetam or IV midazolam if the seizure are not controlled.

Lamotrigine vs. Oxcarbazepine in Combination with Escitalopram in Patients with Co-existing Epilepsy and Depression
Key Trials, Published on: 27 Jan 2021

This study evaluated the antidepressant effect of lamotrigine vs. oxcarbazepine when combined with escitalopram in patients with co-existing epilepsy and depression. The study also evaluated the impact of both the combinations on the quality of life of the patients.

 

Managing Depression with Comorbid Diabetes (Dr. Narender Pruthi)
Expert's Views, Published on: 27 Jan 2021

Diabetes mellitus and depression are major public health issues and depression was associated with a 60% increase of type 2 diabetes while type 2 diabetes was associated with 15% risk of depression. Escitalopram is effective in terms of controlling symptoms of depression without any adverse impact on glycemic parameters when used in depression patients with diabetes mellitus.

Optimizing Management in Parkinson’s Disease (Dr. Mitalee Kar)
Expert's Views, Published on: 27 Jan 2021

PD is a devastating disorder of the human nervous system and the second most common progressive chronic neurodegenerative disease. Amantadine has an effective antiparkinsonian effect and is well-tolerated. It appears to improve dyskinesias, also has a mild benefit on the motor symptoms of PD. It is an effective agent both in early and advanced PD.

Managing Epilepsy in Pregnant Women (Dr. Joseph Sebastian)
Expert's Views, Published on: 27 Jan 2021

Lamotrigine is an important AED in treatment of epilepsy as especially in women with epilepsy it has broad efficacy, long term effectiveness, well tolerable and lack of cognitive impairment. It can be an ideal AED in pregnant women because of its minimal effect on fetus and minimal fetal malformations compared to other AEDs.

Management of Depression and Anxiety (Dr. K. R. Venkatesh)
Expert's Views, Published on: 27 Jan 2021

Depression and anxiety are common comorbid condition, with 35-60% of patients with depression having an anxiety disorder. Escitalopram monotherapy and in combination with clonazepam has good antidepressant effects which significantly improves depressive symptoms and has good tolerability profile in managing depression patients with comorbid anxiety.

Role of Triptans in Migraine Management (Dr. Vandana Arora)
Expert's Views, Published on: 27 Jan 2021

Migraine is common neurological disorder occurring in different phases including prodrome, aura, headache and postdrome phase. Triptans is 5HT 1B/1D receptor agonist which causes cerebral vasoconstriction and reduces pain which can be given by nasal, oral and subcutaneous route. Commonly used triptans are rizatriptan, sumatriptan and zolmitriptan.

Choosing the Right Antipsychotic for Schizophrenia Patients (Dr. Rahul Chandhok)
Expert's Views, Published on: 27 Jan 2021

Schizophrenia is a serious lifelong disorder affecting behaviour, thought and cognition. Psychosocial rehabilitation is important for independent level of optimal functioning & better Quality of life. The 2nd generation antipsychotics such as olanzapine, risperidone, Amisulpride are commonly used drug as they reduce both negative and positive symptoms of schizophrenia with better tolerability profile.

Management of Depression and Anxiety (Dr. A. M. Nagesh)
Expert's Views, Published on: 27 Jan 2021

Depression and anxiety disorder commonly occur together, and they have high severity of illness and significantly impair work functioning and quality of life. Generally, escitalopram, desvenlafaxine, sertraline are commonly utilized to manage depression and anxiety.

Optimizing Epilepsy Care with Appropriate AED Selection (Dr. S. Murugesan)
Expert's Views, Published on: 27 Jan 2021

Epilepsy is common chronic neurological disease characterized by unprovoked seizure. Levetiracetam is a novel AED with wide safety profile with minimal drug interactions. Also, has significantly higher retention rate in patients and better seizure control compared to traditional AED.

Challenges in Neurosurgery (Dr. Darpan Thakre)
Expert's Views, Published on: 27 Jan 2021

Challenges in neurosurgery includes maintaining a modern, efficient, and responsive educational program for neurosurgery; the challenge of maintaining the boundaries of neurosurgical practice and preventing the incursion of subspecialty groups into the performance of neurosurgical procedures. Social stigma about the neurological disease leads to poor access to neurosurgical procedure.

Managing Depression (Dr. Daljeet Singh Ranawat)
Expert's Views, Published on: 27 Jan 2021

Major depressive disorder is severe mood disorder associated with significant low mood for more than 2 weeks. Depression can be managed both by psychotherapy and pharmacotherapy. Psychotherapy involves cognitive behavioural therapy. Pharmacotherapy includes use of various antidepressants such as selective serotonin receptor inhibitors and tricyclic antidepressants.

Optimizing Migraine Management (Dr. C. Preetham Reddy)
Expert's Views, Published on: 27 Jan 2021

Migraine is a chronic neurological disorder with pulsatile headache of moderate to severe intensity. Rrizatriptan and Zolmitriptan shows the quickest onset of action, with high efficacy levels at two hours also its efficacy is improved with an early use within migraine attacks. They are associated with a higher degree of patient satisfaction, with rapid pain relief, ease and better tolerability

Role of Inositols in PCOS Management
eCMEs, Published on: 25 Jan 2021

In his talk, the doctor elaborates on the rising burden of insulin resistance and the associated hyperinsulinemia in PCOS, and thereby highlights the role of myoinositol and d-chiroinositol in its management.

Rapid Progression of CKD in T2DM
Key Trials, Published on: 21 Jan 2021

A substantial proportion of type-2 diabetes mellitus with chronic kidney disease (CKD) have a rapid progression of CKD. Prompt identification of this high-risk subgroup is critical to address their unmet therapeutic needs.

Efficacy of Reduced Doses of both TDF and EFV for the Treatment of HIV-1 Infection
Key Trials, Published on: 21 Jan 2021

This study is the first randomized, controlled trial in an antiretroviral-naive population that evaluated the efficacy of reduced doses of both tenofovir disoproxil fumarate (TDF) and efavirenz (EFV) for the treatment of HIV-1 infection. This 48-week study showed that lower doses regimen of both TDF and EFV was non-inferior to the standard dose regimen of TDF 300 mg plus lamivudine (3TC) 300 mg, and EFV 600 mg.

 

Efficacy of E-VAC Therapy as Rescue Treatment in Refractory Anastomotic Leak and Perforation after Gastro-esophageal Surgery
Key Trials, Published on: 21 Jan 2021

The present study describes the outcomes of endoscopic vacuum therapy (E-VAC) as a rescue treatment in refractory anastomotic leak and perforation after gastro-oesophagal surgery. The study reported complete healing of the leak/perforation, without the need for further treatments suggesting E-VAC therapy as a safe option for leak management.

 

Intravesical BCG Immunotherapy for High-Risk Non-Muscle Invasive Bladder Cancer
Key Trials, Published on: 21 Jan 2021

Radical Cystectomy compared to intravesical BCG immunotherapy for high-risk Non-Muscle Invasive Bladder Cancer – is there a long-term survival difference?

 

Managing Depression with Comorbid Hypertension (Dr. S. Gojendro Singh)
Expert's Views, Published on: 20 Jan 2021

Depression is a severe mood disorder that affects individuals of all ages and is associated with significant morbidity and mortality. Worldwide, 17% of people are likely to experience depression and it is especially prevalent in patients with cardiovascular disorders. Escitalopram is commonly used in depression with comorbid hypertension as it decreases heart rate, improve sleep quality, and decrease blood pressure.

Managing Depression and Comorbid Diabetes (Dr. Rajendra Hegde)
Expert's Views, Published on: 20 Jan 2021

Diabetes mellitus and depression are major public health issues and depression was associated with a 60% increase of type 2 diabetes while type 2 diabetes was associated with 15% risk of depression. Escitalopram is effective in terms of controlling symptoms of depression without any adverse impact on glycemic parameters when used in depression patients with diabetes mellitus.

Managing Depression with Anxiety (Dr. Amit Sharma)
Expert's Views, Published on: 20 Jan 2021

Depression and anxiety are common comorbid condition, with 35-60% of patients with depression having an anxiety disorder. Escitalopram monotherapy and in combination with clonazepam has good antidepressant effects which significantly improves depressive symptoms and has good tolerability profile in managing depression patients with comorbid anxiety.

AAO: Cataract in the Adult Eye-Preferred Practice Patterns (2021)
Guidelines, Published on: 19 Jan 2021
Managing Depression and Anxiety (Dr. Vivek Kirpekar)
Expert's Views, Published on: 18 Jan 2021

Depression and anxiety disorder commonly occur together, and they have high severity of illness and significantly impair work functioning and quality of life. Generally, escitalopram, desvenlafaxine, sertraline are commonly utilized to manage depression and anxiety. Escitalopram monotherapy and in combination with clonazepam significantly improves depressive symptoms and has good tolerability profile.

An Important Add on To Optimize Epilepsy Management (Dr. Sreekanta Swamy)
Expert's Views, Published on: 18 Jan 2021

Lacosamide enhances the slow inactivation of voltage-gated sodium channels (VGSCs) resulting in the stabilization of hyperexcitable neuronal membranes. Add on lacosamide provides effective seizure control and is generally well tolerated when used as a first add on therapy across a broad age range of AEDs.

Managing Epilepsy in Pregnant Women (Dr. Sanjay Ramteke)
Expert's Views, Published on: 18 Jan 2021

Lamotrigine has an important AED in treatment of epilepsy as it has broad efficacy, long term effectiveness, well tolerability, favourable pharmacokinetics properties and lack of cognitive impairment. It can be an ideal AED in pregnant women because of its minimal effect on fetus and minimal fetal malformations compared to other AEDs.

Optimizing Epilepsy Care with Appropriate AED Selection (Dr. Sanjay Varade)
Expert's Views, Published on: 18 Jan 2021

Epilepsy is a group of disorder characterized by two or more unprovoked seizures. Levetiracetam is a newer AED with wide safety margin and minimal interactions with other antiepileptics. Also, it increases the rates of seizure freedom and is generally well tolerated compared to traditional AEDs.

Efficacy and Safety of AED in Bipolar Disorder (Dr. Nilesh Shah)
Expert's Views, Published on: 15 Jan 2021

Bipolar disorder is a chronic mental disorder with repetitive cycles of mania and depressive episodes. Lamotrigine is an effective option for the management of bipolar disorder, most significantly for its role in the prophylaxis of mood episodes and it is relatively safe and effective option for maintenance treatment in women.

Optimizing Management in Epilepsy (Dr. Pravar Passi)
Expert's Views, Published on: 15 Jan 2021

AEDs are the mainstay of the treatment of epilepsy. Review diagnosis if seizure is not controlled and evaluate patients every 3 months. Lamotrigine is effective option in women with epilepsy. It is recommended to initiate monotherapy at low dose to evaluate drug interaction and side effect profile.

Depression Management – Mission Remission and Suppress Relapse (Dr. Roop Sidana)
Expert's Views, Published on: 15 Jan 2021

Major depressive disorder is severe mood disorder associated with significant morbidity and mortality. Escitalopram as an antidepressant has good efficacy which significantly improves the depressive symptoms with minimal drug interaction with better tolerability profile.

Antidepressants Impact on Quality of Life (Dr. Rupesh Dhuri)
Expert's Views, Published on: 15 Jan 2021

Escitalopram leads to a significant improvement of overall quality of life as well as overall pleasure and satisfaction with life which makes them very effective in the treatment of depression. It also provide better efficacy and safety compared to other antidepressants.

Epilepsy Management (Dr. Pankaj Gupta)
Expert's Views, Published on: 15 Jan 2021

Antiepileptic drugs are the mainstay treatment of epilepsy. Levetiracetam is a novel AED with wide safety profile with minimal drug interactions. Also, has significantly higher retention rate and better seizure control compared to traditional AED.

Antidepressants Impact on Quality of Life (Dr. Padmaraj Patil)
Expert's Views, Published on: 15 Jan 2021

Depression is a severe mood disorder with a lifetime prevalence of 16.5% in the adult population. Treatment with escitalopram results in a significant improvement of quality of life, improved sleep, enjoyment and satisfaction in patients with MDD which makes it very effective option for the treatment of depression.

Optimizing Management in Bipolar Disorder (Dr. Manaswi Gautam)
Expert's Views, Published on: 15 Jan 2021

Bipolar disorder is a chronic mental disorder with repetitive cycles of mania/hypomania as well as depressive episodes, resulting in marked impairment in overall functioning and quality of life. Psychotherapy is an important aspect of bipolar management. Lamotrigine is an important pharmacologic option for the management of bipolar disorder as it is relatively safe and effective option for maintenance treatment.

 

Optimizing Epilepsy Care with Appropriate AED Selection (Dr. Mukund Vidhate)
Expert's Views, Published on: 15 Jan 2021

Epilepsy is third most common neurological disorder characterized by two or more unprovoked seizures. Levetiracetam is a newer AED with wide safety profile with minimal drug interactions. Also, has significantly higher retention rate and better seizure control compared to traditional AED.

Efficacy and Safety of AED in Bipolar Disorder (Dr. Nihar Burte)
Expert's Views, Published on: 15 Jan 2021

Bipolar disorder is a common psychiatric disorder with repetitive cycles of mania and depressive episodes. Lamotrigine is an effective option for the management of bipolar disorder, most significantly for its role in the prophylaxis of mood episodes and it is relatively safe and effective option for maintenance treatment.

Managing Bipolar Disorder in Women (Dr. Mahesh Bhirud)
Expert's Views, Published on: 15 Jan 2021

Lamotrigine is an anticonvulsant which is an effective mood stabilizer commonly used for the management of bipolar disorder. It plays and important role in the prophylaxis of mood episodes and it is relatively safe and effective option for maintenance treatment in women with bipolar disorder in the reproductive age group and also pregnant women.

Selection of Right SSRI for Depression Management (Dr. Javed Attar)
Expert's Views, Published on: 15 Jan 2021

Major depressive disorder is severe mood disorder associated with significant morbidity and mortality. Escitalopram as an antidepressant has good efficacy which significantly improves the depressive symptoms. It has minimal drug interaction and better tolerability profile compared to other antidepressants.

Managing Depression and Anxiety (Dr. Dnyanraj Chaudhary)
Expert's Views, Published on: 15 Jan 2021

Depression and anxiety are common comorbid condition, with 35-60% of patients with depression having an anxiety disorder. Escitalopram monotherapy and in combination with clonazepam has good antidepressant effects which significantly improves depressive symptoms and has good tolerability profile in managing depression patients with comorbid anxiety.

Optimizing Management in Epilepsy (Dr. Devashish Ruikar)
Expert's Views, Published on: 15 Jan 2021

Epilepsy is a group of disorder characterized by two or more unprovoked seizures. Levetiracetam is a novel AED with wide safety margin and minimal interactions with other antiepileptics. Another AED lacosamide as an add on provides effective seizure control and is generally well tolerated when used as a first add on therapy across a broad age range of AED.

 

An Effective Add on For Epilepsy Care (Dr. Subhayan Mandal)
Expert's Views, Published on: 15 Jan 2021

Lacosamide is approved as add on therapy in partial onset seizure. It block sodium channels, enhancing slow inactivation of neuronal membrane. It significantly reduces seizure frequency with high rate of longterm seizure freedom. Also, has minimal drug interaction and safer to use.

Optimizing Epilepsy Care (Dr. Deepak Jain)
Expert's Views, Published on: 15 Jan 2021

Epilepsy is a common neurological condition affecting 1-2% of population. Lacosamide is a newer AED which enhances the slow inactivation of voltage-gated sodium channels resulting in the stabilization of hyperexcitable neuronal membranes. Add on lacosamide provides effective seizure control and is generally well tolerated when used as a first add on therapy across a broad age range of AEDs.

Rapid Up-titration of Lacosamide Safe and Well-tolerated in Appropriate Clinical Situations
Key Trials, Published on: 14 Jan 2021

Rapid up-titration of lacosamide seems to be a feasible option in appropriate clinical conditions and may be particularly beneficial for epilepsy patients at high risk of short-term seizure recurrence.

 

Oncological and Functional Outcomes with High-Intensity Focused Ultrasound in the Treatment of Prostate Cancer
Key Trials, Published on: 14 Jan 2021

Partial-gland high-intensity focused ultrasound (HIFU) was safer than whole-gland HIFU, and they had similar oncological outcomes. More prospective randomized controlled trials are warranted to assess the benefits of HIFU for the treatment of prostate cancer.

 

Epilepsy – Special Population Management (Dr. Vineet Sagar)
Expert's Views, Published on: 14 Jan 2021

Diagnosing and categorization of epilepsy type is important for management of epilepsy. The commonly used epilepsy drugs in different types of epilepsy are phenobarbitone which effective in partial seizure; levetiracetam, Briveracetam, clobazam are also commonly used for the management of partial and generalized seizure.

Managing Depression and Anxiety (Dr. Vikas Jain)
Expert's Views, Published on: 14 Jan 2021

Depression is severe mood disorder characterized by low mood, weight changes, insomnia or hypersomnia. Depression and anxiety are common comorbid condition, with 35-60% of patients with depression having an anxiety disorder. Escitalopram monotherapy and in combination with clonazepam has good antidepressant effects which significantly improves depressive symptoms and has good tolerability profile.

Stroke management (Dr. Tejpal Farooda)
Expert's Views, Published on: 14 Jan 2021

Stroke is the second leading cause of death worldwide. In case of haemorrhagic stroke, urgent craniotomy, evacuation of hematoma and decompression is recommended. Mechanical thrombectomy and IV thrombolysis is recommended in patients with ischemic stroke.

An Important Add on to Optimize Epilepsy Management (Dr. Sumit Kumar Rabi)
Expert's Views, Published on: 14 Jan 2021

Epilepsy is a group of disorder characterized by two or more unprovoked seizures. Lacosamide enhances the slow inactivation of voltage-gated sodium channels resulting in the stabilization of hyperexcitable neuronal membranes. Add on lacosamide provides effective seizure control and is generally well tolerated when used as a first add on therapy across a broad age range of AEDs.

Role of Neurosurgery in Stroke (Dr. Shradha Maheshwari)
Expert's Views, Published on: 14 Jan 2021

Stroke is the second leading cause of death worldwide. Immediate airway, breathing and circulation is required in patients with stroke. In case of haemorrhagic stroke, craniotomy, evacuation of hematoma and decompression is recommended. Mechanical thrombectomy and IV thrombolysis is recommended in patients with ischemic stroke.

Management of Bipolar Disorder (Dr. Ravi Rana)
Expert's Views, Published on: 14 Jan 2021

Bipolar disorder is a chronic mental disorder with repetitive cycles of mania/hypomania as well as depressive episodes. Lamotrigine is an effective option for the management of bipolar disorder, most significantly for its role in the prophylaxis of mood episodes and it is relatively safe and effective option for maintenance treatment in women.

Managing Head Injury (Dr SS Ratnawat)
Expert's Views, Published on: 14 Jan 2021

Assessment of head injury can be done by Glasgow comma scale which evaluates the severity of head injury. During head injury management, airway and circulation are managed immediately to avoid secondary injuries. If patient has large occlusion, ICH or hematoma, craniotomy is planned to remove the clot.

 

An Effective Add on for Epilepsy Care (Dr. Pranav Anand)
Expert's Views, Published on: 14 Jan 2021

Lacosamide enhances the slow inactivation of voltage-gated sodium channels resulting in the stabilization of hyperexcitable neuronal membranes. Add on lacosamide provides effective seizure control and is generally well tolerated when used as a first add on therapy across a broad age range of AEDs.

 

Managing Depression and Anxiety (Dr. Pramod Thakre)
Expert's Views, Published on: 14 Jan 2021

Depression and anxiety disorder commonly occur together, and they have high severity of illness and significantly impair work functioning and quality of life. Generally, escitalopram, desvenlafaxine, sertraline are commonly utilized to manage depression and anxiety.

 

Epilepsy – Special Population Management (Dr. Mayank Bibra)
Expert's Views, Published on: 14 Jan 2021

The preferred choice of drugs in neonatal seizure and infants are benzodiazepines such as midazolam, diazepam, lorazepam. The drugs used in infantile spasm are carbamazepine, oxcarbazepine and levetiracetam as they have less drug interaction with other drugs and effective in broad spectrum of different epilepsy types.

 

SSRI in Depression Management (Dr JP Agrawal)
Expert's Views, Published on: 14 Jan 2021

Major depressive disorder is severe mood disorder associated with significant morbidity and mortality. The commonly used SSRI for depression management is Escitalopram. As an antidepressant it has good efficacy which significantly improves the depressive symptoms with minimal drug interaction and better tolerability profile.

 

Management of Epilepsy in Women (Dr. Srinivas Deshmukh)
Expert's Views, Published on: 13 Jan 2021

Epilepsy is a group of disorder characterized by two or more unprovoked seizures. Lamotrigine is an important AED in treatment of women with epilepsy as it has broad efficacy, long term effectiveness, well tolerable and favourable pharmacokinetics properties. It is commonly used AED in pregnant women because of its minimal effect on fetus and minimal fetal malformations compared to other AEDs.

 

Optimizing Epilepsy Care with Appropriate AED Selection (Dr. Santosh Dash)
Expert's Views, Published on: 13 Jan 2021

Levetiracetam is a newer AED with wide safety profile with minimal drug interactions and has significantly higher retention rate and better seizure control compared to traditional AED. Add on lacosamide provides effective seizure control and is generally well tolerated when used as a first add on therapy across a broad age range of AEDs. Lamotrigine is commonly used in WWE because of minimal foetal malformation.

Optimizing Management in Epilepsy (Dr. Rajalaxmi Satapathy)
Expert's Views, Published on: 13 Jan 2021

Antiepileptic drugs are the mainstay treatment of epilepsy. Lacosamide enhances the slow inactivation of voltage-gated sodium channels (VGSCs) resulting in the stabilization of hyperexcitable neuronal membranes. Add on lacosamide provides effective seizure control and is generally well tolerated when used as a first add on therapy across a broad age range of AEDs.

 

Efficacy of AED in Children (Dr. Prashant Utage)
Expert's Views, Published on: 13 Jan 2021

Choice of an AED for the treatment of epilepsy in infants and children depends not only on the efficacy of the agent but also in safety, impact on behavior and learning, and existing patient co-morbidities. LEV has become an attractive choice in children because of its lack of hepatic metabolism, minimal drug interactions, activity against several seizure types.

 

Selection of Right SSRI for Depression Management (Dr. MD Osman Ali)
Expert's Views, Published on: 13 Jan 2021

Major depressive disorder is severe mood disorder associated with significant morbidity and mortality. Escitalopram as an antidepressant has good efficacy which significantly improves the depressive symptoms with minimal drug interaction and has better tolerability profile.

 

Managing Epilepsy in Pregnant Women (Dr. Pradyut Ranjan Bhuyan)
Expert's Views, Published on: 13 Jan 2021

Epilepsy is a group of disorder characterized by two or more unprovoked seizures. Lamotrigine is an important AED in treatment of epilepsy as it has broad efficacy, long term effectiveness, well tolerable and favourable pharmacokinetics properties. It is commonly used AED in pregnant women because of its minimal effect on fetus and minimal fetal malformations compared to other AEDs.

 

144-week Efficacy and Safety of Fixed-dose Combination Bictegravir, Emtricitabine, and Tenofovir alafenamide versus Dolutegravir-containing Regimens for Initial Treatment of HIV-1 Infection
Key Trials, Published on: 13 Jan 2021

This is a randomised, double-blind, multicentre, phase 3 trial evaluating 144-week efficacy and safety of fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection. The findings showed that bictegravir, emtricitabine, and tenofovir alafenamide continued to be non-inferior to dolutegravir-containing regimens at week 144.

Benefits of Dehydroepiandrosterone on Pregnancy Outcomes in Women with Diminished Ovarian Reserve
Key Trials, Published on: 13 Jan 2021

This study demonstrated reduction in the miscarriage rates after DHEA supplementation in women with diminished ovarian reserves (DOR). Miscarriage rates after DHEA supplementation not only were lower than in an average national IVF population but were comparable to rates reported in normally fertile populations. Low miscarriage rates, comparable to those of normal fertile women, are indicative of the possible beneficial effect of DHEA on embryo ploidy.

ESMO: Renal Cell Carcinoma Treatment Recommendations (2020)
Guidelines, Published on: 13 Jan 2021
Nintedanib Reduces the Rate of Progression of Interstitial Lung Disease
Key Trials, Published on: 13 Jan 2021

Treatment with nintedanib resulted in a slower rate of progression of interstitial lung disease and a significantly lower annual rate of decline in forced vital capacity, irrespective of the fibrotic pattern in high resolution computed tomography scan as compared to placebo. Diarrhea was a common adverse event reported by the patients receiving nintedanib.

Optimizing Epilepsy Care with Appropriate AED Selection (Dr. Reji Thomas)
Expert's Views, Published on: 13 Jan 2021

Epilepsy is a group of disorder characterized by two or more unprovoked seizures. Epilepsy management depends on type of seizure and individual patients. Lacosamide is effective in patient with partial epilepsy. Levetiracetam and lamotrigine is effective in women with epilepsy in childbearing age bcz of minimal drug interaction and better tolerability profile.

 

Patient Centred Care for The Medical Treatment of LUTS in Patients with BPH
Clinical Tools, Published on: 13 Jan 2021

Besides diagnosis and treatment, in LUTS/BPO, comprehensive assessment of patient’s illness, preference & expectations needs equal attention. Such patient centric approach may further improve drug adherence and some unmet needs in this area, potentially reducing complications and cost.

 

Managing Depression and Anxiety (Dr. Umar Mushir)
Expert's Views, Published on: 13 Jan 2021

Depression and anxiety are common comorbid condition, with 35-60% of patients with depression having an anxiety disorder. Escitalopram monotherapy and in combination with clonazepam has good antidepressant effects which significantly improves depressive symptoms and has good tolerability in managing depression patients with comorbid anxiety

 

Optimizing Depression Management (Dr. Sumanta Ghosh Maulik)
Expert's Views, Published on: 13 Jan 2021

Major depressive disorder is severe mood disorder associated with significant morbidity and mortality. Escitalopram as an antidepressant has good efficacy which significantly improves the depressive symptoms with minimal drug interaction with better tolerability profile.

 

Epilepsy Management (Pankaj Kumar Popli)
Expert's Views, Published on: 13 Jan 2021

Epilepsy is a chronic neurological condition which affects over one million women of childbearing age. Lamotrigine and levetiracetam are effective in childbearing age and pregnant women because of its minimal effect on foetus and less drug interaction with oral contraceptive. Also, both drugs are safe and better tolerability profile

 

Managing Depression and Comorbid Diabetes (Dr. Neeraj Loona)
Expert's Views, Published on: 13 Jan 2021

Diabetes mellitus (DM) and depression are major public health issues. Depression could facilitate the onset of diabetes through disturbances in eating behaviours and drug induced weight gain. Escitalopram is effective in terms of controlling symptoms of depression without any adverse impact on glycemic parameters when used in depression patients with diabetes mellitus.

 

Selection of Right SSRI for Depression Management (Dr. M Asok Kumar)
Expert's Views, Published on: 12 Jan 2021

Escitalopram as an antidepressant is associated with high therapy continuity, high efficacy, adherence due to high tolerability and reduced risk of relapse. It is an effective first line option in the management of patients with MDD.

 

Efficacy of AED in Children (Dr. Joban John)
Expert's Views, Published on: 12 Jan 2021

Choice of an AED for the treatment of epilepsy in infants and children depends not only on the efficacy of the agent but also in safety, impact on behavior and learning, and existing co-morbidities. Levetiracetam is effective in children with epilepsy because of minimal drug interactions, activity against several seizure types and with possible no evident side effect

 

Optimizing Management in Bipolar Disorder (Dr. GP Sachdeva)
Expert's Views, Published on: 12 Jan 2021

Bipolar disorder is a chronic mental disorder with repetitive cycles of mania/hypomania as well as depressive episodes. Lamotrigine is an important pharmacologic option for the management of bipolar disorder, most significantly for its role in the prophylaxis of mood episodes, also it is relatively safe and effective option for management of BD

 

Efficacy of AED in Adults (Dr. Jeevan Nair)
Expert's Views, Published on: 12 Jan 2021

Management of epilepsy in adults depends on various factors including comorbidity, type of seizure and concomitant medication. Levetiracetam is effective in diverse epilepsies, and the evidence shows that it increases the rates of seizure freedom and well tolerated without major adverse effects. Also, it has an advantage in pregnant women as it decreases risk of congenital malformation.

 

Safety of AED in Adults (Dr. Abdul Aleem)
Expert's Views, Published on: 12 Jan 2021

Epilepsy is a group of disorder characterized by two or more unprovoked seizures. levetiracetam is a novel AED with wide safety margin without any requirement for serum drug monitoring, and minimal drug interactions with other antiepileptics. It significantly increases the rates of seizure freedom and well tolerated without major adverse effects

 

Managing Head Injury (Dr. Abhishek Goyal)
Expert's Views, Published on: 12 Jan 2021

The patient with head injury is classified as mild moderate and severe head injury by Glasgow comma scale. During head injury management, airway and circulation are managed immediately to avoid secondary injuries. If patient has large occlusion, ICH or hematoma, craniotomy is planned to remove the clot.

 

EHNS-ESMO-ESTRO: Squamous Cell Carcinoma of the Oral Cavity, Larynx, Oropharynx and Hypopharynx: Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up (2020)
Guidelines, Published on: 12 Jan 2021
Shifting Gears in the Management of Rare Lung Diseases
eCMEs, Published on: 08 Jan 2021

Rare lung diseases are rare but integral part of for pulmonary medicine. Many young clinicians need guidance on how to differentiate and treat various Rare Lung Diseases. Also, there are new updates on Chronic Hypersensitivity Pneumonitis. This PURVIEW is an opportunity as it entails discussions on broad spectrum of Rare Lung Diseases and their management.

 

Epilepsy in Children (Dr. Vinayak Rastogi)
Expert's Views, Published on: 08 Jan 2021

Children with epilepsy have higher rates of learning difficulties. Hence, the treatment should be individualized for children with epilepsy. Selection of AEDs depends on patients, type of seizure, drug interaction and comorbidity. Levetiracetam, clobazam, topiramate are the common AEDs preferred in children.

 

Behavioural and Psychological Symptoms of Dementia, Their Pharmacological Management (Dr. Gaurav Bhagat)
Expert's Views, Published on: 08 Jan 2021

Dementia is major cause of disability in late life. The prevalence of dementia is 6-8% in patient above 65 years of age and 30% or more in patient aged 80 years and above. Donepezil and Rivastigmine are the commonly used drug to treat dementia with minimal drug interaction and better tolerability profile than other drugs

 

Treatment of Obsessive Compulsive Disorder (Dr. Bharati Patil)
Expert's Views, Published on: 08 Jan 2021

OCD is disease with obsession and compulsion in which patients has doubts, suspicions and repetitive actions. Psychotherapy and CBT is important aspect of managing OCD. SSRI are commonly used medication to supress the symptoms of OCD.

 

Management of Bipolar Disorder (Dr. Abhishek Chowhan)
Expert's Views, Published on: 08 Jan 2021

Lamotrigine is effective in patients with bipolar disorder with superior efficacy, better tolerability and is safer to use. It is more effective in depressive phase compared to maniac phase and usually recommended for maintenance treatment of bipolar disorder.

 

Indoor Pollution Increases the Risk of Acute Respiratory Infections in Children Aged below Five Years in India
Key Trials, Published on: 07 Jan 2021

This large-scale Indian study demonstrated a high risk of acute respiratory infection due to indoor pollution in children aged below 5 years. Policies that would cut down the exposure to indoor air pollution are warranted.

Case with Acute Myocardial Infarction and Dyspnoea
Expert's Views, Published on: 07 Jan 2021

Dr Uday Jadhav talks about the case of a patient with myocardial infarction and dyspnoea.

 

Hypertension Case Diagnosed as HFpEF
Expert's Views, Published on: 07 Jan 2021

Dr Uday Jadhav talks about the case of hypertensive patient diagnosed as HFpEF.

Chronic HFrEF and Acute Decompensation
Expert's Views, Published on: 07 Jan 2021

Dr Uday Jadhav talks about chronic HFrEF and acute decompensation.

           

 

Role of Cardiac Fibrosis Markers in Heart Failure
Expert's Views, Published on: 07 Jan 2021

Dr Uday Jadhav talks about the role of cardiac fibrosis markers in heart failure.

 

AIOS/VRSI: Diabetic Retinopathy Screening Guidelines in India (2020)
Guidelines, Published on: 05 Jan 2021
Efficacy and Safety of Nintedanib in Systemic Sclerosis-Associated Interstitial Lung Disease
Key Trials, Published on: 05 Jan 2021

Results of the SENSCIS trial demonstrated that nintedanib had a lower annual rate of decline in forced vital capacity among patients with interstitial lung disease (ILD) associated with systemic sclerosis as compared to placebo. There was no other clinical benefit observed for other manifestations of systemic sclerosis. Nintedanib treatment had a safety profile similar to that observed in patients with idiopathic pulmonary fibrosis, with diarrhea being the most common adverse event.

 

Fixed Dose Combination of Oral Cefixime and Moxifloxacin Improves Symptoms in Lower Respiratory Tract Infections
Key Trials, Published on: 05 Jan 2021

In a real-world clinical setting, the fixed dose combination of oral cefixime (400 mg) and moxifloxacin (400 mg) was effective in improving all symptoms in patients with lower respiratory tract infections without causing any adverse event.

 

NAEPP: Asthma Management Guidelines: Focused Updates (2020)
Guidelines, Published on: 05 Jan 2021
AAO: Primary Open Angle Glaucoma-Preferred Practice Patterns (2020)
Guidelines, Published on: 05 Jan 2021
AAO: Primary Open Angle Glaucoma Suspect-Preferred Practice Patterns (2020)
Guidelines, Published on: 05 Jan 2021
Varicocele Repair in Infertile Men Increases Pregnancy and Live Birth Rate
Key Trials, Published on: 04 Jan 2021

Varicocele repair increased the pregnancy and live birth rates irrespective of the semen analysis result. Varicocele treated azoospermic men had higher sperm retrieval success rate. Varicocele repair might benefit infertile men prior to joining a fertility program.

 

Long Acting Injectables (CAB+RPV) for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase III ATLAS and FLAIR Studies
Key Trials, Published on: 04 Jan 2021

The present study is the pooled analysis of two phase III studies, ATLAS and FLAIR, that compared efficacy and safety of monthly intramuscular (IM) injections of long-acting (LA) cabotegravir (CAB) + LA rilpivirine (RPV) to the oral current antiretroviral regimen (CAR). The study showed that monthly IM injections of CAB + RPV LA are noninferior to CAR in maintaining HIV-1 virologic suppression in treatment-experienced participants.

 

Epilepsy Management (Dr. Sachin Chhabra)
Expert's Views, Published on: 31 Dec 2020

Epilepsy management depends on efficacy, safety and pharmacokinetic profile of AED, seizure type and patient characteristics. It is recommended to start monotherapy, if there’s in adequate response to the monotherapy the add on drug can be included in management. Lamotrigine, levetiracetam, lacosamide are commonly used drug in focal epilepsy

 

Migraine Updates (Dr. Piyusha Ranjan Nayak)
Expert's Views, Published on: 31 Dec 2020

Migraine is headache disorder which is more common in female occurring at younger age. The first line drugs for chronic migraine includes sodium valproate, propranolol. In case of acute migraine, the first line medication includes ibuprofen, aspirin and triptans including rizatriptan and zolmitriptan.

ACC/AHA: Diagnosis and Treatment of Hypertrophic Cardiomyopathy (2020)
Guidelines, Published on: 31 Dec 2020
AACE: American Association of Clinical Endocrinologists/ American College of Endocrinology Clinical Practice Guidelines for The Diagnosis and Treatment of Postmenopausal Osteoporosis— 2020 Update (2020)
Guidelines, Published on: 30 Dec 2020
Lacosamide Effective and Well-tolerated in Patients with Focal Epilepsy
Key Trials, Published on: 30 Dec 2020

According to the findings of this Saudi Arabian study, lacosamide was effective and well-tolerated in patients with focal epilepsy.

 

Managing Depression and Anxiety (Dr. Prakash Tolar)
Expert's Views, Published on: 30 Dec 2020

Depression is a mental disorder associated with persistent low mood. Depression and anxiety disorder commonly occur together, with high severity of illness which significantly impair work functioning and quality of life. SSRI and psychotherapy is the recommended choice of therapy for treating depression and comorbid condition.

Managing epilepsy in adults – Tips and Tricks (Dr. P.R. Prabash)
Expert's Views, Published on: 30 Dec 2020

AEDs are the mainstay for epilepsy management. Compared to conventional AEDs, newer AEDs are better tolerated and safer to use in epilepsy patients. Amongst newer AEDs, levetiracetam is the novel drug with wide safety margin, does not require serum drug monitoring and has no/minimal drug interaction with other AEDs.

 

Latest Updates on Neurology (Dr. Partha Ghorai)
Expert's Views, Published on: 30 Dec 2020

In epilepsy, despite the availability of many antiepileptic drugs (AEDs) more than 30% of patients continue to experience seizures and have drug-resistant epilepsy which can be eased by Precision medicine (PM) which is tailoring of medical treatment to the individual characteristics of each patient. In epilepsy, the precision medicine can be used for medical treatments that target specifically the mechanisms responsible for the manifestations of the disease in individual patients to reduce seizures.

 

Optimizing Schizophrenia Management with Antipsychotics (Dr. Nazim Ahmed Saikia)
Expert's Views, Published on: 30 Dec 2020

Schizophrenia is disorder of thought, perception and behaviour with or without cognitive functioning. The 2nd generation antipsychotics such as olanzapine, risperidone, Amisulpride are commonly used drug as they reduce both negative and positive symptoms of schizophrenia with better tolerability profile. Schizophrenia patient with aggression and suicidal tendency usually requires hospitalization.

Choosing the Right SSRI for Depression Management (Dr. J Vinodh Kumar)
Expert's Views, Published on: 30 Dec 2020

According to NICE guidelines, the choice of antidepressants should be based on side effect profile, patient preference and previous patient exposure. SSRI are commonly used as first line for treatment of depression in adults and children. Amongst them, escitalopram is commonly preferred SSRI because of better efficacy and safety profile.

Optimizing Management in Epilepsy (Dr. Gaurav Rai Sharma)
Expert's Views, Published on: 30 Dec 2020

Lacosamide enhances the slow inactivation of voltage-gated sodium channel and it is available as tablet and injection formation. Initially, the administration is started as 50 mg/day. As an AED it provides effective seizure control and is generally well tolerated when used as a first add on therapy across a broad age group.

Optimizing Epilepsy Management (Dr. Deepashu Sachdeva)
Expert's Views, Published on: 30 Dec 2020

Epilepsy majorly consist of 2 types: generalized and focal. The aim of management is to reduce the seizure frequency and preventing seizure. Oxcarbazepine, lamotrigine, levetiracetam are commonly used first line antiepileptic drugs. Recently approved lacosamide is the most commonly used add on AED for epilepsy management.

 

Migraine – Differential Diagnosis and Confirming Migraine Diagnosis (Dr. Amit Shankar Singh)
Expert's Views, Published on: 30 Dec 2020

Migraine is most common headache disorder which is diagnosed with certain clinical criteria including unilateral or bilateral headache which last from 4 -72 hours and pain is usually pulsated. Most common differential diagnosis is tension type headache, secondary headache, trigeminal autonomic cephalgia which needs to be diagnosed for the correct management.

 

Secondary Fracture Prevention - Summary of Consensus Recommendations (2020)
Guidelines, Published on: 30 Dec 2020

Recognizing the widening “treatment gap,” the ASBMR developed a consensus of a broad multi-stakeholder coalition regarding several aspects of Osteoporosis treatment.

 

Myths and Facts About Hair
Patient Education, Published on: 30 Dec 2020

Few facts about common myths related to hair.

 

A Breath of Fresh Air in OAD: Can Simpler Delivery Platforms Help Reduce Risk of Exacerbations?
eCMEs, Published on: 30 Dec 2020

A LIVE symposium on ‘Breath of Fresh Air in OAD’, with a focus on the importance of preventing exacerbations in OAD management. This symposium aims to provide clinical perspectives on understanding pathogenesis of OAD exacerbations, highlighting the various triggers, patient factors and their interactions leading to exacerbations and discuss various preventive measures available with newer therapies and drug delivery systems to reduce the burden and impact of exacerbations on the patient.

 

NICE: Diagnosis and Management of Peripheral Arterial Disease- An Update (2020)
Guidelines, Published on: 30 Dec 2020
IAS-USA: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: Recommendations of the International Antiviral Society–USA Panel (2020)
Guidelines, Published on: 30 Dec 2020
ARIA: Guidelines for Allergic Rhinitis based on GRADE and Real-world Evidence (2020)
Guidelines, Published on: 30 Dec 2020
NICE: Management of Acute Coronary Syndrome (2020)
Guidelines, Published on: 30 Dec 2020
CDC: Prevention and control of Staphylococcus aureus infections in the NICU (2020)
Guidelines, Published on: 29 Dec 2020
Depression and its Management (Dr. Sethunath Mangarappallil)
Expert's Views, Published on: 27 Dec 2020

Depression is a mood disorder characterised by persistent low mood. Mild depression can be treated by psychotherapy; however, moderate and severe episodes of depression require pharmacotherapy. SSRIs are recommended as first line treatment in managing depression and the response can be evaluated at intervals before up titrating the dose.

 

Choosing Right Antipsychotic Agent for Managing Schizophrenia Patients (Dr. J Mayurnath Reddy)
Expert's Views, Published on: 27 Dec 2020

The dilemma of selection of right antipsychotic in the real world revolves around a medication that shows efficacy, tolerability and is safer to use. It is recommended to initiate treatment with monotherapy and up titrate the dose before initiating polytherapy. Olanzapine and respiredone are the first choice in overweight patient.

 

Treatment of Obsessive Compulsive Disorder (Dr. Sumit Saha)
Expert's Views, Published on: 27 Dec 2020

OCD is a disease with obsession and compulsion in which patients has doubts, suspicions and repetitive actions. Psychotherapy and CBT are important for managing OCD. SSRI are recommended as the first line medication to supress the symptoms of OCD.

 

Latest Updates on Migraine (Dr. Vipin Ola)
Expert's Views, Published on: 27 Dec 2020

Migraine treatment should be initiated as soon as the migraine attack starts. CGRP antagonist, CGRP monoclonal antibodies are the new emergent therapies in migraine. CGRP antagonist including erenumab injection is found to be effective in migraine management with no major side effects.

 

PIONEER-HF: Efficacy and Safety of Sacubitril/Valsartan in ADHF Patients as per the Dose Level Achieved
Key Trials, Published on: 27 Dec 2020

Sacubitril/valsartan exhibited generally consistent efficacy and safety across various dose levels in hemodynamically stabilized patients with ADHF. Sacubitril/valsartan should therefore be broadly initiated in-hospital and continued post-hospitalization even in patients who may not tolerate early up-titration to the target dose.

Errors in IVF Lab: How KPI can be a Savior
eCMEs, Published on: 27 Dec 2020

The doctor talks about errors in ART labs and how setting these key performance indicators can be beneficial to check performance and to maintain standard, assure quality and benchmark against established standards.

 

Efficacy and Safety of Colistin Loading Dose in Critically Ill Children, Affected with Nosocomial Infections
Key Trials, Published on: 23 Dec 2020

According to this first-of-its kind study conducted in pediatric population, loading dose of colistin improved the overall efficacy without any adverse impact on the renal function (vs. no loading dose) in critically ill children affected with severe nosocomial infections.

 

GESTOSIS Score - Hypertensive Disorders in Pregnancy
eCMEs, Published on: 23 Dec 2020

In this webinar, the doctor briefs about effectiveness of a dynamic quantification tool - the HDP GESTOSIS score - to screen hypertensive disorders of pregnancy.

 

Efficacy and Safety of Saccharomyces boulardii in Acute Childhood Rotavirus Diarrhoea
Key Trials, Published on: 23 Dec 2020

The present study evaluated Saccharomyces boulardii (SB) as a possible therapeutic intervention in acute rotavirus diarrhoea in Indian children. The study showed that SB 250 mg orally twice a day for 5 days given during an acute episode of rotavirus diarrhoea in children aged under five resulted in significant shortening in the diarrheal duration and duration of hospitalization without any adverse events.

 

Safety and Efficacy of a Short-term versus High-dose LVFX Regimen for the Treatment of Patients with cUTI or APN
Key Trials, Published on: 23 Dec 2020

The present study compared the efficacy and safety of intravenous levofloxacin (LVFX) at 750 mg per day for 5 days with an intravenous/oral regimen of LVFX at 500 mg per day for 7–14 days in the treatment of patients with complicated urinary tract infection and acute pyelonephritis. The study showed that two therapies had similar clinical efficacy, microbiological efficacy, and tolerance.

Loop Diuretic Dose Change and the Outcomes in Chronic HF Patients: Insights from the ESC-EORP HF Long-Term Registry
Key Trials, Published on: 22 Dec 2020

This large-scale study demonstrated very low rate of loop diuretic (LD) dose down-titration in chronic HF patients, depicting the high discordance between ‘real-world’ HF practice patterns and guidelines. Clinicians should attempt LD dose down-titration in stable euvolemic patients.

 

Improving Outcomes after Fertilization Failure with ICSI
eCMEs, Published on: 18 Dec 2020

In her talk, the doctor gives brief on the nuances of ICSI, including sperm morphology and motility, and indications of and advances in IMSI.

 

Lacosamide may Improve Depression and Anxiety Symptoms in Patients with Focal Refractory Epilepsy
Key Trials, Published on: 18 Dec 2020

Lacosamide appeared to improve depression and anxiety symptoms in patients with focal refractory epilepsy. This effect was independent of the seizure control effect of lacosamide.

 

Letrozole Might Be Safe and Effective in the Medical Treatment of Ectopic Pregnancy
Key Trials, Published on: 17 Dec 2020

Treatment with letrozole was associated with high resolution rate and better safety profile as compared with a chemotherapeutic agent such as methotrexate in the medical treatment of ectopic pregnancy.

 

Mirabegron Add-on Therapy Safe and Effective in Men Receiving Tamsulosin for LUTS Associated with BPH
Key Trials, Published on: 16 Dec 2020

The results of this first North American and European study showed no unexpected safety concerns and a similar safety profile of mirabegron add-on therapy to that expected for the individual monotherapies in men with overactive bladder symptoms associated with benign prostatic hyperplasia receiving tamsulosin.

 

Once-Daily Dosing of Mesalazine is As Effective and Safe as Twice-Daily Dosing in Ulcerative Colitis
Key Trials, Published on: 16 Dec 2020

The efficacy and safety of once-daily (OD) dosing of mesalazine was comparable to twice-daily (BD) dosing in patients with ulcerative colitis. Since ulcerative colitis requires long-term treatment, OD dosing regime can be more convenient than BD dosing regime.

 

Bleeding in Late Pregnancy
eCMEs, Published on: 16 Dec 2020

In the first session, doctor elaborates on how placenta accreta is emerging as one of the biggest obstetric Challenge and how it can be managed optimally. In the panel discussion, the moderator takes us through various case scenarios of effectively managing bleeding in late pregnancy, such as, due to abruptio placentae, placenta previa, vasa previa and rupture uterus.

 

Efficacy and Safety of Omalizumab in Chronic Rhinosinusitis with Nasal Polyps
Key Trials, Published on: 11 Dec 2020

Treatment with omalizumab resulted in significant improvements in endoscopic, clinical, and patient-reported outcomes in severe chronic rhinosinusitis with nasal polyps (CRSwNP) with inadequate response to intranasal corticosteroids. Omalizumab was safe and well tolerated in all the patients.

 

Revolution in Air Quality Management in IVF Lab
eCMEs, Published on: 10 Dec 2020

In his talk, the doctor elaborates on impact of air quality of ART lab in the IVF outcomes, volatile organic compounds and their management, as well as latest developments.

 

Lapatinib plus Capecitabine versus Capecitabine Alone in Women with Progressive HER2-positive in Locally Advanced or Metastatic Breast Cancer
Key Trials, Published on: 10 Dec 2020

The present study compared lapatinib plus capecitabine with capecitabine alone in women with progressive, HER2-positive, locally advanced or metastatic breast cancer. The study showed that lapatinib plus capecitabine was superior to capecitabine alone in women with HER2-positive advanced breast.

Rivazest (Rivaroxaban) Monograph
Our Publications, Published on: 10 Dec 2020

Rivaroxaban is a potent, selective, orally active direct inhibitor of the activated serine protease Factor X (FXa), which plays a central role in the blood coagulation. It has good bioavailability (80%), is highly protein-bound, and has few drug interactions.

 

 

Nintedanib, Effective and Safe in Idiopathic Pulmonary Fibrosis
Key Trials, Published on: 07 Dec 2020

Nintedanib 150 mg twice a day demonstrated acceptable safety profile and was associated with reduction in the decline in lung function, with fewer acute exacerbations and preserved quality of life in patients with idiopathic pulmonary fibrosis.

 

A Case Based Discussion on Role of L-AMP in Immunocompromised Patients of Aspergillosis and Zygomycosis Infections
eCMEs, Published on: 07 Dec 2020

This webcast provides the detailed place in therapy of Liposomal Amphotericin B for the management of invasive fungal infections (IFIs) in hematological patients who are at the highest risk to get infected with IFIs.

 

Pre-implantation Genetic Testing in IVF
eCMEs, Published on: 07 Dec 2020

In this webinar, the doctor talks about history of IVF, where do we stand in terms of PGT and current trends in PGT.

 

Pharmacokinetics of Meropenem by Continuous Infusion in Critically Ill Patients with Nosocomial Pneumonia
Key Trials, Published on: 07 Dec 2020

Administration of meropenem by continuous infusion improves drug exposure in plasma and epithelial lining fluid (ELF) in critically ill patients with nosocomial pneumonia. The highest licensed dose of 6 g/day (2 g/8 h) seemed to be necessary to achieve an optimal coverage in ELF for all susceptible isolates (MIC ≤ 2 mg/L) in patients with conserved renal function. An alternative therapy should be considered in the treatment of nosocomial pneumonia caused by gram-negative bacteria with a MIC greater than 2 mg/L.

 

MII-pH Testing Improves Clinical Outcomes in Children with GERD
Key Trials, Published on: 07 Dec 2020

This is one of the first studies that clinically validated MII-pH testing and ascertained its ability in guiding clinical management in children with suspected GERD.  Treatment decisions guided by MII-pH testing were associated with improved symptom and QOL in children.

 

PGT for All? Criteria for Patient Selection
eCMEs, Published on: 07 Dec 2020

The doctor gives perspectives whether preimplantation genetic testing (PGT) is meant for all patients undergoing IVF, starting with its advantages and disadvantages and what does evidence say about PGT in IVF.

 

AHA: Consensus on Neonatal Life Support-Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science (2020)
Guidelines, Published on: 04 Dec 2020
Gatifloxacin/Prednisolone Fixed-Dose Combination for Topical Prophylaxis and Inflammation Control after Phacoemulsification
Key Trials, Published on: 03 Dec 2020

The study demonstrated that a fixed-dose combination of gatifloxacin/prednisolone eye drops was as effective as the non-fixed combination of individual agents for preventing infection and inflammation in patients undergoing phacoemulsification and IOL implantation.

Clinical Efficacy of Lapatinib Combined with Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor-Positive Metastatic Breast Cancer
Key Trials, Published on: 03 Dec 2020

This trial compared the combination of letrozole plus lapatinib with letrozole plus placebo as first-line treatment of patients with HR-positive MBC, including a population with known HER2- positive tumours. Results showed that letrozole-lapatinib combination was well tolerated and produced a clinically meaningful improvement in several efficacy endpoints.

 

Managing Elderly Patient with Epilepsy (Dr. UP Sharma)
Expert's Views, Published on: 03 Dec 2020

Epilepsy occurs due to abnormal firing of neuron. In elderly it is associated with significant morbidity and mortality. Treatment in elderly is challenging as they are on multiple drugs. Hence the monotherapy AED treatment is recommended at low dose with drug having minimal drug interactions such as levetiracetam, brivaracetam.

 

Optimizing Epilepsy Care (Dr. Furqan Nizami)
Expert's Views, Published on: 03 Dec 2020

Lacosamide is a newer antiepileptic drug (AED) approved for as an adjunct for partial seizure which modulates sodium voltage gated channel. It reduces seizure frequency when given with another AED at dose of 400-600 mg a day. It is also well tolerated drug and has comparable efficacy with conventional AEDS.

 

Managing Elderly Patients with Epilepsy (Dr. Deepak Goel)
Expert's Views, Published on: 03 Dec 2020

Epilepsy is the most common neurological disorder and the most common cause in elderly patients includes stroke related seizure, dementia and trauma. The preferred drugs for managing elderly patients with epilepsy includes levetiracetam and lamotrigine as they are well tolerated and have less drug interactions. AEDs which also acts as depressants should be avoided in elderly patient.

 

Mifepristone Combined with Misoprostol Increases Success of Miscarriage Management Than Misoprostol Alone
Key Trials, Published on: 02 Dec 2020

Pre-treatment with mifepristone followed by misoprostol was more effective than misoprostol alone in the management of missed miscarriage. Mifepristone and misoprostol combination treatment increased the chance of successful miscarriage and reduced the need for surgical intervention.

Unmet Need Scenarios in Pandemic: Panel Discussion
eCMEs, Published on: 01 Dec 2020

In this panel discussion, the moderator and panelists try to bust myths and misconceptions associated with contraception, thereby ensuring optimal usage and protection against unwanted pregnancy.  

 

MEC Criteria: For Optimizing Contraception Prescriptions
eCMEs, Published on: 01 Dec 2020

In this talk, the doctor briefs on how contraception can pose a challenge in women with medical disorders and elaborates the WHO medical eligibility criteria for contraceptive use.

 

Law Governing Abortion Practice
eCMEs, Published on: 01 Dec 2020

The doctor highlights various aspects of Indian penal code, MTP act and POCSO act in association with safe abortion.

 

Challenges for Contraception Services during the Pandemic
eCMEs, Published on: 01 Dec 2020

The doctor elaborates on how the pandemic gave rise to challenges in accessing contraception, opportunities and solutions in obtaining the same.  

 

Safe Abortion Service - How to Ensure?
eCMEs, Published on: 01 Dec 2020

In this talk, the doctor elaborates on how a practicing gynaecologist can ensure safe abortion with the help of components laid in comprehensive abortion care guidelines.

 

Contraception - Expanding the Basket of Choices
eCMEs, Published on: 01 Dec 2020

The doctor highlights the huge unmet need for modern contraceptives in India; existing and newer contraceptive options along with their advantages and disadvantages.

 

APA: Treatment of Patients with Schizophrenia (2020)
Guidelines, Published on: 01 Dec 2020
Fluticasone is Comparable to Mometasone in Alleviating Symptoms of Allergic Rhinitis
Key Trials, Published on: 01 Dec 2020

Treatment for 8 weeks with fluticasone was as effective as mometasone in patients with moderate-to-severe allergic rhinitis and resulted in a significant improvement in the total nasal symptom score, with no significant difference between the two.   

 

Effect of Azithromycin Administration in Reducing the Risk of Subsequent Wheezing Episodes and Hospital Readmission in Infants with AB
Key Trials, Published on: 01 Dec 2020

The present study evaluated whether administration of azithromycin during an acute bronchiolitis (AB) event reduces subsequent wheezing and hospital readmissions. The 6 months follow-up results indicated that azithromycin at the time of admission for AB showed relevant protection for recurrence of wheezing 3 months after hospitalisation for AB.

Current Practices in Fertility Preservation
eCMEs, Published on: 27 Nov 2020

The doctor talks about current fertility preservation techniques and options for both, males and females, and what is the future of this procedure.

 

Colistin & β-lactams – No Significant Difference in Nephrotoxicity Study
Key Trials, Published on: 27 Nov 2020

This study highlights that colistin is erroneously blamed for nephrotoxicity and nephrotoxicity rates may be over-estimated as AKI is common in sepsis and independent of drugs used to treat sepsis. There is no statistical difference in nephrotoxicity observed in patients receiving colistin compared to those receiving βL- βLIs or carbapenem.

 

Lacosamide does not Adversely Impact the Lipid Profile in Patients with Newly Diagnosed Epilepsy
Key Trials, Published on: 27 Nov 2020

Lacosamide exhibited no adverse impact on the lipid profile in patients with newly diagnosed epilepsy.

 

Nintedanib Reduces Decline in Lung Function in Idiopathic Pulmonary Fibrosis
Key Trials, Published on: 27 Nov 2020

Nintedanib reduced the decline in forced vital capacity (FVC), which is consistent with a slowing of disease progression in patients with idiopathic pulmonary fibrosis (IPF). The most frequent adverse event reported by the nintedanib groups was diarrhea, which led to discontinuation of the study drug in less than 5% of patients.

 

Efficacy and Safety of Lefamulin vs Moxifloxacin for Treatment of Community-acquired Bacterial Pneumonia
Key Trials, Published on: 27 Nov 2020

The present study is the pooled analysis of studies LEAP 1 and LEAP 2 that compared efficacy and safety of lefamulin with moxifloxacin for treatment of community-acquired bacterial pneumonia. The analysis showed that lefamulin achieved a similar clinical response as moxifloxacin.

Comparative Study of Endoscopic and Surgical Drainage of the Pancreatic Duct in Chronic Pancreatitis
Key Trials, Published on: 24 Nov 2020

The present study compared the outcomes of endoscopic and surgical drainage in patients with chronic pancreatitis. The 2-year follow-up results suggested that surgical drainage was more effective than endoscopic treatment.

Simple Intervention Bundle Improves Antimicrobial Stewardship Practices
Key Trials, Published on: 24 Nov 2020

A simple, low-cost quality intervention bundle can significantly increase appropriate antimicrobial prescribing and appropriate investigations and reduce the duration of the total antibiotics.

 

Panel Discussion: The Pregnancy Rate is Down – What is Wrong?
eCMEs, Published on: 23 Nov 2020

In this panel discussion, the moderators and panelists shed light on important factors that can affect the pregnancy rates in IVF.

 

Safety and Feasibility of ERAS for Total Laparoscopic Uncut Roux-en-Y Gastrojejunostomy after Distal Gastrectomy
Key Trials, Published on: 23 Nov 2020

Uncut Roux-en-Y gastrojejunostomy after distal gastrectomy is still the essential treatment for gastric cancer. The present study evaluated the safety and feasibility of enhanced recovery after surgery (ERAS) for total laparoscopic uncut Roux-en-Y gastrojejunostomy after distal gastrectomy. Findings showed that perioperative administration of the ERAS concept showed obvious advantages when intraoperative parameters, postoperative clinical indicators, and postoperative stress responses were analysed.

 

Impact of Sacubitril/Valsartan on Sudden Cardiac Death as per ICD Use and HF Cause
Key Trials, Published on: 23 Nov 2020

This sub-group analysis of the PARADIGM HF study demonstrates under-usage of ICD in patients with HFrEF despite reduction in sudden cardiac death. Sacubitril/valsartan reduced the risk of SCD in this patient subgroup regardless of the use of ICD.

 

Managing Epilepsy in Adults: Tips and Tricks ( Dr. AV Srinivasan)
Expert's Views, Published on: 20 Nov 2020

Epilepsy is a group of disorder characterized by two or more unprovoked seizures. The speaker mentioned that Levetiracetam as an AED has wide safety margin and minimal drug interactions with other antiepileptics. Also, it increases the rates of seizure freedom and is generally well tolerated.

Impact of Antidepressants on Quality of Life (Dr Tushar Kant)
Expert's Views, Published on: 19 Nov 2020

Major depressive disorder is a severe mood disorder associated with significant morbidity and mortality. Escitalopram as an antidepressant has good efficacy which significantly improves the depressive symptoms with minimal drug interaction and improved QoL.

Managing Elderly Patients with Epilepsy (Dr. Ch Vijay)
Expert's Views, Published on: 19 Nov 2020

Epilepsy is the third most common neurological disorder. The most common cause in elderly includes stroke related seizure followed by dementia & trauma. The management in elderly requires adequate evaluation of pharmacokinetic properties of AED & non-AEDs for the correct dosing regimen to reduce the side effects of AEDs and better efficacy.

Managing Depression and Comorbid Panic Attack (Dr. Wilona Braganza)
Expert's Views, Published on: 18 Nov 2020

The global burden of disease has found both depression and panic to rank very high in terms of its disabling impact on individual. SSRI are preferred drug because of simplicity of use and generally safer and tolerable profile which enhance compliance in the patients.

 

Managing Elderly Patients with Epilepsy (Dr. Prashant Makhija)
Expert's Views, Published on: 18 Nov 2020

Epilepsy in elderly poses both diagnostic and therapeutic challenges to the individual. Some important differentials to be considered in elderly includes syncope, stroke, metabolic disturbances. Treatment is challenging because of associated comorbidity and drug interactions which needs to be considered during treatment.

 

DREAM Study: Severity of Dry Eye Disease and Its Impact on Work Productivity and Activity Impairment
Key Trials, Published on: 18 Nov 2020

This sub-study of the DREAMS study demonstrates that increasing severity of dry eye disease leads to decreased work productivity and activity level and has a negative economic impact.

Efficacy and Safety of Lacosamide as Adjunctive Therapy for Epilepsy: Evidence form Real-world Setting
Key Trials, Published on: 18 Nov 2020

This real-world study conducted in Taiwan, demonstrated lacosamide to be effective and safe in patients with focal impaired awareness seizures and/or secondarily generalized seizures

 

KDIGO: Management of Diabetes in Chronic Kidney Disease (2020)
Guidelines, Published on: 17 Nov 2020
VERIFY: Early Initiation of Vildagliptin plus Metformin Delays Treatment Escalation in Treatment Naïve Young-onset Diabetes Patients
Key Trials, Published on: 17 Nov 2020

According to sub analysis of VERIFY trial early aggressive combination with vildagliptin and metformin provides greater and durable glycaemic control in YOD patients (who face a very long duration of disease) compared to metformin alone.

PIONEER HF: Sacubitril/valsartan in African-American Patients with ADHF
Key Trials, Published on: 11 Nov 2020

This subgroup analysis of the PIONEER-HF trial demonstrated sacubitril/valsartan to be equally effective and safe in African-American and non-African-American patients with acute decompensate heart failure.

Do’s and Don’ts While Taking Iron Supplements
Patient Education, Published on: 11 Nov 2020

Many common factors increase or decrease absorption of iron. Knowing these factors may help avoid mistakes one makes while taking iron supplements, and thereby help improve the haemoglobin concentration.

Zinc: Low Dose vs. High Dose for Childhood Diarrhoea
Key Trials, Published on: 09 Nov 2020

Amongst children with acute diarrhoea, low dose zinc (10 mg and 5 mg per day) was non-inferior to high dose zinc (20 mg/day) in terms of duration of diarrhoea and mean number of stools. The use of lower doses was associated with lower risk of vomiting.

 

Latest Updates on Migraine
Expert's Views, Published on: 09 Nov 2020

According to WHO, headache accounts for top 10 disability worldwide. CGRP antagonist, CGRP monoclonal antibodies and 5HT 1F receptors are the new emergent therapies in migraine. Botox is an additional option for severe treatment of migraine.

A New Urine DNA mutation Detection Test Offers Promise in Detecting Recurrence in Non-Muscle-Invasive Bladder Cancer
Key Trials, Published on: 06 Nov 2020

As per the results of this diagnostic study, the new urine-based DNA mutation detecting test is a promising alternative for the detection of recurrence in patients with non-muscle-invasive bladder cancer.

 

Effect of PARA, IBUP ACEC on Success of Maxillary Infiltration Anaesthesia in Patients with Irreversible Pulpitis
Key Trials, Published on: 05 Nov 2020

This is a prospective, randomized study evaluating the effect of preoperative administration of paracetamol (PARA), ibuprofen (IBUP), or aceclofenac (ACEC) on the success of maxillary infiltration anaesthesia in patients with irreversible pulpitis. The study showed significant improvement in the efficacy of maxillary infiltration anaesthesia with preoperative administration of PARA, IBUP, and ACEC in patients with irreversible pulpitis

 

Efficacy of Ibuprofen and Aceclofenac on Pain, Facial Swelling and Trismus Following Extraction of Impacted Third Molar
Key Trials, Published on: 05 Nov 2020

Ibuprofen (400 mg) and aceclofenac (100 mg) were found to be effective in controlling postoperative swelling, pain and trismus after surgical removal of impacted lower-third molars. Alleviation of pain and trismus was found to be better with ibuprofen as compared to aceclofenac. Both the drugs had comparable efficacy with respect to control of facial swelling.

 

Emzumab (Omalizumab) Monograph
Our Publications, Published on: 04 Nov 2020

Emzumab is omalizumab 150mg powder for subcutaneous injection. This Emzumab monograph captures efficacy studies, safety data, how to reconstitute Emzumab, dose calculators and much more.

 

Impact of adding Dorzolamide 2% or Brinzolamide 1% to Timolol 0.5% on Visual Field Progression in Patients with POAG
Key Trials, Published on: 04 Nov 2020

This study identifies various risk factors associated with progression of visual field in primary open angle glaucoma patients. The study further demonstrates that adding dorzolamide rather than brinzolamide to timolol significantly reduced the risk of progression.

 

Efficacy Evaluation of Solifenacin and Tamsulosin Combination Therapy vs. Tamsulosin Monotherapy
Key Trials, Published on: 04 Nov 2020

Tamsulosin and Solifenacin combination improves Prostate & OAB symptom scores and QOL scores as compared to Tamsulosin alone.

Silodosin, An Efficacious and Safe Drug for Relief from Nocturia Due to BPH
Key Trials, Published on: 04 Nov 2020

Silodosin, a selective α1A-adrenoceptor antagonist, is a safe option that yields relief and improves health-related QoL in patients suffering from nocturia in BPH.

Intramuscular Ketorolac vs. Diclofenac Sodium: Pre-emptive Analgesic Effect following Surgical Extraction of the Third Molar
Key Trials, Published on: 30 Oct 2020

Amongst patients undergoing surgical extraction of the third molar, intramuscular ketorolac had a better pre-emptive analgesic effect over diclofenac sodium. Immediate post-operative pain free period did not differ significantly between the two groups.

 

Efficacy of Saccharomyces boulardii verse Lactic Acid as Probiotics in Acute Paediatric Diarrhoea
Key Trials, Published on: 30 Oct 2020

The present study compared the efficacy of Saccharomyces boulardii and lactic acid-producing probiotics in acute paediatric diarrhoea. The study data suggest that Saccharomyces boulardii is more effective than lactic acid-producing probiotics in children six months to 5 years of age.

 

High Rates of Clinical Recovery with Remdesivir in Pregnant Women Hospitalized with Severe COVID-19
Key Trials, Published on: 30 Oct 2020

Compassionate use of remdesivir in pregnant and postpartum women hospitalized with severe Covid-19 was associated with high clinical recovery rates and was safe and well tolerated.

 

Triple Therapy Beneficial in Smokers and Non-Smokers with COPD – An Indian Real-World Study
Key Trials, Published on: 30 Oct 2020

Triple therapy with the once-daily combination of TFC (tiotropium/formoterol/ciclesonide) resulted in improvements in pulmonary function and health status in patients with chronic obstructive pulmonary disease (COPD). The effects were more pronounced in non-smokers as compared with smokers, suggesting that non-smokers with COPD might benefit from added treatment with inhaled corticosteroid.

 

ADVANCE Trial: 96-week Efficacy and Safety of DTG Combined with FTC and TAF or TDF versus EFV Combined with FTC and TDF
Key Trials, Published on: 30 Oct 2020

The ADVANCE trial compared the efficacy and safety of a triple-therapy combination of emtricitabine and dolutegravir plus either of two tenofovir prodrugs - tenofovir alafenamide fumarate or tenofovir disoproxil fumarate against the tenofovir disoproxil fumarate, emtricitabine and efavirenz. The results of this study confirmed the 48-week efficacy and safety data.

 

CREDENCE: Early Change in Albuminuria with Canagliflozin Predicts Kidney and CV Outcomes in Patient with T2DM and CKD
Key Trials, Published on: 29 Oct 2020

Amongst patients with T2DM and CKD, canagliflozin treatment was associated with early, sustained reductions in albuminuria that were independently associated with lower incidence long-term kidney and CV outcomes. Monitoring albuminuria during canagliflozin treatment is important to track kidney and CV prognosis.

 

5-Year Efficacy and Safety Results of TCZ Monotherapy in Patients Who Were Part of the AMBITION Study
Key Trials, Published on: 29 Oct 2020

This is the long-term extension study that evaluated efficacy and safety of tocilizumab monotherapy in patients who were part of the AMBITION study. The 5-year results confirm the continued efficacy and safety of TCZ as monotherapy in patients with active rheumatoid arthritis.

 

Effectiveness of Two Levels of Physical Activity Interventions Before and Up to Six and Half Months After Bariatric Surgery
Key Trials, Published on: 29 Oct 2020

This is the first study to measure the effects of physical activity interventions that begin before bariatric surgery and continue postoperatively. The study compared two levels of interventions with bariatric surgery alone in promoting physical activity and structured, bout-related exercise. The study showed that patients in exercise counselling group had more steps and bout-minutes/week than standard care and pedometer group, demonstrating that combining self-monitoring, education, and a collaborative approach to exercise promotion can be effective.

 

Obeticholic Acid is Effective and Safe in Primary Biliary Cholangitis – A 3-Year Interim Analysis of POISE Trial
Key Trials, Published on: 29 Oct 2020

The 3-year interim analysis of the ongoing POISE trial demonstrated long-term efficacy and safety of obeticholic acid in patients with primary biliary cholangitis who are intolerant or inadequately responsive to ursodeoxycholic acid. Treatment with obeticholic acid resulted in improvements in markers of cholestasis and liver enzymes.

 

Dr. Subhas Mukherjee: A Forgotten Pioneer
eCMEs, Published on: 29 Oct 2020

In this keynote lecture, the doctor talks about evolution of infertility management and journey of IVF in India and the pioneering work of Dr. Subhas Mukherjee in the field of IVF.

 

Smile Design Principals
eCMEs, Published on: 28 Oct 2020

It’s a case based discussion on different aspects of smile design principles. With the special mention on, why the smile design principles are important to know and what is the application of it in the field of dentistry.

Case Presentation of HTN with discomfort & fatigue diagnosed as HFpEF
Expert's Views, Published on: 28 Oct 2020

Dr P K Hazra talks about the case of hypertensive patient with discomfort and fatigue diagnosed as HFpEF.

 

Initiate MRA early in HFrEF
Expert's Views, Published on: 28 Oct 2020

Dr P K Hazra talks about the importance of the time of initiation of MRA in HFrEF patients.

 

MRA therapy across the HF Continuum
Expert's Views, Published on: 28 Oct 2020

Dr P K Hazra talks about the use of MRA therapy across the HF continuum.

 

When to Start Different Therapies in Heart Failure
Expert's Views, Published on: 28 Oct 2020

Dr P K Hazra talks about when to start different therapies in heart failure.

 

Evolution of Different Heart Failure Therapies
Expert's Views, Published on: 28 Oct 2020

Dr P K Hazra talks about the evolution of different heart failure therapies.

 

Rate of Intra-operative Hyponatraemia Following Use of Intravenous Fluids in Children Undergoing Surgical Procedures
Key Trials, Published on: 28 Oct 2020

This study determined the rates of intra-operative hyponatraemia development post use of hypotonic intravenous fluids in children undergoing minor elective surgical procedures. The study showed a comparable risk of developing hyponatremia in healthy children managed with hypotonic or parenteral maintenance solutions intraoperatively

 

ESMO 2020 Update in Genitourinary Cancer
Conference Proceedings, Published on: 28 Oct 2020

Key highlights in Genitourinary cancer of the European Society of Medical Oncology (ESMO) 2020 Virtual Congress held from 19th to 21st September 2020.

 

ESMO 2020 Update in Lung Cancer
Conference Proceedings, Published on: 28 Oct 2020

Key highlights in Lung cancer of the European Society of Medical Oncology (ESMO) 2020 Virtual Congress held from 19th to 21st September 2020.

 

Non-operative Management Using Antibiotic Therapy vs. Laparoscopic Appendectomy in Children with Uncomplicated Appendicitis
Key Trials, Published on: 27 Oct 2020

Amongst children with uncomplicated appendicitis, an initial non-operative strategy with antibiotics alone was successful in substantial proportion of patients compared with an urgent surgery approach. Patients treated with the former approach had fewer disability days at one year.

 

Calcium Orotate Increases Serum Calcium and Physical Activity in Postmenopausal Osteoporotic Women
Key Trials, Published on: 27 Oct 2020

Treatment for 2 months with calcium orotate resulted in two-fold increase in the serum calcium levels, highly significant increased physical activity and symptomatic relief as compared to calcium carbonate + vitamin D3 in postmenopausal osteoporotic women. Treatment with calcium orotate was safe and well tolerated.

 

Remdesivir Shortens Time to Recovery in Hospitalized Patients with COVID-19
Key Trials, Published on: 26 Oct 2020

Treatment with remdesivir shortened the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection as compared to placebo.

 

Dupilumab Effective and Safe in Chronic Rhinosinusitis with Nasal Polyps
Key Trials, Published on: 26 Oct 2020

Treatment with dupilumab was effective in reducing polyp size, sinus opacification, and symptom severity and was well tolerated in adults with chronic rhinosinusitis with nasal polyps (CRSwNP). Adding dupilumab to daily standard of care for patients with severe CRSwNP might be a good alternative.  

 

DISCOVER Study: Efficacy and Safety of F/TAF with F/TDF for the Prevention of HIV Among Cisgender MSM and Transgender Women Who Have Sex with Men
Key Trials, Published on: 26 Oct 2020

DISCOVER Study is the first active-controlled, phase 3, non-inferiority trial comparing a new regimen for pre-exposure prophylaxis; emtricitabine and tenofovir alafenamide (F/TAF) with the current standard-of-care regimen, emtricitabine and tenofovir disoproxil fumarate (F/TDF). The study showed that F/TAF has non-inferior efficacy and has more favourable effects on bone mineral density and biomarkers of renal safety versus F/TDF when used as PrEP in HIV prevention.

Assessing Meibomian Gland Dysfunction at Different Ages: The Role of Tear-film Lipid Layer Thickness
Key Trials, Published on: 26 Oct 2020

The study explores the role of tear-film assessment using the lipid layer thickness (LLT) evaluation in patients with meibomian gland dysfunction (MGD) across various age groups. LLT evaluation is a valuable screening tool for MGD.

Carbamazepine vs. Oxcarbazepine: Analysing the Adverse Drug Reactions Profile
Key Trials, Published on: 26 Oct 2020

The current study demonstrated that oxcarbazepine had lower adverse drug reaction (ADR) profile as compared to carbamazepine and should be preferred over the latter as the first-line antiepileptic. The study also hints on using a lower than recommended dosage for both the medications considering the ADRs even at a low dosage.

Novel Exhalation Delivery System with Fluticasone Propionate Improves Clinical Outcomes in Chronic Rhinosinusitis with Nasal Polyps
Key Trials, Published on: 20 Oct 2020

The novel exhalation delivery system with fluticasone (EDS-FLU) resulted in significant improvements in all 4 diagnostically defining disease symptoms, polyp grade, and quality of life in patients with chronic rhinosinusitis with nasal polyps.

 

Artificial Urinary Sphincter Implantation Improves Functional Outcomes in Women with Stress Urinary Incontinence
Key Trials, Published on: 20 Oct 2020

Artificial urinary sphincter implantation in women with stress urinary incontinence provided satisfactory long-term functional outcomes and is an effective treatment option after failure of first-line therapy.

 

Exploring the Role of Healthy Lifestyle in Restoring the Antioxidant Balance and Retarding the Progression of Age-related Macular Degeneration
Key Trials, Published on: 16 Oct 2020

Imbalance of antioxidant system correlates with the severity of age-related macular degeneration (AMD). Incorporating healthy lifestyle (healthy dietary habits supplemented with physical activity) may help restore the antioxidant balance and delay the progression of AMD.

 

Long-term Efficacy, Tolerability, and Safety of Levetiracetam, Lamotrigine and Oxcarbazepine in Patients with Newly Diagnosed Focal Epilepsy: Real-world Data
Key Trials, Published on: 15 Oct 2020

This study provides a first head-to-head comparison on the long-term efficacy, safety and tolerability of three antiepileptic dugs in patients with newly diagnosed focal epilepsy.

 

Nebulized Glycopyrrolate Reduces the Risk of Clinically Important Deterioration in Moderate-to-Severe COPD
Key Trials, Published on: 15 Oct 2020

Nebulized glycopyrrolate (GLY) 25 mcg BID and 50 mcg BID significantly reduced the risk of clinically important deterioration in patients with moderate-to-severe COPD. Treatment with GLY prevented clinically meaningful worsening in forced expiratory volume in 1 sec (FEV1) and patient-reported health status.

Efficacy of 6 Months of Capecitabine vs. 12 Months as Adjuvant Chemotherapy for Patients with Stage III CRC
Key Trials, Published on: 14 Oct 2020

This is the first phase III trial on postoperative adjuvant chemotherapy in which the duration of oral 5-fluoropyrimidine drug for colorectal cancer was directly compared. The study showed that adjuvant chemotherapy with capecitabine for 12 months had substantial clinical impact compared to 6 month capecitabine.

Short-term Clinical and Bacteriological Efficacy and Safety of Ciprofloxacin for 7 Days versus 14 Days in Women with Acute Pyelonephritis
Key Trials, Published on: 14 Oct 2020

This study compared the efficacy and safety of ciprofloxacin for 7 Days versus 14 Days in women with acute pyelonephritis. The findings showed that community-acquired acute pyelonephritis in women can be treated successfully and safely with oral ciprofloxacin for 7 days and even in older patients and those with a more severe infection.

Comparative Effectiveness of Various Classes of Antihyperglycemic Agents on Risk of Kidney Outcomes: Real-world Evidence
Key Trials, Published on: 14 Oct 2020

This first-of-its-kind, large-scale, real-world study demonstrated that amongst T2DM patients, treatment with SGLT2i or GLP-1RA was associated with a lower risk of adverse kidney outcomes vs. DPP4i or SU.

Meta-analysis on the Efficacy and Safety of Sacubitril/valsartan in Heart Failure
Key Trials, Published on: 14 Oct 2020

According to this meta-analysis, sacubitril/valsartan, as compared with ACE inhibitors or ARBs, was associated with reduced risk of all-cause and CV mortality in patients with HFrEF and of HF hospitalization in patients with HFrEF and HFpEF.

Higher Relative Bioavailability of Calcium from Calcium Orotate than Calcium Carbonate
Key Trials, Published on: 14 Oct 2020

Calcium orotate was associated with significantly higher oral bioavailability than calcium carbonate; Rapid, early and higher rate and extent of absorption compared to calcium carbonate; Substantially and significantly greater increases in serum calcium concentration, greater DAUC for serum calcium increment, and greater decreases in iPTH than equimolar amounts of calcium from supplements based on calcium carbonate.

 

Efficacy and Safety of mXELIRI Regimen versus Standard FOLFIRI Regimen, W or W/o Bevacizumab as a Second-line Therapy for Metastatic Colorectal Cancer
Key Trials, Published on: 14 Oct 2020

This study is the first phase 3 randomised trial evaluating whether the mXELIRI regimen is non-inferior to the standard FOLFIRI regimen, with or without bevacizumab in both regimens, as second-line therapy for patients with metastatic colorectal cancer. The results showed that mXELIRI with or without bevacizumab is non-inferior and well tolerated to FOLFIRI with or without bevacizumab in terms of overall survival.

 

Colistin Dosage Calculator
Clinical Tools, Published on: 13 Oct 2020

This tool helps in calculating colistin loading and maintenance doses for the patients as per the guidelines.

 

Obeticholic Acid Reduces Alkaline Phosphatase and Bilirubin Levels in Primary Biliary Cholangitis
Key Trials, Published on: 12 Oct 2020

Treatment for 12 months with obeticholic acid, administered either with ursodiol or as monotherapy, in patients with primary biliary cholangitis resulted in significant decreases in alkaline phosphatase level, total bilirubin level, and other biochemical markers of disease. Obeticholic acid was associated with an increased incidence of pruritus, which was dose-dependent.

 

Coadministration of Telmisartan/amlodipine and Rosuvastatin Safe and Effective in Hypertensive Patients with Dyslipidemia
Key Trials, Published on: 12 Oct 2020

Combined administration of telmisartan/amlodipine 80/5 mg and rosuvastatin 20 mg significantly reduced blood pressure and improved lipid control in hypertensive patients with dyslipidemia. The combination may help achieve the therapeutic goal of higher compliance over the long term.

 

Optimizing Depression Management
Expert's Views, Published on: 09 Oct 2020

Major depressive disorder is a severe mood disorder associated with significant morbidity and mortality. Escitalopram as an antidepressant has good efficacy. It significantly improves the depressive symptoms with minimal drug interaction with better tolerability profile.

 

Triptans in Acute Treatment of Migraine
Expert's Views, Published on: 08 Oct 2020

Migraine is a common neurological disorder occurring in different phases including prodrome, aura, headache and postdrome phase. Triptan is 5HT 1B/1D receptor agonist which causes cerebral vasoconstriction and reduces pain. It can be given by nasal, oral and subcutaneous route.

 

Ferrous Ascorbate Formulation with 16:84 Iron: Ascorbic Acid Ratio Might Have Better Gastrointestinal Tolerability than Conventional Formulations
Key Trials, Published on: 08 Oct 2020

The gastrointestinal tolerability of ferrous ascorbate containing 16:84 iron:ascorbic acid ratio was better than the conventional formulations containing 13:87 or 20:80 ratio of iron and ascorbic acid respectively, resulting in 30% reduction in the gastrointestinal side effects and 50% reduction in epigastric burning sensation. The absorption of the test product was found to be better than the conventional formulations.

 

Young-onset Diabetes, Prediabetes and Early Glycaemic Recovery-Establishing their Link with All-cause and CVD Mortality
Key Trials, Published on: 06 Oct 2020

Young-onset diabetes or prediabetes increased CVD risks and all-cause mortality in long-term.  This long-term risk for CVD incidence and all-cause mortality could be reduced with recovery of hyperglycaemia.

 

Ceftriaxone, Sulbactam and Disodium EDTA Combination Effective Against E. coli Infections
Key Trials, Published on: 05 Oct 2020

Ceftriaxone plus sulbactam plus EDTA significantly reduced the efflux pump expression and can be considered as an alternative in treating the E coli infections with efflux over expressed strains. EDTA disodium increases the susceptibility of E coil efflux over expressed strains by inhibiting efflux pumps

 

Azelastine Hydrochloride and Fluticasone Propionate Combination Nasal Spray Offers Better and Complete Symptom Relief in Allergic Rhinitis
Key Trials, Published on: 05 Oct 2020

The intranasal spray containing azelastine hydrochloride (AZE) and fluticasone propionate (FP) offered significantly better, more rapid and more complete symptom control as compared to AZE monotherapy in Russian patients with moderate-to-severe seasonal allergic rhinitis or rhinoconjunctivitis.

 

Prognosis of Schizophrenia in Rehabilitated Women
Expert's Views, Published on: 05 Oct 2020

Schizophrenia is a serious lifelong disorder affecting behaviour, thought and cognition Psychosocial rehabilitation is important for independent level of optimal functioning & better Quality of life. The key characteristics of successful rehabilitation depends on integrative care & active involvement of multiple caregivers.

Epilepsy Management
Expert's Views, Published on: 05 Oct 2020

Antiepileptic drugs are the mainstay treatment of epilepsy. Levetiracetam is a novel AED with wide safety profile with minimal drug interactions. Also, has significantly higher retention rate and better seizure control compared to traditional AED.

 

Management of Depression and Anxiety
Expert's Views, Published on: 05 Oct 2020

Depression and anxiety disorder commonly occur together, and they have high severity of illness and significantly impair work functioning and quality of life. Escitalopram, desvenlafaxine and sertraline are commonly utilized to manage depression and anxiety.

 

Cefpodoxime Safe and Effective in Empirical Treatment of Upper Respiratory Tract Infections
Key Trials, Published on: 30 Sep 2020

Empirical treatment with cefpodoxime resulted in high cure rates and clinical improvement in patients with acute maxillary sinusitis and acute tonsillopharyngitis. The favorable safety and tolerability profile seem to make cefpodoxime an empirical choice in adult Egyptian patients with acute upper respiratory tract infections.

 

Effective Antibiotic for Prevention of Bacteremia Following Dental Extraction
Key Trials, Published on: 30 Sep 2020

Amoxicillin is the drug of choice in patients ‘at risk’ of developing bacteremia following dental extractions (BDE). Moxifloxacin seems a promising safe alternative for the prevention of BDE when beta-lactams are not indicated.

 

ESMO 2020: Update in Breast Cancer
Conference Proceedings, Published on: 30 Sep 2020

Key highlights in Breast cancer of the European Society of Medical Oncology (ESMO) 2020 Virtual Congress held from 19th to 21st September 2020.

 

Postoperative Treatment with Amoxicillin/Clavulanic Acid for Preventing Infectious and Inflammatory Complications Following Impacted Mandibular Third Molar Extraction
Key Trials, Published on: 30 Sep 2020

The present study assessed whether the frequency of postoperative infectious and inflammatory complications in patients treated with placebo is greater than those treated with antibiotic after extraction of an impacted mandibular third molar. The study showed that postoperative treatment with amoxicillin/ clavulanic acid was efficacious in preventing complication.

An Important Add on to Optimize Epilepsy Management
Expert's Views, Published on: 29 Sep 2020

Epilepsy is recurrent unprovoked seizure that requires accurate identification along with its type for the management and prognosis of patient. Lacosamide is widely used add on antiepileptic as it provides synergistic epilepsy control and controls the seizures.

 

Case Discussion on Acute MI with Fatigue and Dyspnoea
Expert's Views, Published on: 29 Sep 2020

Dr P P Mohanan talks about the case discussion on acute MI with fatigue and dyspnoea.

 

Case Discussion on HTN with Discomfort, Fatigue Diagnosed as HFpEF
Expert's Views, Published on: 29 Sep 2020

Dr P P Mohanan talks about the case of hypertensive patient with discomfort and fatigue diagnosed as HFpEF

Case Discussion on Chronic HFrEF and Acute Decompensation
Expert's Views, Published on: 29 Sep 2020

Dr P P Mohanan talks about the case of chronic HFrEF patient now hospitalized for acute decompensation.

 

Importance of MRA in HF
Expert's Views, Published on: 29 Sep 2020

Dr P P Mohanan talks about the importance of MRAs in heart failure.

 

Clinical Outcomes, Effects on Glucose and Serum Lipids with Metformin versus Ethinyl Estradiol-Cyproterone Acetate in PCOS
Key Trials, Published on: 29 Sep 2020

Treatment with ethinyl estradiol + cyproterone acetate had better clinical outcomes than metformin with respect to control of menstrual cycle regulation and hyperandrogenism. Metformin, on the other hand, showed beneficial effects on serum lipids; improving glucose tolerance; reducing body weight and improve conception in PCOS cases.

 

Managing Depression with Comorbid Diabetes
Expert's Views, Published on: 29 Sep 2020

Patients suffering from diabetes are 3 times more likely to have depression, also more likely to have diabetic burnout affecting physical &mental health. Escitalopram effectively manages depression and comorbid diabetes by increasing serotonin level and insulin level improving glycaemic controls, also in long term improve HB1AC levels.

Latest Advancement in Psychiatry
Expert's Views, Published on: 29 Sep 2020

Deep brain stimulation is recent advancement in psychiatry utilized in several disorder that involves electric stimulus which is minimally invasive, safe, adjustable and reversible nerve involvement technology.

Cataract Surgery Antibiotic Prophylaxis: The Practice Pattern in India
Key Trials, Published on: 28 Sep 2020

This first-of-its-kind survey conducted among ophthalmologists associated with AIOS presents the current practice patterns of ophthalmologists in India for prevention of endophthalmitis following cataract surgery.

 

Choosing the Right Antipsychotic in Schizophrenia
Expert's Views, Published on: 25 Sep 2020

Schizophrenia is common psychiatric disorder treated by typical and atypical antipsychotic. Atypical antipsychotics such as olanzapine, risperidone, quetiapine and aripiprazole are recommended for the patient with agitation, aggression, acute psychotic symptoms and prophylaxis. The efficacy and side effect of antipsychotics aids clinicians in choosing right antipsychotic.

Efficacy and Safety of Levetiracetam as an Adjunctive to Carbamazepine and Phenytoin for treating Focal Seizures in Indian Patients
Key Trials, Published on: 22 Sep 2020

Amongst patients with focal seizures, levetiracetam can be a good adjunctive to carbamazepine or phenytoin when patients fail to achieve adequate seizure control with monotherapy

TRANSITION: Impact of Sacubitril/valsartan on NT-proBNP in Hospitalized HFrEF Patients
Key Trials, Published on: 22 Sep 2020

This post hoc analysis of TRANSITION study demonstrated a rapid and significant reduction in NT-proBNP, and favourable outcomes in patients with ADHF when sacubitril/valsartan was initiated in-hospital. Early in-hospital initiation of sacubitril/valsartan maybe beneficial in this patient subgroup.

 

Safety, Feasibility, and Clinical Efficacy of ERAS in Patients Undergoing Radical Gastrectomy
Key Trials, Published on: 22 Sep 2020

The present study evaluated the safety, feasibility, and clinical efficacy of enhanced recovery after surgery (ERAS) in patients undergoing radical gastrectomy. The study demonstrated that ERAS was associated with significant clinical and economic benefits in gastric cancer patients undergoing radical gastrectomy.

 

Ketoroloac vs. Ketorolac in Combination with Tramadol/Acetaminophen to Manage Pain followingThird Molar Surgery
Key Trials, Published on: 22 Sep 2020

Both ketorolac and the combination of ketorolac plus tramadol/acet­aminophen showed good control of pain following the third molar surgery, the pain difference between the two was small and not relevant clinically. Use of combination was associated with extra cost and increased adverse events.

 

How is Telemedicine in Pediatric Practice Becoming the Need of The Hour?
Expert's Views, Published on: 21 Sep 2020

In India, providing In-person healthcare is challenging, given the large geographical distances and limited resources.  Telemedicine can provide an optimal solution in pedaitric practice in these times as it allows pediatricians to deliver their services for diagnosis, treatment of diseases, for research, evaluation, and for continuous education with the help of information and communication technologies. Find out more views from an expert panel about the advantages of telemedicine in pediatric practice.

 

What is Telemedicine (Telehealth) And Where Do We Stand Currently?
Expert's Views, Published on: 21 Sep 2020

In India, providing In-person healthcare is challenging, given the large geographical distances and limited resources.  In this type of scenario, telemedicine can provide an optimal solution as it allows health care professionals to deliver their services for diagnosis, treatment of disease, for research, evaluation, and for continuous education with the help of information and communication technologies. Find out more views from an expert panel about the practice of telemedicine and its advantages.

 

Webinar Snippet: Role of Warfarin in Patients with Chronic Kidney Disease
Expert's Views, Published on: 18 Sep 2020
Webinar Snippet: How to Optimize Warfarin Doses from Corresponding INR Values in Routine Clinical Practice?
Expert's Views, Published on: 18 Sep 2020
Webinar Snippet: What Are the Important Aspects of Warfarin Pharmacotherapy?
Expert's Views, Published on: 18 Sep 2020
Webinar Snippet: Place of Warfarin in Current Era of NOACs in AF: India Update
Expert's Views, Published on: 18 Sep 2020
Meta-Analysis of Prostaglandin Analogues for Treating IOP in Patients with POAG or OHT
Key Trials, Published on: 18 Sep 2020

The systematic review and meta-analysis demonstrates 0.03% bimatoprost to be more effective for controlling IOP compared to 0.005% latanoprost 0.004% travoprost in patients with POAG and OHT. However, 0.005% latanoprost is better tolerated in patients with POAG or OHT.

 

A Real-World Indian Study Demonstrates Efficacy and Safety of Triple Therapy in COPD Patients
Key Trials, Published on: 18 Sep 2020

Triple therapy with once-daily combination of tiotropium, formoterol and ciclesonide (TFC) significantly improved pulmonary function, symptoms, and quality of life in patients with chronic obstructive pulmonary disease (COPD), irrespective of their smoking history. The effects were more pronounced among non-smoker COPD patients, indicating a beneficial effect of adding inhaled corticosteroid to the bronchodilators.

 

Improving CV Outcomes in COPD
eCMEs, Published on: 17 Sep 2020

COPD and cardiovascular diseases commonly coexist. In these patients, use of appropriately dosed bronchodilators is safe. In fact, optimized COPD therapy in high-risk patients reduces both respiratory and cardiac mortality.

 

Why is My COPD Patient Not Responding to Standard Treatments?
eCMEs, Published on: 17 Sep 2020

This case-based session addresses many practical aspects in daily COPD management. Both the international and Indian experts shared their experience and highlighted how evidence can be translated in daily practice to optimize COPD management.

 

Efficacy and Safety of ZOL With or Without MTX for Treatment and Prevention of Osteoporosis in RA Patients
Key Trials, Published on: 15 Sep 2020

This study evaluated the efficacy and safety of zoledronic acid with or without methotrexate for the prevention and treatment of bone destruction rheumatoid arthritis(RA) patients. The study showed that zoledronic acid has a synergistic effect when combined with methotrexate, inhibiting RA disease activity, reducing fracture risk, and improving quality of life in RA patients with secondary osteoporosis.

Accuracy of Combined Ultrasound and Radiography for Diagnosis of Obstructive Ureteric Stone in Patients with Acute Flank Pain
Key Trials, Published on: 15 Sep 2020

Combined ultrasound (US) with radiography offers promising result for the diagnosis of obstructive ureteric stone in patients presenting with acute flank pain to the emergency department. The combined modality approach might reduce the need for computed tomography (CT) scan, thereby reducing the radiation exposure to the patient.

 

Non-Inferiority of Newly Developed Highly Purified Human Menopausal Gonadotrophin to Conventional HMG in IVF
Key Trials, Published on: 15 Sep 2020

The newly developed highly purified HP-HMG preparation was non-inferior to the conventional HP-HMG in the number of oocytes retrieved in women undergoing IVF using the GnRH antagonist protocol. The clinical efficacy and safety profile of this formulation was comparable to the conventional preparation.

 

Why is 1st Generation Antihistamine No Longer Indicated to Treat Allergic Rhinitis or Urticaria?
Expert's Views, Published on: 14 Sep 2020

Allergic disorders like allergic rhinitis (AR) and urticaria are now being recognised as global health problems affecting millions of children worldwide. Although not life-threatening, the consequences of these conditions are not trivial. Antihistamines targeting the histamine H1 receptor play an important role in improving and maintaining the quality of life of patients. Despite having efficacy, 1st generation antihistamines are not preferred instead 2nd generation oral antihistamines are recommended as first line treatment for allergic diseases. Take a view of the excerpt to know the reasons why first generation antihistamines are a less preferred option.  

 

How Common Are Allergic Diseases Like Allergic Rhinitis and Urticaria and What is its Impact on Quality of Life of Children?
Expert's Views, Published on: 14 Sep 2020

Allergic disorders like allergic rhinitis (AR) and urticaria are now being recognised as global health problems affecting millions of children worldwide. Although not life-threatening, the consequences of these conditions are not trivial. Allergies impose a substantial socio-economic burden on patients, their families and society and they have a negative impact on patient's quality of life. Find out the expert's opinion on the epidemiology and impact of these disorders in children.

Comparative Study of Early Stoma Closure with Conventional Stoma Closure Following Bowel Surgery
Key Trials, Published on: 14 Sep 2020

The present study compared the outcomes of early stoma closure with conventional stoma closure following bowel surgery. The study showed that early stoma closure was not associated with an increased risk of postoperative complications and leads to better a quality of life.

 

Anticoagulants in Clinical Practice and The Place in Therapy of Warfarin- The Gold Standard VKA
eCMEs, Published on: 14 Sep 2020

Warfarin remains the gold standard oral anticoagulant (OAC) in the Indian clinical practice. In the era of newer OACs, warfarin still has wider real world clinical use.

 

Efficacy and Safety of Cefixime in Children with Community-acquired Infections
Key Trials, Published on: 14 Sep 2020

This study evaluated the efficacy of oral third generation cephalosporin-cefixime given as a single dose to outpatients with a confirmed community-acquired infection. The study showed that cefixime demonstrated good efficiency in patients with community-acquired infections suffering from acute otitis media, lower respiratory tract infections and in uncomplicated urinary tract infections.

 

Impact of Glucose-lowering Drugs or Strategies on CV Events in Individuals with or at Risk of T2DM
Key Trials, Published on: 14 Sep 2020

This updated systematic review and meta-analysis demonstrated that use of glucose lowering drugs or strategies reduced the risk of fatal and non-fatal atherosclerotic events in individuals with type-2 diabetes mellitus or at risk of the disease.

 

Useful Predictors in Analysing the Presence of Detrusor Overactivity in Male Patients with Lower Urinary Tract Symptoms
Key Trials, Published on: 14 Sep 2020

This review provides you a brief insight on useful predictors in analysing the presence of detrusor overactivity in male patients with lower urinary tract symptoms.

 

ENSURE Trial: Erlotinib versus Gemcitabine/cisplatin as First-line Treatment in EGFR mutation-positive Non-small-cell Lung Cancer Patients
Key Trials, Published on: 11 Sep 2020

ENSURE was the first and largest trial to prospectively investigate erlotinib versus chemotherapy in a broad Asian population. The study showed that erlotinib provides a statistically significant improvement in progression-free survival compared with gemcitabine/cisplatin in Asian patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer patients.

 

Efficacy and Safety of Er: Glass Laser Combined with Topical 5% Minoxidil versus 5% Minoxidil Alone in Male Androgenetic Alopecia Treatment
Key Trials, Published on: 11 Sep 2020

The present study evaluated the efficacy and safety of Er: Glass laser used in combination with topical 5% minoxidil versus 5% minoxidil alone for the treatment of male androgenetic alopecia. The study demonstrated that treatment with combination therapy resulted in superior clinical outcomes of hair growth compared to monotherapy.

 

Experience sharing on Dose optimization of Minocycline Injection
Expert's Views, Published on: 10 Sep 2020

In the era of increasing resistance of Antibiotics, how High Dose of Minocycline plays a pivotal role to manage gram negative Bacilli. Dr Vishnu Rao an Infectious Disease expert from Apollo Hyderabad shares his experience of High Dose Minocycline in the current era & how dose optimization of Minocycline IV Is the need of the hour .

Role of Echocardiographic Biomarkers to Ascertain the Effect of Sacubitril–valsartan on Vascular Properties in Patients with HFrEF
Key Trials, Published on: 10 Sep 2020

Sacubitril-valsartan treatment was associated with improvement in indices of vascular compliance as ascertained by echocardiographic evaluation. The echocardiographic biomarkers can be potentially used to assess the effectiveness of sacubitril-valsartan in HFrEF patients.

 

Use of Intra-articular Hyaluronic Acid in Osteoarthritis – Outcome of Long-Term Follow-up
eCMEs, Published on: 10 Sep 2020

A webinar on long term effectiveness of viscosupplementation with various types of Intra-articular Hyaluronic acid in Osteoarthritis in maintaining functional improvement of the knees.

 

Improved Discrimination between NTG and POAG: Insights from the Leuven Eye Study
Key Trials, Published on: 04 Sep 2020

Amongst glaucoma patients, those with NTG prominently exhibit signs of vascular dysfunction. Hence a combination of conventional and advanced assessment techniques may be important to understand the role of non-IOP-related factors associated with NTG in these patients.

 

Real World Experience with Pirfenidone on Tolerability and Survival: Indian Study
Key Trials, Published on: 04 Sep 2020

This is the first study from India which reports that full dose of pirfenidone ie 2400mg/d offers a significant survival advantage in idiopathic pulmonary fibrosis (IPF) patients. About 42% of the study subjects tolerated the full dose of pirfenidone (2400 mg/day), while 29.6 of the study subjects tolerated a dose of 1800-2400mg/day.

 

New Approaches Towards Treating Men with Metastatic Prostate Cancer
eCMEs, Published on: 03 Sep 2020

This Webcast focuses on the role of Enzalutamide, a second generation androgen receptor inhibitor for the treatment of men with metastatic prostate cancer. It covers advances in management of mCRPC and mCSPC and provides practical tips while prescribing Enzalutamide. The speaker also covers decision making algorithm in management of metastatic prostate cancer.

Does Remdesivir Provide a Benefit on Clinical Status for Patients Hospitalized with Moderate COVID-19 Pneumonia?
Key Trials, Published on: 03 Sep 2020

The present randomized clinical trial studied the effect of remdesivir vs standard care on clinical outcomes at 11 Days in patients with moderate COVID-19 patients. The study showed that the 5-day course of remdesivir had a statistically significantly better clinical status compared with those randomized to standard care at 11 days after initiation of treatment in patients with moderate disease.

 

Lacosamide as First Add-on therapy for Focal-onset Epilepsy: The Real-World Data from LACONORTE Study
Key Trials, Published on: 03 Sep 2020

The LACONORTE study provides real-world data on the efficacy and safety of lacosamide when used as a first add-on therapy for treating patients with focal onset epilepsy.

 

Anticoagulation Management Post-PEA in Patients with CTEPH: The Current Scenario
Key Trials, Published on: 02 Sep 2020

This is the largest study that provides a direct comparison of vitamin K antagonists and direct oral anticoagulants used for the management of patients with chronic thromboembolic pulmonary hypertension, following pulmonary endarterectomy.

 

Remdesivir Improves Survival Outcomes in ICU Patients with COVID-19 under Mechanical Ventilation
Key Trials, Published on: 02 Sep 2020

The mortality rate of patients with COVID-19 under mechanical ventilation is high. Treatment with remdesivir resulted in improved survival outcomes in these patients.

 

Montelukast Combined with Antihistaminics Might Benefit Patients with Resistant Allergic Rhinitis
Key Trials, Published on: 02 Sep 2020

Antihistaminics should be the first choice of treatment in patients with allergic rhinitis (AR). Montelukast should be combined with antihistaminics in resistant AR cases.

 

Webinar Snippet: What are The Current Guideline Recommendations on Management of Allergic Rhinitis and Urticaria?
Expert's Views, Published on: 02 Sep 2020

Allergic  disorders like allergic rhinitis (AR) and urticaria are now being recognised as global health problems affecting millions of children worldwide. Although not life-threatening, the consequences of these conditions are not trivial. Various guidelines recommend second generation oral antihistamine as first line treatment for symptomatic control of these disorders. Take a look at the expert's opinion stating these guideline recommendations on treatment of AR and urticaria in children. 

 

Webinar Snippet: Why Should Bilastine Be Preferred in Children with Allergic Rhinitis and Urticaria?
Expert's Views, Published on: 02 Sep 2020

Allergic disorders like allergic rhinitis (AR) and urticaria are now being recognised as global health problems affecting millions of children worldwide. Although not life-threatening, the consequences of these conditions are not trivial. Second generation oral antihistamines are preferred choice in treatment of such diseases. Bilastine is a most modern, second-generation antihistamine approved for use in children with allergic rhinoconjunctivitis and urticaria. It has the highest number of desired features for a modern antihistamine according to international ARIA guidelines. Take a look at the expert's comments on various positive attributes and efficacy of bilastine.

 

Webinar Snippet: How Safe is Bilastine?
Expert's Views, Published on: 02 Sep 2020

Allergic disorders like allergic rhinitis (AR) and urticaria are now being recognised as global health problems affecting millions of children worldwide. Although not life-threatening, the consequences of these conditions are not trivial. Second generation oral antihistamines are preferred choice in treatment of such diseases. Bilastine is a most modern, second-generation antihistamine approved for use in children with allergic rhinoconjunctivitis and urticaria. It has been shown to have an efficacy similar to that of other second-generation oral H1 antihistamines and an excellent safety profile with minimal sedative effect. Take a look at opinion of an allergy expert on various safety aspects of bilastine in children. 

 

Diagnosis and Monitoring of Asthma and COPD in the Era of Social Distancing
eCMEs, Published on: 01 Sep 2020

There are conflicts in terms of what is recommended for diagnosis of airway diseases and what is currently practiced. This lecture highlights important clinical aspects to optimize diagnosis and monitoring of airway diseases in current era.

 

Efficacy and Safety of Intravesical Bacillus Calmette-Guérin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria (ABU)
Key Trials, Published on: 01 Sep 2020

This study provides you a brief insight on the efficacy and safety of intravesical BCG instillations when used in patients with Non-Muscle-Invasive Bladder Cancer, presenting with asymptomatic bacteriuria (ABU).

CREDENCE: Impact of Canagliflozin on Cardio-Renal Outcomes in T2DM Patients with CKD
Key Trials, Published on: 01 Sep 2020

According to the findings of the CREDENCE trial, canagliflozin rendered protection against renal and cardiovascular outcomes in type-2 diabetes mellitus patients with albuminuric chronic kidney disease.

 

Non-Inferiority of Degarelix with Goserelin in Chinese Men with Prostate Cancer
Key Trials, Published on: 01 Sep 2020

Degarelix was non-inferior to goserelin in achieving and maintaining testosterone suppression at castrate levels with an acceptable safety profile during 1-year treatment in the Chinese patients with prostate cancer. Treatment with degarelix resulted in improved disease control, indicated by significantly higher prostate-specific antigen progression-free survival (PSA-PFS).

 

Random-Start Controlled Ovarian Stimulation Effective in Fertility Preservation in Cancer Patients
Key Trials, Published on: 01 Sep 2020

Random-start controlled ovarian stimulation (COS) was as effective as conventional-start COS in fertility preservation in cancer patients. Random-start COS significantly decreased the total time for an IVF cycle without affecting the oocyte yield, maturity or competence. This protocol would minimize delays and allow more patients to undergo fertility preservation and still proceed with cancer treatment within 2–3 weeks.

 

EURTAC Trial: Erlotinib versus Standard Chemotherapy as First-line Treatment in Advanced EGFR mutation-positive NSCLC Patients
Key Trials, Published on: 01 Sep 2020

EURTAC is the first prospective head to- head phase 3 study comparing the efficacy and safety of first-line erlotinib with platinum-based chemotherapy in non-Asian patients with advanced NSCLC and EGFR mutations. The study showed that erlotinib could improve median progression-free survival in European patients with EGFR mutation-positive NSCLC compared with standard chemotherapy.
 

CANVAS Program: Canagliflozin Delays the Initiation of Insulin or other Antihyperglycemic Agents in T2DM Patients
Key Trials, Published on: 01 Sep 2020

According to this post hoc analysis of the CANVAS program, use of canagliflozin vs. placebo, along with other background antihyperglycemic agents (AHA) was associated with a lesser likelihood of initiating insulin or new AHA in T2DM patients.

CREDENCE: Impact of Canagliflozin on Clinical Outcomes across a Broad eGFR Range
Key Trials, Published on: 01 Sep 2020

Canagliflozin reduced the risk of renal and CV events consistently across a broad range of eGFR including an eGFR of 30 to <45 ml/min per 1.73 m2. These findings support the use of canagliflozin even in T2DM patients with a lower eGFR.

 

CANVAS Program: The Synergistic Impact of Canagliflozin with GLP1 RA on Intermediate Markers of CV Risk in T2DM
Key Trials, Published on: 01 Sep 2020

According to the post hoc analysis of the CANVAS Program, canagliflozin, when added to glucagon like peptide-1 receptor agonist (GLP1 RA) exerted a synergistic impact on the intermediate cardiometabolic markers in T2DM patients.

 

CANVAS Program: Impact of Canagliflozin on Cardiovascular and Renal Outcomes in Type-2 Diabetes Patients
Key Trials, Published on: 01 Sep 2020

The CANVAS Program demonstrates that canagliflozin reduces the risk of CV events in type-2 diabetes patients who are at high risk of CVD.

AAD-NPF: Guidelines of Care for the Management and Treatment of Psoriasis with Awareness and Attention to Comorbidities (2020)
Guidelines, Published on: 28 Aug 2020
AAD-NPF: Guidelines of Care for the Management and Treatment of Psoriasis with Biologics (2020)
Guidelines, Published on: 28 Aug 2020
AAD-NPF: Guidelines of Care for the Management and Treatment of Psoriasis with Phototherapy (2020)
Guidelines, Published on: 28 Aug 2020
AAD-NPF: Guidelines of Care for the Management and Treatment of Psoriasis in Pediatric Patients (2020)
Guidelines, Published on: 28 Aug 2020
AAD-NPF: Guidelines of Care for the Management of Psoriasis with Systemic Non-biological Therapies (2020)
Guidelines, Published on: 28 Aug 2020
AAD-NPF: Guidelines of Care for the Management and Treatment of Psoriasis with Topical Therapy and Alternative Medicine Modalities for Psoriasis Severity Measures (2020)
Guidelines, Published on: 28 Aug 2020
Webinar Snippet: Is the MIC of Minocycline Greater than 2? Time to Optimize Dose of Minocycline
Expert's Views, Published on: 28 Aug 2020

 In the era of increasing resistance of Antibiotics, how High Dose of Minocycline plays a pivotal role to manage gram negative Bacilli. Dr Chandrashish Chakravarty a Critical Care expert  from Apollo Kolkata  shares his experience of High Dose Minocycline in the current era & how dose optimization of Minocycline IV Is the need of the hour .

GOLD: Global Strategy for Prevention, Diagnosis and Management of COPD (2020)
Guidelines, Published on: 28 Aug 2020
HF Cascade and Role Of MRA
Expert's Views, Published on: 28 Aug 2020

Dr Vijay Chopra talks about  benefits of MRA in heart failure management.

 

Initiate MRA Early in HF Patients
Expert's Views, Published on: 28 Aug 2020

Dr Vijay Chopra talks about the importance of the time of initiation of MRA.

 

 

Spironolactone in HFpEF
Expert's Views, Published on: 28 Aug 2020

Dr Vijay Chopra talks about the role of spironolactone in HFpEF patients.   

 

Role of Eplerenone in HF
Expert's Views, Published on: 28 Aug 2020

Dr Vijay Chopra talks about the role of eplerenone in heart failure.

Optimization of Tigecycline
Expert's Views, Published on: 27 Aug 2020

In the era of increasing resistance of Antibiotics, how High Dose of Tigecycline plays a pivotal role to manage gram negative Bacilli. Dr RP Gupta a Critical Care expert from Neuro One Hospital , Trichy  shares his experience of High Dose Tigecycline in the current era & how dose optimization of Tigecycline IV Is the need of the hour .

Impact of Sacubitril/Valsartan on Renal Outcomes in HFpEF Patients
Key Trials, Published on: 26 Aug 2020

The post hoc analysis of PARAGON-HF study demonstrated renal benefits of sacubitril/valsartan vs. valsartan alone in patients with HFpEF. Patients treated with sacubitril/valsartan had reduced risk of renal events and attenuated eGFR decline vs. those treated with valsartan.

 

PRADAR Study: Virological Efficacy of Abacavir/Lamivudine + DRV/r vs Abacavir/ Lamivudine + RAL in Treatment -naïve HIV Patients with CD4<200 cells/μL
Key Trials, Published on: 26 Aug 2020

The present prospective, multicenter, randomized open-label, 2-arm, phase-3 trial compares the 48-week virological efficacy of two drug regimens containing abacavir/lamivudine plus either raltegravir twice a day or darunavir/r once a day in HIV pastients with advanced disease. The 48 weeks results showed that the rate of virologic success was higher than 65% in both arms with a median CD4 cell count >200/μL at week 48.

 

NeoMero1: Meropenem vs. Standard of Care for Treating Late Onset Sepsis in Neonates
Key Trials, Published on: 25 Aug 2020

There was no evidence on standard of care antibiotic regimen being non-inferior to meropenem for treating critically ill premature infants with late onset sepsis (LOS). Meropenem should therefore be reserved for neonates who would more likely have Gram-negative LOS.

 

Impact of Fluid Overload on Cardiac Structure and Function in Diabetes Patients with Non-dialysis Dependent Stage 5 CKD
Key Trials, Published on: 25 Aug 2020

Fluid overload is responsible for structural and functional alterations in diabetes patients with non-dialysis dependent stage 5 CKD. Early evaluation of structural and functional cardiac abnormalities and volume status in such patients is therefore crucial. 

 

Omalizumab Improves Lung Function and Reduces Eosinophils in Adolescents with Allergic Asthma
Key Trials, Published on: 25 Aug 2020

Omalizumab therapy significantly improved the lung function and decreased the blood eosinophil counts in adolescents with moderate-to-severe uncontrolled asthma. The results of this post hoc analysis highlight the potential effect of omalizumab therapy in adolescents whose asthma is not controlled with the current therapies and the need to optimize treatment early in the disease course.

 

Infertility: Current Concepts & Managing Complications (in association with Gurgaon Obstetrics & Gynaecological society)
eCMEs, Published on: 24 Aug 2020

A webinar to discuss the current concepts in Infertility treatment. IVF Experts present lectures on current concepts of ART Prework & Negative FNAC followed by a panel discussion on Obstetrics Complications in ART pregnancies.

 

Infertility: Current Concepts & Managing Complications (in association with Vishakhapatnam ObGy Society)
eCMEs, Published on: 24 Aug 2020

A live Webinar to discuss the current concepts in Infertility treatment. IVF Experts will present lectures on current concepts of ART Prework & Negative FNAC in azoospermia followed by a panel discussion on Obstetrics Complications in ART pregnancies.

 

Hydrodistension and Pentosan polysulfate Combination Vs. Pentosan polysulfate Monotherapy In IC/BPS Treatment
Key Trials, Published on: 24 Aug 2020

The present single-center retrospective trial gives a comparison between efficacy of Hydrodistension and Pentosan polysulfate combination vs. Pentosan polysulfate monotherapy based on the aspects of compliance and therapeutic outcomes in female IC/BPS patients.

 

Long-term Treatment with PPIs, Effective and Safe for Treating Eosinophilic Esophagitis in Children
Key Trials, Published on: 24 Aug 2020

Majority of pediatric patients with eosinophilic esophagitis remain in histological and clinical remission when treated with proton pump inhibitors (PPIs) for one year. The treatment with PPIs was found to be safe in this patient population.

 

Webinar Snippet: Indian Scenario of Patients with STEMI during COVID-19 Pandemic: Poll Results
Expert's Views, Published on: 24 Aug 2020
Webinar Snippet: ESC Guidance for General Precautions for Clinicians in The Cath Labs During COVID-19 Pandemic
Expert's Views, Published on: 24 Aug 2020
Webinar Snippet: ESC Guidance on The Clinical Importance of High-Sensitivity Troponin Test in This Pandemic Time?
Expert's Views, Published on: 24 Aug 2020
Webinar Snippet: In the Recent Pandemic, What Are the Factors That Affect Timely Reperfusion Therapy in Patients With STEMI?
Expert's Views, Published on: 24 Aug 2020
Webinar Snippet: ESC Guidance on The Protocol for Triage/Testing of STEMI Patients in The Current Times
Expert's Views, Published on: 24 Aug 2020
Favipiravir: Frequently Asked Questions
Our Publications, Published on: 24 Aug 2020

Favipiravir is a novel antiviral approved in 2014 by Japan for the treatment of novel or re-emerging pandemic influenza virus infections. In the wake of the pandemic it has been repurposed for use in patients with COVID-19. This booklet is a compilation of the most frequently asked questions on the use of Favipiravir in COVID-19

 

Ciplenza (Favipiravir) Monograph
Our Publications, Published on: 24 Aug 2020

Favipiravir is a novel antiviral approved in 2014 by Japan for the treatment of novel or re-emerging pandemic influenza virus infections. In the wake of the pandemic it has been repurposed for use in patients with COVID-19. This product monograph provides an overview of the available pharmacokinetics and clinical studies evaluating the safety and efficacy of favipiravir in patients with COVID-19

 

Swiss Trial: Comparison of Diclofenac versus Norfloxacin in Women with Uncomplicated Lower UTI
Key Trials, Published on: 21 Aug 2020

The SWISS trial is a randomized double-blind study that compared the symptom resolution effect of diclofenac with norfloxacin in women with uncomplicated lower urinary tract infection. The study showed that diclofenac was inferior to norfloxacin in terms of symptom resolution.

 

Evolving Role of Anti-Virals in Mild to Moderate COVID-19
eCMEs, Published on: 21 Aug 2020

A practical insight into the evolving role of favipiravir in the current times.

 

GNP - Mouthpiece versus Facemask
Patient Education, Published on: 20 Aug 2020

With the evolving science of nebulization with respect to current pandemic, using the preferred patient-device interface like mouthpiece would decrease wastage of exhaled aerosol during nebulization. This would increase pulmonary drug deposition and also increase safety profile of inhaled medication.

 

GNP - Maintenance of Nebulizer
Patient Education, Published on: 20 Aug 2020

With the evolving science of nebulization with respect to current pandemic, cleaning and disinfection of nebulizer accessories after each use is the most important and integral of nebulization as it would safe guard the health of doctors, patients, caregivers and bystanders.

 

GNP - Precaution during Nebulization
Patient Education, Published on: 20 Aug 2020

With the evolving science of nebulization with respect to current pandemic, adherence to nebulization is most important aspect for optimal therapy through safe nebulization.

 

GNP in Home Setting
Patient Education, Published on: 20 Aug 2020

With the evolving science of nebulization with respect to current pandemic, patients can continue to use nebulization at home as prescribed by their physician. Performing nebulization at home safely is the need of the hour.

 

ACS: Cervical Cancer Screening for Individuals at Average Risk (2020)
Guidelines, Published on: 19 Aug 2020
Practice Management: Introduction to Quality and Accreditation to Improve Practice During COVID Times
eCMEs, Published on: 18 Aug 2020

The current pandemic scenario has impacted ophthalmology in many ways. In the background of reduced patient load, dwindled revenues, infection risk, IPC protocols, etc. this would be an ideal time to facilitate the integration of quality standards to improve our practice image, branding and patient satisfaction.

Telyse (Tenecteplase) Monograph
Our Publications, Published on: 18 Aug 2020

In the management of STEMI in India, pharmacoinvasive strategy involving thrombolytics is the preferred therapy in cases of delays in primary PCI. Third generation thrombolytics such as tenecteplase offer ease of administration with single bolus IV dose.

 

Recurrent Pseudomonas aeruginosa Infections after Allogenic Hematopoietic Cell Transplantation
Key Trials, Published on: 17 Aug 2020

The rate of recurrent Pseudomonas aeruginosa (PSA) infections in allogeneic hematopoietic cell transplantation (allo-HCT) recipients is high. The findings suggest that a targeted antibiotic treatment for a minimum duration of 14 days might prevent recurrent infections. However, more prospective studies are warranted to confirm these findings and define the optimal duration of treatment to prevent infection recurrence.

 

Rapid Onset of Action of Azelastine hydrochloride and Fluticasone propionate Combination Nasal Spray
Key Trials, Published on: 17 Aug 2020

The combination nasal spray containing azelastine hydrochloride (AZE) and fluticasone propionate (FP) had a more rapid onset of action of 5 mins and was more effective than monotherapies of loratadine and intranasal FP in patients with allergic rhinitis (AR).

 

3 reasons to Optimize the Dose of Minocycline
Expert's Views, Published on: 13 Aug 2020

In the era of increasing resistance of antibiotics, high dose of minocycline plays a pivotal role to manage gram negative Bacilli. Dr Sanjith Saseedharan, a Critical Care expert  from S.L Raheja Mumbai, shares his experience of High Dose Minocycline in the current era & how dose optimization of Minocycline IV Is the need of the hour .

Webinar Snippet: Standard Management Protocol (Antibiotics/Prophylaxis/ Vaccine/Probiotics) & Cases Where Surgical Management is Needed
Expert's Views, Published on: 13 Aug 2020
Webinar Snippet: UTI in Diabetic Women - Case Illustrations
Expert's Views, Published on: 13 Aug 2020
Webinar Snippet: Assessment of UTI In Elderly Women
Expert's Views, Published on: 13 Aug 2020
Webinar Snippet: UTI in Elderly Women (Aging & Urinary Tract)
Expert's Views, Published on: 13 Aug 2020
Webinar Snippet: Pathophysiology & Predisposing Factors for UTI in Elderly Women
Expert's Views, Published on: 13 Aug 2020
Webinar Snippet: Fosfomycin in UTI – MOA, Dosage, Advantages & Place in Therapy
Expert's Views, Published on: 13 Aug 2020
Webinar Snippet: UTI & Its Recurrence in Pregnancy
Expert's Views, Published on: 13 Aug 2020
Webinar Snippet: Non-antibiotic Strategies for Prevention of UTI In Adolescent Girls and Females of Reproductive Age
Expert's Views, Published on: 13 Aug 2020
Webinar Snippet: Choosing an Antibiotic Treatment in Acute Uncomplicated Cystitis & Recurrent UTI In Adolescent Girls and Females of Reproductive Age
Expert's Views, Published on: 13 Aug 2020
Webinar Snippet: Acute Uncomplicated Cystitis in Adolescent Girls and Females of Reproductive Age – Diagnosis (History, Urine Analysis & Special Investigations)
Expert's Views, Published on: 13 Aug 2020
Webinar Snippet: Acute Uncomplicated Cystitis in Adolescent Girls and Females of Reproductive Age (Etiology, Risk factors & Clinical presentation)
Expert's Views, Published on: 13 Aug 2020
Improved Survival Outcomes with Androgen-Receptor-Axis-Targeted Therapies in Metastatic Castration-Sensitive Prostate Cancer
Key Trials, Published on: 13 Aug 2020

Androgen-receptor-axis-targeted (ARAT) agents improve the overall survival outcomes in patients with metastatic castration-sensitive prostate cancer. The findings of this meta-analysis discourage the concurrent or sequential use of both docetaxel and an ARAT agent regardless of the tumor volume or other factors.

Analysis of the Effects of Artificial Urinary Sphincter Placement in Men with Overactive Bladder and Urgency Urinary Incontinence
Key Trials, Published on: 10 Aug 2020

This article gives you an insight on persistence of overactive bladder (OAB) and urgency urinary incontinence (UUI) in patients with post-prostate incontinence (IPT) with an emphasis on discrepancies in surgical intervention vs radiation.

 

Efficacy and Safety of Remdesivir 5 Days Course verses 10 Days Course in Treatment of Patients with Severe Covid-19 Disease
Key Trials, Published on: 07 Aug 2020

The present trial compared the efficacy and safety outcomes of remdesivir 5 Days verses 10 Days in treatment of patients with severe Covid-19 disease

 

Impact of Lamotrigine on Cognitive Function in Patients with Depression of Recurrent BPD
Key Trials, Published on: 07 Aug 2020

The study demonstrates the benefits of lamotrigine in terms of alleviating clinical symptoms and improving cognitive function in patients with depression of recurrent bipolar disorder. This effect of lamotrigine may be mediated by alteration of serum inflammatory cytokines levels.

Comparison of in vitro Antimicrobial Efficacy of Octenidine against Staphylococcus epidermidis (S. epidermidis) for Root Canal Disinfection
Key Trials, Published on: 07 Aug 2020

Bacteria have been identified as the main cause of pulp infection and periapical disease. This trial explained the role of octenidine as a root canal disinfection in the management of dental pulp infection due to Staphylococcus epidermidis.

Oral Disorders and Gastrointestinal Disease in Children
Key Trials, Published on: 07 Aug 2020

An association between alterations in the oral cavity and systemic health has been widely proven. Oral disorders can be an expression of gastrointestinal disease. This study talks about the prevalence of oral manifestations among pediatric GERD patients.

Efficacy of A Pre-Operative, Single Dose of Anti-Inflammatory Drugs for The Prevention and Control of Post-Endodontic Pain
Key Trials, Published on: 07 Aug 2020

Posttreatment endodontic pain has been reported in 25%–40% of all endodontic patients. Effective management of endodontic pain represents a continuing challenge. This trial explained the role of pre-treatment medication in controlling post endodontic pain

Comparative Efficacy of Oral Ketorolac and Tramadol after Impacted Mandibular Third Molar Surgery
Key Trials, Published on: 07 Aug 2020

Impacted third molar extraction involves both soft and bone tissue trauma and may result in an acute inflammation with intense discomfort as well as pain. This study compared the efficacy of two different analgesics, Tramadol and Ketorolac after impacted mandibular third molar surgery.

Comparative Plaque Removal Efficacy Between a Manual Toothbrush and an Interactive Power Toothbrush in Adolescents
Key Trials, Published on: 07 Aug 2020

Adolescents are at increased risk for caries and gingivitis. This study explained the impact of an interactive power toothbrush on plaque removal and its compliance among population.

Clinical Analysis of Microbial Flora and Evaluation of Antibiotic Response in Odontogenic Infections
Key Trials, Published on: 07 Aug 2020

This study explores the various bacterial isolates in patients with odontogenic infection and its antibiotic susceptibility to different antibiotics which are routinely used as prophylaxis in such types of infection in odontology.

 

LIPPSMAck-POP Trial: Efficacy of a Single Preoperative Physiotherapy Session to Reduce Postoperative Pulmonary Complications After Upper Abdominal Surgery
Key Trials, Published on: 06 Aug 2020

The present study tested the hypothesis that preoperative education and breathing exercise training delivered within six weeks of surgery by physiotherapists reduces the incidence of  postoperative pulmonary complication after upper abdominal surgery.

 

Importance of Food Choices to Lower Low-Density Lipoprotein Cholesterol and Improve the Overall Lipoprotein Profile
Clinical Tools, Published on: 06 Aug 2020

Guidance on lifestyle modifications and dietary habits to improve the overall lipoprotein profile.

 

Impact of Specific Lifestyle Changes on Lipid Levels
Clinical Tools, Published on: 06 Aug 2020

Guidance to reduce lipid levels by lifestyle changes.

 

The Real Benefit of MRA- Reduction in SCD
Expert's Views, Published on: 06 Aug 2020

Dr Tiny Nair talks about the real benefits of MRA in SCD reduction.

 

Benefit of MRA Depending on Phenotype
Expert's Views, Published on: 06 Aug 2020

Dr Tiny Nair talks about benefit of MRA depending on phenotype.

When to Start MRA; Earlier the Better
Expert's Views, Published on: 06 Aug 2020

Dr Tiny Nair talks about the right time to start with MRA.

 

MRA Benefit Beyond Neurohormones In Heart Failure
Expert's Views, Published on: 06 Aug 2020

Dr Tiny Nair talks about various benefits of MRA's other than neuro hormones in heart failure patients.

 

MRA Benefit Beyond Diuresis
Expert's Views, Published on: 06 Aug 2020

Dr Tiny Nair talks about various benefits of MRA's other than diuresis in heart failure patients.

 

Insights from PARAGON-HF: Sacubitril/Valsartan Favorably Alter the Biomarkers of Extracellular Matrix Regulation in HFpEF Patients
Key Trials, Published on: 06 Aug 2020

This substudy of the PARAGON-HF study demonstrates the favorable impact of sacubitril/valsartan vs. valsartan alone on various biomarkers related to ECM homeostasis in patients with HFpEF.

 

Greater Patient Satisfaction After Switching to Esomeprazole in Gastro-oesophageal Reflux Disease
Key Trials, Published on: 06 Aug 2020

Switching over to esomeprazole therapy is associated with greater patient satisfaction and better symptom control in primary-care patients receiving proton pump inhibitor (PPI) therapy for gastro-oesophageal reflux disease (GORD).

 

Clinical Impact of COVID-19 in Pregnancy
Key Trials, Published on: 06 Aug 2020

The pregnant and reproductive aged non-pregnant women infected with SARS-CoV-2 had comparable clinical course and outcomes. The results of the study demonstrated no associations between pregnancy and severity of COVID-19, virus clearance time, and length of hospital stay. There was no evidence supporting vertical transmission of COVID-19 in the late stages of pregnancy, including vaginal delivery.

 

Warfarin Dosage Nomograms
Clinical Tools, Published on: 05 Aug 2020

In patients treated with warfarin, dose-response to warfarin among patients is highly variable and depends on interpatient differences. Dose titration is based on periodic monitoring for assessing patient’s prothrombin time (PT) and International Normalized Ratio (INR) in order to ensure safety and efficacy of warfarin.

 

OPTIMAL Trial: Erlotinib versus Chemotherapy as First-line Treatment for Patients with Advanced EGFR Mutation-positive Non-small-cell Lung Cancer
Key Trials, Published on: 05 Aug 2020

OPTIMAL is the first prospective head-to-head phase 3 study to examine the efficacy and safety of first-line erlotinib versus platinum doublet chemotherapy in patients with advanced NSCLC whose tumours harbour activating mutations in EGFR

 

GiACTA Trial: Effect of the Tocilizumab on the Rates of Relapse During Glucocorticoid Tapering in Patients with Giant-cell Arteritis
Key Trials, Published on: 05 Aug 2020

This study presents the 1-years results of Giant-Cell Arteritis Actemra (GiACTA) trial that investigated whether tocilizumab resulted in higher rates of sustained glucocorticoid-free remission of giantcell arteritis than placebo through a period of 52 weeks.

 

Webinar Snippet: Use Of Anticoagulants In Patients With STEMI Treated With Fibrinolytics
Expert's Views, Published on: 04 Aug 2020

In the management of STEMI in India, pharmacoinvasive strategy is the preferred therapy in cases of delays in primary PCI. Third generation thrombolytics such as Reteplase and Tenecteplase offer benefits like bolus dose and lesser bleeding events compared with streptokinase.

 

Webinar Snippet: Role Of Reteplase In STEMI
Expert's Views, Published on: 04 Aug 2020

In the management of STEMI in India, pharmacoinvasive strategy is the preferred therapy in cases of delays in primary PCI. Third generation thrombolytics such as Reteplase and Tenecteplase offer benefits like bolus dose and lesser bleeding events compared with streptokinase.

 

Webinar Snippet: Dosing And Administration Of Reteplase In Patients With STEMI
Expert's Views, Published on: 04 Aug 2020

In the management of STEMI in India, pharmacoinvasive strategy is the preferred therapy in cases of delays in primary PCI. Third generation thrombolytics such as Reteplase and Tenecteplase offer benefits like bolus dose and lesser bleeding events compared with streptokinase.

 

Webinar Snippet: Comparison Between Fibrinolytic Agents In STEMI
Expert's Views, Published on: 04 Aug 2020

In the management of STEMI in India, pharmacoinvasive strategy is the preferred therapy in cases of delays in primary PCI. Third generation thrombolytics such as Reteplase and Tenecteplase offer benefits like bolus dose and lesser bleeding events compared with streptokinase.

 

Webinar Snippet: In Management Of Patients With STEMI, Is Pharmaco-Invasive Approach Equivalent To Primary PCI In Terms Of Outcomes?
Expert's Views, Published on: 04 Aug 2020

In the management of STEMI in India, pharmacoinvasive strategy is the preferred therapy in cases of delays in primary PCI. Third generation thrombolytics such as Reteplase and Tenecteplase offer benefits like bolus dose and lesser bleeding events compared with streptokinase.

 

Webinar Snippet: What Are The Barriers To Gold Standard Treatment And How Can These Be Alleviated For Indian Patients With STEMI?
Expert's Views, Published on: 04 Aug 2020

In the management of STEMI in India, pharmacoinvasive strategy is the preferred therapy in cases of delays in primary PCI. Third generation thrombolytics such as Reteplase and Tenecteplase offer benefits like bolus dose and lesser bleeding events compared with streptokinase.

 

Webinar Snippet: What Is The Most Important Factor In The Management Of STEMI?
Expert's Views, Published on: 04 Aug 2020

In the management of STEMI in India, pharmacoinvasive strategy is the preferred therapy in cases of delays in primary PCI. Third generation thrombolytics such as Reteplase and Tenecteplase offer benefits like bolus dose and lesser bleeding events compared with streptokinase.

 

Impact of Topical Carbonic Anhydrase Inhibitors on Ocular Blood Flow: Literature Review and Meta-analysis
Key Trials, Published on: 04 Aug 2020

Topical CAI had a beneficial impact on ocular hemodynamics with increased ocular blood flow velocities and reduced vascular resistance in the primary retinal circulation, central retinal and short posterior ciliary arteries.

 

Nutritional Strategies in Optimising Women’s Health
eCMEs, Published on: 04 Aug 2020

In this webinar conducted in collaboration with FOGSI, AMOGS & ICOG, the eminent panelists emphasize on one of the most challenging topics - “Nutrition” - to optimize women’s health via Nutriconnect.

 

Higher Ovulation Rates with Combination Therapy of Letrozole and Clomiphene Citrate in Women with PCOS
Key Trials, Published on: 04 Aug 2020

Combination of letrozole and clomiphene citrate (CC) was associated with significantly higher ovulation rates than letrozole alone in women with polycystic ovarian syndrome (PCOS). Combination therapy may be an alternate low-risk, low-cost infertility treatment with superior ovulation rates.

 

Trochanteric Fractures
eCMEs, Published on: 04 Aug 2020

In this video, the speaker has discussed complexity of unstable trochanteric fractures and tips and tricks for its fixation along with case discussion.

Prolonged DAPT Favorably Impacts the Risk-Benefit Ratio in ‘TWILIGHT’-like High-Risk Patients after Complex PCI
Key Trials, Published on: 31 Jul 2020

Amongst high-risk patients who underwent complex PCI, DAPT >12 months lowered the risk of ischemic events without any increase in bleeding risk as compared with DAPT ≤ 12 months. Long-term DAPT may favorably impact risk-benefit ratio in such high-risk population.

 

Long-term Impact of CVD and CKD on Life Expectancy and on Direct Medical Costs in Patients with Diabetes
Key Trials, Published on: 31 Jul 2020

Presence of CVD (heart disease and stroke) and CKD lead to increased mortality and increased direct medical costs in diabetes patients over a period of 10 years. This adverse impact was additive and non-overlapping for any combinations of these diseases.

 

Effectiveness of Integrated Personalised Diabetes Care with Digital Therapeutics to Improve Glycemic Control in T2DM Patients
Key Trials, Published on: 31 Jul 2020

An Indian study presented at ATTD 2020 measured effectiveness of Digital Therapeutics WellthyCare in T2DM patients. Study showed significant reduction in blood glucose level indicating integrated personalised care can be effective tool for improving self-management, thereby enabling better glycemic control.

 

Different Breastfeeding Positions: A Guide to New Moms
Patient Education, Published on: 31 Jul 2020

A mother may use one of several positions to hold her baby while breastfeeding. There is no one "best" position for every baby and mother; the best position is one that is comfortable for both and allows the baby to latch-on, suckle, and swallow easily. Here are some tips that can help a new mother to understand these positions in a lucid manner.

 

Management of Urinary Tract Infection in Women
eCMEs, Published on: 30 Jul 2020

Watch eminent experts to know more about Urinary Tract Infection, the highly prevalent condition affecting females of all ages; and to understand the most effective way of management.

 

Efficacy of Zoledronic Acid in Patients with Cervical Spondylosis and Osteoporosis after Anterior Cervical Discectomy and Fusion Surgery
Key Trials, Published on: 30 Jul 2020

The present study evaluated the clinical effect of zoledronic acid  in patients with cervical spondylosis and osteoporosis after anterior cervical discectomy and fusion surgery.

 

Reduced Penile Prosthesis Infection Rates with Intraoperative Irrigation using Vancomycin/Gentamicin vs Povidone-Iodine
Key Trials, Published on: 30 Jul 2020

Use of povidone-iodine irrigation was associated with a 9-fold increased likelihood of penile prosthesis infection. The results demonstrated significant reduction in the infection rates when the irrigation solution was changed from povidone-iodine to vancomycin/gentamicin among men undergoing penile prosthesis placement in both primary and revision cases.

 

Global Trends in Heart Failure – Issue 5 Q9
Expert's Views, Published on: 30 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Global Trends in Heart Failure – Issue 5 Q8
Expert's Views, Published on: 30 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Global Trends in Heart Failure – Issue 5 Q7
Expert's Views, Published on: 30 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Global Trends in Heart Failure – Issue 5 Q6
Expert's Views, Published on: 30 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Global Trends in Heart Failure – Issue 5 Q5
Expert's Views, Published on: 30 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Global Trends in Heart Failure – Issue 5 Q4
Expert's Views, Published on: 30 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Global Trends in Heart Failure – Issue 5 Q3
Expert's Views, Published on: 30 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Global Trends in Heart Failure – Issue 5 Q2
Expert's Views, Published on: 30 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Global Trends in Heart Failure – Issue 5 Q1
Expert's Views, Published on: 30 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Ceftriaxone, Sulbactam and Disodium EDTA Combination Therapy Might Spare Carbapenems in Management of Multidrug Resistant Nosocomial Infections
Key Trials, Published on: 28 Jul 2020

The bacteriological and clinical efficacy of ceftriaxone, sulbactam, and disodium EDTA (AAE) in combination with colistin was significantly better than meropenem + colistin in the management of various nosocomial MDR Gram-negative infections. A significant proportion of patients who failed to respond to meropenem responded well to the AAE therapy highlighting the new hope to spare carbapenems.

 

Risk Factors for Frequent Exacerbations in Chronic Obstructive Pulmonary Disease
Key Trials, Published on: 28 Jul 2020

Any critical error, body mass index (BMI) < 25 kg/m2 and high modified Medical Research Council (mMRC) were independent risk factors for frequent exacerbations in patients with chronic obstructive pulmonary disease (COPD).  COPD patients, especially frequent exacerbators should be carefully monitored and educated about correct handling of inhaler devices.

 

Long-term Efficacy and Safety of Dimethyl Fumarate in Patients with RRMS: Insights from DEFINE, CONFIRM, and ENDORSE
Key Trials, Published on: 28 Jul 2020

Dimethyl fumarate demonstrated a sustained long-term efficacy and safety in patients with relapsing remitting multiple sclerosis who continued the treatment for 11 years.

 

Efficacy of Daily Norfloxacin vs. Weekly Ciprofloxacin Prophylaxis for to Spontaneous Bacterial Peritonitis Prevention
Key Trials, Published on: 27 Jul 2020

This is a randomized control a trial comparing the efficacy of once-weekly ciprofloxacin with that of daily norfloxacin for the prevention of spontaneous bacterial peritonitis in liver cirrhosis patients with ascites

 

How to Ensure Overall Well-being of Your Child?
Patient Education, Published on: 27 Jul 2020

A child’s physical, mental, emotional and social health are important and they contribute to his/her well-being. Keeping a child healthy and well is always a priority of any parent. Here are some ways in which a parent can improve their child’s well-being.

 

Comparative Evaluation of Effects of Normal Saline and an Acetate-buffered Chloride-reduced Crystalloid on the Need for Vasopressors for Cardio-circulatory Support in Patients Undergoing Major Abdominal Surgery
Key Trials, Published on: 27 Jul 2020

This double-blind, randomized controlled trial investigated whether normal saline or a balanced crystalloid has distinct effects on vasopressor use in patients undergoing major abdominal surgery.

 

Dorzolamide/Timolol vs. Brinzolamide/Timolol Fixed Combinations in Patients with POAG/NTG
Key Trials, Published on: 23 Jul 2020

A fixed dose combination of dorzolamide/timolol rather than brinzolamide/timolol maybe a preferred choice in patients with primary open angle glaucoma and normal tension glaucoma, as the former provided better reduction in the intraocular pressure and was better tolerated than the latter.

 

Tinidazole versus Metronidazole in Treatment of Amoebic Liver Abscess
Key Trials, Published on: 23 Jul 2020

The present study compared the effectiveness and safety profile of metronidazole and tinidazole in the treatment of amebic liver abscess.

 

RSSDI-ESI: Clinical Practice Recommendations for the Management of Type-2 Diabetes Mellitus (2020)
Guidelines, Published on: 23 Jul 2020
ESMO: Clinical Practice Guidelines - Localized Colon Cancer (2020)
Guidelines, Published on: 23 Jul 2020
ESMO: Bladder Cancer Treatment Recommendations (2020)
Guidelines, Published on: 23 Jul 2020
Quality and Accreditation of Eye Hospitals – Introductory Session (Part 1)
eCMEs, Published on: 23 Jul 2020

With increasing awareness on the need for Accreditation and many eye care organisations starting their journey for NABH Accreditation, this webinar is the 1st Part of a two webinar series designed to convey the needs of Accreditation, step-by-step guidelines for implementation, infrastructure needs, hospital infection control guidelines, etc. in a nut shell by eminent NABH assessors.

 

Remdesivir Shortens Time to Recovery in Patients Hospitalized with COVID-19
Key Trials, Published on: 23 Jul 2020

Remdesivir was superior to placebo in shortening the time to recovery in adults hospitalized with Covid-19. The benefit was most apparent in patients with a baseline ordinal score of 5 (requiring oxygen).

 

Impact of Oral Sildenafil on Clinical Outcomes while treating PPHN
Key Trials, Published on: 23 Jul 2020

Oral sildenafil appears to be a promising medication to treat persistent pulmonary hypertension in newborns in settings when nitric oxide is unavailable.

 

Cataract Kaleidoscope
eCMEs, Published on: 22 Jul 2020

Cataract Kaleidoscope is an interactive webinar on how to deal with complex cataract surgery and manage complications. This event has roped some of the best cataract surgeons of the country who will discuss the various surgical scenarios through their instructive videos. This program brings to table, the most relevant and practical tips for managing complex cataract surgery.

 

Webinar Snippet: Indian Scenario Of Patients With STEMI During COVID-19 Pandemic: Poll Results
Expert's Views, Published on: 22 Jul 2020
Webinar Snippet: ESC Guidance On The Clinical Importance Of High-Sensitivity Troponin Test In This Pandemic Time?
Expert's Views, Published on: 22 Jul 2020
Webinar Snippet: ESC Guidance For General Precautions For Clinicians In The Cath Labs During COVID-19 Pandemic
Expert's Views, Published on: 22 Jul 2020
Webinar Snippet: ESC Guidance On The Protocol For Triage/Testing Of STEMI Patients In The Current Times
Expert's Views, Published on: 22 Jul 2020
Webinar Snippet: In The Recent Pandemic, What Are The Factors That Affect Timely Reperfusion Therapy In Patients With STEMI?
Expert's Views, Published on: 22 Jul 2020
CLSI Guidelines: Colistin & Polymyxin B Update (2020)
Guidelines, Published on: 20 Jul 2020

The 2020 CLSI Guidelines on Polymyxins have changed the MIC cutoffs, wherein it has removed sensitivity cutoff and just provides Intermediate and resistant cutoffs. The guidelines suggest the dosages which are to be followed for both colistin and polymyxin B and mentions use of these molecules in combination only.

 

Management of Complicated UTI – A Case Discussion (Case 3)
Expert's Views, Published on: 20 Jul 2020
Management of Complicated UTI – A Case Discussion (Case 2)
Expert's Views, Published on: 20 Jul 2020

A case based discussion on Management of Urosepsis in young patient.

 

Pentosan Polysulfate for The Treatment of Interstitial Cystitis
Key Trials, Published on: 20 Jul 2020

Efficacy of pentosan polysulfate for the treatment of interstitial cystitis/bladder pain syndrome: results of a systematic review of randomized controlled trials

Efficacy & Safety Of Novel Nebulized Glycopyrrolate For The Treatment Of COPD- GOLDEN Studies
Expert's Views, Published on: 17 Jul 2020
Inhaled Medication: Which Device For Which Patient?
Expert's Views, Published on: 17 Jul 2020
Nebulized Glycopyrrolate Advantage And Disadvantage
Expert's Views, Published on: 17 Jul 2020
Alleviating Night-Time Symptoms Unmet Need Of COPD Patients
Expert's Views, Published on: 17 Jul 2020
Glycopyrrolate Is More Potent Than Indacaterol
Expert's Views, Published on: 17 Jul 2020
Glycopyrrolate Bronchodilator With A Rapid Onset Of Action And For A Prolonged
Expert's Views, Published on: 17 Jul 2020
National Inhaled Drug Delivery Forum (Day 2)
eCMEs, Published on: 17 Jul 2020

This webinar discusses the clinical efficacy and safety of Omalizumab use over the last 2 decades across the globe, while also getting insights from Indian experts on the perspective of use of Omalizumab in Indian patients.

 

Experience Sharing of High Dose Minocycline by Infectious Disease Specialist
Expert's Views, Published on: 17 Jul 2020

In the era of increasing resistance of Antibiotics, how High Dose of Minocycline plays a pivotal role to manage gram negative Bacilli. Dr Senthur Nambi an Infectious Disease specialist from Chennai shares his experience of High Dose Minocycline in the current era & how dose optimization of Minocycline IV Is the need of the hour.

 

Evaluating the Safety and Efficacy of Fluticasone Furoate Nasal Spray in Asian Pediatric Patients with Perennial Allergic Rhinitis
Key Trials, Published on: 16 Jul 2020

Fluticasone furoate was safe and effective in treating Japanese children (age 2 to <15 years) with perennial allergic rhinitis. The medication was generally well-tolerated and most of the children had low systemic exposure to the medication with 12 weeks of treatment.

 

Esomeprazole Achieves Relief of Nighttime Heartburn and Improves Sleep Quality in GERD
Key Trials, Published on: 16 Jul 2020

Treatment with esomeprazole 20 mg once daily significantly achieved relief of nighttime heartburn symptoms and improved sleep quality, work productivity and functionality in patients with moderate-to-severe nighttime heartburn and gastro-esophageal reflux disease-related sleep disturbances.

 

Effect of Application of Combination Serum Containing Vitamin C, Vitamin E, and Ferulic acid on Lentigine and Melasma after QSNL Laser Treatment
Key Trials, Published on: 16 Jul 2020

This prospective, randomized, split-face, controlled study assessed the efficacy of a combination serum containing vitamin C, vitamin E, and ferulic acid as an adjuvant to QSNL laser treatment among patients with environment-induced lentigine and melasma.

 

Clinical Safety and Oncologic Outcomes with GnRH Antagonists and Agonists in Metastatic Prostate Cancer
Key Trials, Published on: 15 Jul 2020

The GnRH antagonists were associated with lower risk of overall mortality, cardiovascular and musculoskeletal events as compared to agonists, according to the data based from trials with a short-term duration. The incidence of adverse events and injection site reaction rates were lower with GnRH agonists. The PSA progression, serious adverse events and drop-out rates were similar with both these forms of androgen deprivation therapy.

 

LABA/LAMA Combination Therapy vs Monotherapy in Patients with Symptomatic COPD
Key Trials, Published on: 15 Jul 2020

The long-acting beta-2-receptor agonist (LABA) and long-acting muscarinic antagonist (LAMA) combination therapy was associated with reduced risk of exacerbations and hospitalizations in chronic obstructive pulmonary disease (COPD) patients who complain of dyspnea and/or exercise intolerance as compared to LABA or LAMA monotherapy

 

Breathing Exercises for COPD
Patient Education, Published on: 15 Jul 2020

Tips on breathing exercises for COPD patients.

 

Find Out If Your Child’s Cough is More than Just a Cough
Patient Education, Published on: 15 Jul 2020

Informative patient education material highlighting the fact that frequent and chronic cough in children could be a sign of asthma.

 

Eating Right: Tips for the COPD Patients
Patient Education, Published on: 15 Jul 2020

Tips on diet for the COPD patients.

 

Know about COPD
Patient Education, Published on: 15 Jul 2020

Informative patient education material to know more about chronic obstructive pulmonary disease (COPD).

 

Are You Ignoring Your Cough?
Patient Education, Published on: 15 Jul 2020

Informative patient education material for better asthma management.

 

The Omega Study: Benefit of Vildagliptin/Metformin addition to T2DM Patients Uncontrolled on Insulin
Key Trials, Published on: 15 Jul 2020

Vildagliptin with/without metformin as an add-on to insulin was effective in demonstrating good glycemic control and was well-tolerated, without any hypoglycemic events.

 

Mexiletine FAQ Booklet
Our Publications, Published on: 15 Jul 2020

Mexiletine is a class 1B antiarrhythmic agent, which blocks the sodium channels and is indicated in suppression of ventricular arrhythmias. The Mexiletine FAQ booklet describes complete information of pharmacology and clinical usage of mexiletine in the management of ventricular arrhythmias.

 

Approach to Rectal Bleeding
eCMEs, Published on: 14 Jul 2020

In this webinar, Dr. Manoj Kumar Sahu, who is a renowned Gastroenterologist, Hepatologist and Advanced Therapeutic Endoscopist, helps us better understand the clinical approach adopted for management of rectal bleeding.

 

Common Mistakes in Ulcerative Colitis Management
eCMEs, Published on: 14 Jul 2020

In this webinar, prominent gastroenterologist Dr. Ajay K. Jain will help us better understand how to avoid mistake and improve diagnosis in managing ulcerative colitis patients.

 

Full Endoscopic Lumbar Transforaminal Interbody Fusion (FELTIF): A Novel Technique – Breaking the Glass Ceiling in the Field of Spinal Endoscopy
eCMEs, Published on: 14 Jul 2020

The speakers in this video explain about the new technique i.e. spinal endoscopic technique for Lumbar Transforaminal Interbody Fusion and its advantages over conventional surgical procedures.

 

Webinar Snippet: What Are The Current Roles Of Mexiletine In The Management Of VT?
Expert's Views, Published on: 14 Jul 2020

In the pharmacological therapy for ventricular tachycardias (VT), mexiletine, a class IB agent, is preferred as add-on therapy in recurrent VTs despite standard treatment. A case report demonstrated the role of mexiletine in VT storm associated with myocardial infarction.

 

Webinar Snippet: Case Presentation: Ventricular Tachycardia Storm Associated With Myocardial Infarction
Expert's Views, Published on: 14 Jul 2020

In the pharmacological therapy for ventricular tachycardias (VT), mexiletine, a class IB agent, is preferred as add-on therapy in recurrent VTs despite standard treatment. A case report demonstrated the role of mexiletine in VT storm associated with myocardial infarction.

 

Webinar Snippet: How Does Mexiletine Act As An Antiarrhythmic Drug?
Expert's Views, Published on: 14 Jul 2020

In the pharmacological therapy for ventricular tachycardias (VT), mexiletine, a class IB agent, is preferred as add-on therapy in recurrent VTs despite standard treatment. A case report demonstrated the role of mexiletine in VT storm associated with myocardial infarction.

 

ASCO 2020 Update in Hepatocellular Carcinoma
Conference Proceedings, Published on: 10 Jul 2020

Key highlights in Hepatocellular Carcinoma of the American Society of Clinical Oncology (ASCO) 2020 Virtual Conference held from 29th to 31st May 2020. 

 

REMDESIVIR: Evidence to Experience
eCMEs, Published on: 10 Jul 2020

This Webcast provides overview on usage of the New Antiviral Remdesivir introduced for treatment of COVID – 19  and Challenges in the management  of COVID – 19 patients.

 

SUPERPERC- What, When and Why: Semi-Live Workshop
eCMEs, Published on: 10 Jul 2020

Semi-Line workshop on patented PCNL technology SUPERPERC.

 

Efficacy of PRP With and Without Topical Minoxidil versus Placebo and Standard Treatment
Key Trials, Published on: 10 Jul 2020

This is a prospective, randomized, double-blind control trial evaluating the efficacy of platelet‑rich plasma with and without topical 5% minoxidil and compared with placebo and standard treatment in male‑type baldness

 

Respiratory Crosstalks: Exploring the Cardiopulmonary Link
eCMEs, Published on: 10 Jul 2020

Various studies have taken a closer look at asthma & COPD and the comorbidities associated with them. Cardiovascular disorders have been found to be commonly associated with these obstructive airway diseases. This webinar explores the cardio-pulmonary linkage better and attempts to discuss how comorbidities impacts patient outcomes.

 

Role of IL-6 Inhibition in Giant Cell Arteritis
eCMEs, Published on: 10 Jul 2020

In this talk, Dr. Dasgupta explains the pleiotropic role of Interleukin-6 (IL-6) in Giant cell arteritis (GCA) pathogenesis, clinical benefits & therapeutic efficacy of Tocilizumab (IL-6 inhibitor) for treating GCA. Published data demonstrated that tocilizumab enables sustained remission with rapid glucocorticoid tapering over 6 months in GCA patients.

 

Glaucoma Crossfire Season 1
eCMEs, Published on: 10 Jul 2020

Glaucoma diagnosis and treatment is often difficult and not straightforward. “Glaucoma Crossfire Season 1” presents some challenging case studies in glaucoma management and will guide the practitioner to take informed decisions in various clinical situations.

 

Compassionate Use of Remdesivir to Treat Patients with Severe Covid-19
Key Trials, Published on: 09 Jul 2020

The results of this small-scale study demonstrated a significant clinical improvement amongst patients hospitalized for COVID-19 when they were treated with compassionate use remdesivir for 10 days.

 

Early Intervention with Remdesivir Associated with Clinical Improvement in Severe COVID-19 Patients
Key Trials, Published on: 09 Jul 2020

The results did not show statistically significant clinical benefits with the use of remdesivir in patients hospitalized for severe COVID-19. Nevertheless, there was a numerical reduction in time to clinical improvement in patients treated earlier with remdesivir.Remdesivir was well tolerated with no new safety concerns identified.

 

Efficacy, Safety and Cognitive Effects of Solifenacin in Elderly
Key Trials, Published on: 09 Jul 2020

Efficacy of Solifenacin in relieving symptoms of OAB and information on its safety, tolerability and effects on cognitive function in elderly population.

 

OPTIMISE Trial: Impact of Antihypertensive Medication Reduction in Elderly Hypertensive Patients
Key Trials, Published on: 07 Jul 2020

The OPTIMSE trial demonstrates that reducing antihypertensive medication in elderly (aged 80 years and above) with SBP lower than 150 mmHg while on more than one antihypertensive medications, may not change the blood pressure substantially.

 

Montelukast Improves Symptom Severity Score in Allergic Rhinitis
Key Trials, Published on: 07 Jul 2020

Daily dose of 10 mg montelukast resulted in an improvement in the common symptoms of allergic rhinitis (AR). The improvement in symptom severity score was maximum in sneezing and least in rhinorrhea.

 

AFFIRM Trial: Enzalutamide Significantly Prolonged Survival in Men with Metastatic Castration-Resistant Prostate Cancer After Chemotherapy
Key Trials, Published on: 07 Jul 2020

The present study evaluated whether enzalutamide prolongs survival in men with castration-resistant prostate cancer after chemotherapy.

 

RED VELVT Study: Warfarin vs. DOAC for the Treatment of Left Ventricular Thrombi
Key Trials, Published on: 07 Jul 2020

A substantial proportion of left ventricular thrombi patients receive off-label direct oral anticoagulants (DOACs). The RED VELVT study demonstrates a high risk of stroke and systemic embolism with DOACs vs. warfarin, thus challenging the off-label use of DOAC for this indication.

 

Effects of Increase Time Intervals Between CRT Completion and Surgery on Oncological and Safety Outcomes in Locally Advanced Rectal Cancer Patients
Key Trials, Published on: 07 Jul 2020

The present study evaluated the effect and safety of the current trend of increasing time interval between the end of chemoradiotherapy and surgery (< 10 weeks vs ≥ 10 weeks) on postoperative morbidity and pathological outcomes in patients with locally advanced rectal cancer patients

 

Reimagining Good Nebulization Practices in the Current Era
eCMEs, Published on: 07 Jul 2020

Various studies have said that Nebulization is not a Viral Aerosol Generating Procedure since the droplets are from the machine and not from the patient. However, sharing of nebulization accessories like facemask and mouthpiece is an unhygienic practice with a high-risk potential of spreading infection. This webinar talks about Nebulization therapy in the current era.

 

Global trends in Heart Failure – Issue 4: Q5
Expert's Views, Published on: 06 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Global trends in Heart Failure – Issue 4: Q4
Expert's Views, Published on: 06 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Global trends in Heart Failure – Issue 4: Q6
Expert's Views, Published on: 06 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Global trends in Heart Failure – Issue 4: Q3
Expert's Views, Published on: 06 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Global trends in Heart Failure – Issue 4: Q2
Expert's Views, Published on: 06 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Global trends in Heart Failure – Issue 4: Q1
Expert's Views, Published on: 06 Jul 2020

Global Experts in Heart Failure emphasize the importance of multidisciplinary approach for Heart Failure. They recommend the use of NT Pro-BNP as a biomarker for Heart Failure in high risk patients. They also recommend the essential pharmacological agents for the management of HF and the concerns associated with ARNI and how to address them.

 

Complicated UTI & Urosepsis: Uro- Physician Perspectives
eCMEs, Published on: 03 Jul 2020

This webcast provides an overview on etiology of UTI complications & management of Urosepsis. Management of complicated UTIs with judicious use of antibiotics & understanding the antimicrobial stewardship in Urology.

 

Webinar Snippet: What Precautions Need To Be Taken By Patients Taking Nebulization At Home?
Expert's Views, Published on: 03 Jul 2020
Webinar Snippet: Is It Appropriate To Share The Nebulizer In This Current Pandemic?
Expert's Views, Published on: 03 Jul 2020
Webinar Snippet: What Are The Patient Profiles For Nebulization In Current Pandemic?
Expert's Views, Published on: 03 Jul 2020
Webinar Snippet: Do All Nebulizers Have Equal Risk For Spreading Virus In Current Pandemic?
Expert's Views, Published on: 03 Jul 2020
Webinar Snippet: What Precautions Need To Be Taken While Nebulizing A Patient In Clinic Settings?
Expert's Views, Published on: 03 Jul 2020
Webinar Snippet: Is There Any Case-Study To Prove That Infection Risk Is Not Due To Nebulization?
Expert's Views, Published on: 03 Jul 2020
Webinar Snippet: What Recommendations Did CDC And BTS/NICE Made Concerning The Spread Of Infection Via Nebulizer In This Pandemic?
Expert's Views, Published on: 03 Jul 2020
Webinar Snippet: Is It Safe To Do Nebulization In Current Pandemic Era?
Expert's Views, Published on: 03 Jul 2020
Webinar Snippet: What Is The Infection Risk Involved With Nebulizers For Spreading The Virus To HCW Or Bystanders?
Expert's Views, Published on: 03 Jul 2020
Reduced Risk of Metabolic Disease with Myoinositol and D-Chiro Inositol Combined Therapy in PCOS Overweight Patients
Key Trials, Published on: 03 Jul 2020

A combined therapy of myoinositol (MI) and D-chiro inositol (DCI) in physiological plasma ratio (40:1) might be useful as the first line approach in PCOS overweight patients, who need to control insulin levels and increase ovarian MI content, reducing the risk of developing a metabolic disease.

 

ARTEMIS-1: Midazolam Nasal Spray for Outpatient Treatment of Seizure Clusters
Key Trials, Published on: 03 Jul 2020

The ARTEMIS-1 study demonstrates the efficacy of midazolam-nasal spray (MDZ-NS) to safely treat seizure clusters in epilepsy patients aged above 12 years in an outpatient setting.

 

ASCO 2020 Update in Prostate Cancer
Conference Proceedings, Published on: 03 Jul 2020

Key highlights in Prostate Cancer of the American Society of Clinical Oncology (ASCO) 2020 Virtual Conference held from 29th to 31st May 2020.

IOL Power Calculation in Children
eCMEs, Published on: 03 Jul 2020

One of the most difficult decisions in a pediatric cataract is to take decision on the IOL power, the webinar would provide an opportunity to learn from the experts the correct way to calculate the IOL power in children

 

Terrible Triad
eCMEs, Published on: 03 Jul 2020

In this video, the speaker has discussed complexity of terrible triad and tips and tricks for its fixation along with case discussion.

Azelastine hydrochloride and Fluticasone propionate Combination Nasal Spray Safe and Effective in Allergic Rhinitis
Key Trials, Published on: 03 Jul 2020

The nasal spray containing azelastine hydrochloride (AZE) and fluticasone propionate (FP) was safe and offered better symptomatic improvement as compared to AZE monotherapy in patients with allergic rhinitis (AR).

 

Identifying Atrial Fibrillation Patients using Smartwatch App Detected Pulse Irregularities
Key Trials, Published on: 02 Jul 2020

A smartwatch app may identify atrial fibrillation (AF) patients, based on an irregular pulse notification. Although the probability of receiving an irregular pulse notification was low, 84% of these notifications were concordant with AF.

 

Social Prescription for Chronic Diseases
eCMEs, Published on: 01 Jul 2020

Chronic disease place a tremendous burden on the patient and the caregiver. Management of the disease often begins at the diagnosis and ends with a prescription by the clinician. Yet for the patient and the caregiver, treatment is only the beginning of the management of the disease. There is a great deal of strain felt by the families of these patients to accommodate the needs of the sufferer. Watch this webinar to understand ways to extend care and support to patients beyond treatment. 

 

PROSPER Trial: Enzalutamide Associated with Significantly Prolonged Overall Survival than Placebo in Men with Nonmetastatic, Castration-resistant Prostate Cancer Receiving Androgen-deprivation Therapy
Key Trials, Published on: 01 Jul 2020

This is the prespecified interim analysis and final analysis of overall survival in the PROSPER trial. PROSPER trial evaluated the efficacy and safety of enzalutamide compared to placebo in men with nonmetastatic, castration-resistant prostate cancer who were continuing to receive androgen-deprivation therapy.

 

Insights from Analysis of ELEMENT 5 Study: LY IGlar vs. IGlar in Asian Indian and East Asian Population
Key Trials, Published on: 01 Jul 2020

This first-of-its-kind study compared the efficacy and safety of LY IGlar vs. IGlar in Indian and East Asian T2DM patients. The outcomes for this study population were generally similar to those observed in the total population of the ELEMENT 5 study.

 

Terbinafine versus Itraconazole in Treatment of Dermatophytic Infection of Skin
Key Trials, Published on: 29 Jun 2020

This study compared the clinical and mycological cure rates of terbinafine with itraconazole in patients with tinea corporis and tinea cruris.

 

Switching to FTC/TAF from FTC/TDF in Virologically Suppressed Patients receiving a Boosted PI or an Unboosted Third Agent
Key Trials, Published on: 29 Jun 2020

This is a 48-week subgroup analysis of evaluating the efficacy and safety of FTC/ TAF by the class of coadministered third agent (boosted PI vs unboosted third agent). In this study, FTC/TAF demonstrated high efficacy in along with renal and bone safety advantages regardless of the class of coadministered third agent

 

ICS LABA in Pediatric Asthma
eCMEs, Published on: 29 Jun 2020

Hear from a leading Paediatric Pulmonologist on use of ICS LABA in pediatric asthma. A Guidline based approach in treating Uncontrolled Asthma.

Short term Surgical and Long-term Survival Outcomes of Laparoscopic versus Open Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma
Key Trials, Published on: 29 Jun 2020

This is a single-center propensity score matching study comparing surgical and survival outcomes of laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (PDAC). The findings suggest LDP as feasible and safe for PDAC treatment

 

ASCO 2020 Update in Colorectal Cancer
Conference Proceedings, Published on: 29 Jun 2020

Key highlights in Colorectal Cancer of the American Society of Clinical Oncology (ASCO) 2020 Virtual Conference held from 29th to 31st May 2020.

 

Efficacy and Safety of Tenofovir Alafenamide in Chronic Hepatitis B Infection
Key Trials, Published on: 29 Jun 2020

After 2 years of treatment, tenofovir alafenamide (TAF) was as effective as tenofovir disoproxil fumarate (TDF) in suppressing hepatitis B virus (HBV) replication with no documented virologic resistance and associated with a better renal and bone safety profile as compared to TDF.

 

Intracameral Moxifloxacin for Endophthalmitis Prophylaxis following M-SICS- Findings from a Large-scale Indian Study
Key Trials, Published on: 29 Jun 2020

This large-scale Indian study demonstrates that use of intracameral (IC) moxifloxacin following M-SICS significantly reduces the rate of post-operative endophthalmitis. IC moxifloxacin is therefore recommended for endophthalmitis prophylaxis following M-SICS.

 

Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Unsatisfactory Response to Initial Αlpha1 Blocker Therapy: The SPLASH Study
Key Trials, Published on: 25 Jun 2020

Switching to silodosin is an effective and safe therapy in yielding relief from LUTS due to BPH and improving quality of life in patients with unsatisfactory treatment response to other alpha 1 blockers.
 

 

Long-term Efficacy and Safety of Polyethylene Glycol as Maintenance Treatment for Childhood Functional Constipation
Key Trials, Published on: 24 Jun 2020

Functional constipation (FC) is a common childhood problem. Polyethylene glycol (PEG) is a safe and effective option for long-term maintenance treatment for childhood FC. The treatment should be initiated immediately after disimpaction to avert FC relapse.

 

Serum Progesterone May Not Define Pharmacokinetics of Vaginal Progesterone for Preterm Birth Prevention
Key Trials, Published on: 24 Jun 2020

Serum progesterone is not likely to be a good biomarker for determining pharmacokinetics or dosing of vaginal progesterone in pregnancy for preterm birth prevention.

 

 

Distal Femur Fractures Nailed
eCMEs, Published on: 24 Jun 2020

In this video, the speaker has discussed the importance of surgical technique-nailing in distal femoral fracture cases.

Essential Statistics for the Busy Clinician
eCMEs, Published on: 24 Jun 2020

Statistics enables the clinician to form reasonable and accurate inferences from collected information, and sound decisions in the presence of uncertainty. Statistics are key to preventing errors and biases in medical research. This webinar will cover the key concepts of statistics and their applications in clinical practice. 

 

Lung Function and Exacerbations with Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in COPD
Key Trials, Published on: 23 Jun 2020

Glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) 18/9.6 μg improved the pulmonary function and reduced the risk of exacerbations as compared to monotherapies and placebo in patients with moderate-to-very severe COPD. The benefits were greater in subgroups of patients with higher symptom burden and those with an exacerbation history.

 

Factors Increasing Risk of Secondary Osteoarthritis
Clinical Tools, Published on: 23 Jun 2020

Several disorders are well recognized as causes of secondary osteoarthritis. Interventions on modifiable risk factors improve not only the symptoms of Osteoarthritis  but also affect the osteoarthritic joint as a whole. 

Management of Complicated UTI – A Case Discussion
Expert's Views, Published on: 23 Jun 2020

A case based discussion on Management of recurrent UTI in young patient.

ISH: Global Guideline on Hypertension (2020): How to Measure Blood Pressure Correctly?
Guidelines, Published on: 23 Jun 2020

The current issue summarizes on how to measure blood pressure correctly for the management of hypertension from International Society of Hypertension (ISH) global clinical practice guideline for hypertension 2020.

 

ISH: Global Guideline on Hypertension (2020): Lifestyle Modifications for the Management of Hypertension
Guidelines, Published on: 23 Jun 2020

This issue summarizes the lifestyle interventions recommended for the management of Hypertension by the ISH-global clinical practise guideline for hypertension -2020.

 

Role of Lipid Analyses for CV Disease Risk Estimation-ESC 2019-Lipid Guidelines
Clinical Tools, Published on: 23 Jun 2020

This issue highlights the role of lipid analyses for CV disease risk estimation for good therapeutic approach in primary prevention settings.

 

Mind in Middle of Chaos: Helping Patients Cope with Loneliness
eCMEs, Published on: 22 Jun 2020

Current time is the time of transition and chaos. With face to face social interactions changing into virtual one, people are also battling loneliness. Eminent psychiatrists across the country talk about how to help patients cope with loneliness.

 

 

Impact of Valproate vs. Lamotrigine Treatment on Reproductive Endocrine System in Newly Diagnosed Female Epileptic Patients
Key Trials, Published on: 22 Jun 2020

The treatment of women of child-bearing age with epilepsy is very challenging. The antiepileptic drugs have impacts on various factors including body weight, fertility, sexual functions, pregnancy etc. which should be considered before initiating the treatment in these patients.

 

Long Term Efficacy and Safety of Tenofovir in Chronic Hepatitis B infection
Key Trials, Published on: 22 Jun 2020

Treatment with tenofovir disoproxil fumarate (TDF) for over 10 years was well tolerated, safe, and effective in patients with chronic hepatitis B (CHB) infection. TDF was effective in suppression of viral replication without development of resistance in CHB patients.

 

DASSION Trial: 2 -Year Efficacy and Safety of Dasatinib versus Imatinib in Treatment of Newly Diagnosed CML-CP
Key Trials, Published on: 22 Jun 2020

The present study reports the 2-year results of DASISION Trial that compared safety and efficacy of dasatinib versus imatinib in newly diagnosed chronic myeloid leukaemia (CML)- chronic phase (CP) The study showed that dasatinib demonstrated faster and deeper responses compared with imatinib in patients with newly diagnosed CML-CP.

 

ASCO 2020 Update in Lung cancer
Conference Proceedings, Published on: 22 Jun 2020

Key highlights in lung cancer of the American Society of Clinical Oncology (ASCO) 2020 Virtual Conference held from 29th to 31st May 2020.

ASCO 2020 Update in Renal Cell Carcinoma
Conference Proceedings, Published on: 22 Jun 2020

Key highlights in renal cell carcinoma of the American Society of Clinical Oncology (ASCO) 2020 Virtual Conference held from 29th to 31st May 2020.

 

Webinar Snippet: How is the Usage of Mexiletine in Indian Practice?
Expert's Views, Published on: 19 Jun 2020

Among the antiarrhythmic drugs, mexiletine, a class IB agent, has safer electrophysiological properties. This makes it effective drug, as an add-on to standard therapy, in the management of recurrent ventricular tachycardia.

Webinar Snippet: What is the Role of Mexiletine in Combination with Beta Blockers?
Expert's Views, Published on: 19 Jun 2020

Among the antiarrhythmic drugs, mexiletine, a class IB agent, has safer electrophysiological properties. This makes it effective drug, as an add-on to standard therapy, in the management of recurrent ventricular tachycardia.

Webinar Snippet: What are the Electrophysiologic Properties of Mexiletine, a Class Ib AAD?
Expert's Views, Published on: 19 Jun 2020

Among the antiarrhythmic drugs, mexiletine, a class IB agent, has safer electrophysiological properties. This makes it effective drug, as an add-on to standard therapy, in the management of recurrent ventricular tachycardia.

Webinar Snippet: Role of amiodarone in management of VAs
Expert's Views, Published on: 19 Jun 2020

Among the antiarrhythmic drugs, mexiletine, a class IB agent, has safer electrophysiological properties. This makes it effective drug, as an add-on to standard therapy, in the management of recurrent ventricular tachycardia.

Webinar Snippet: Diagnosis of Different Types of Ventricular Arrythmias
Expert's Views, Published on: 19 Jun 2020

Among the antiarrhythmic drugs, mexiletine, a class IB agent, has safer electrophysiological properties. This makes it effective drug, as an add-on to standard therapy, in the management of recurrent ventricular tachycardia.

Webinar Snippet: Evaluation of a Patient with Ventricular Tachycardia
Expert's Views, Published on: 19 Jun 2020

Among the antiarrhythmic drugs, mexiletine, a class IB agent, has safer electrophysiological properties. This makes it effective drug, as an add-on to standard therapy, in the management of recurrent ventricular tachycardia.

Synergistic Effect of Tadalafil and L-arginine in Erectile Dysfunction
Key Trials, Published on: 19 Jun 2020

The efficacy of l-arginine was comparable to tadalafil in the mild-erectile dysfunction (ED) population with a lower incidence of AEs. Combination therapy with both tadalafil 5 mg and arginine 2.5 grams once a day was superior to monotherapies alone in overall cohort and in patients with mild and severe ED.

 

Webcast Snippet: Flaps in Urethroplasty
Expert's Views, Published on: 18 Jun 2020
Webcast Snippet: Redo Anastomotic Urethroplasty for PFUI
Expert's Views, Published on: 18 Jun 2020
Webcast Snippet: Case Of 7-Year-Old Girl Having Pelvic Fracture Urethral Injury (14 Prior Failed Urethroplasty)
Expert's Views, Published on: 18 Jun 2020
Webcast Snippet: Panurethral Stricture – Kulkarni Technique
Expert's Views, Published on: 18 Jun 2020
Webcast Snippet: Post TURP Ventral Onlay For Proximal Urethral Strictures
Expert's Views, Published on: 18 Jun 2020
Webcast Snippet: Dorsal Onlay BMG with Ventral Strictureplasty
Expert's Views, Published on: 18 Jun 2020
Webcast Snippet: Dorsal Onlay with Double Face BMG Urethroplasty
Expert's Views, Published on: 18 Jun 2020
Webcast Snippet: A Novel Two Stage Technique For Complex Penile Strictures – Failed Hypospadias
Expert's Views, Published on: 18 Jun 2020
Webcast Snippet: Buccal Mucosa Harvesting for Urethroplasty
Expert's Views, Published on: 18 Jun 2020
Webcast Snippet: Penile Urethroplasty
Expert's Views, Published on: 18 Jun 2020
Webcast Snippet: Lingual Graft Harvesting For Urethroplasty
Expert's Views, Published on: 18 Jun 2020
Intermittent Exotropia
eCMEs, Published on: 18 Jun 2020

Though intermittent exotropia remains one of the common type of strabismus seen in our country, lot of confusion remains in managing these patients starting from the target angle to be treated to the postoperative exercises, unilateral versus bilateral surgery and recurrences.

 

Current Developments in Management of Male Infertility
eCMEs, Published on: 18 Jun 2020

The speaker discusses the recent advances in the diagnosis and medical management of male infertility.

 

PURVIEW: How Research Can Change Your Practice?
eCMEs, Published on: 18 Jun 2020

Many young clinicians are genuinely interested in Research. It is intriguing to know how research & clinical practice go hand in hand. This webcast is an attempt to address this question in many young practitioners’ minds. Watch this webcast to comprehend how research can change clinical practice.

Challenging Cases in Cataract, Cornea & Refractive Surgeries
eCMEs, Published on: 18 Jun 2020

Challenges occur in every segment. Experts in ophthalmic fraternity discuss challenging cases in cataract, cornea & refractive surgeries.

 

Changes in Pediatric General Anesthesia Practices for Eye Setups Post Current Pandemic Situation
eCMEs, Published on: 18 Jun 2020

Experts discuss the general anesthesia practices for eye setups post current pandemic situation.

 

Telemedicine: A New Forward
eCMEs, Published on: 18 Jun 2020

In this webinar, doctor has explained various telemedicine guidelines, elements to be considered before beginning along with do’s and don’ts’ of teleconsultation. 

Medicolegal Issues: Practical Aspects for General Practitioner (GPs)
eCMEs, Published on: 18 Jun 2020

Medical profession has its own ethical parameters and code of conduct. In this webinar, doctor has explained need of medicolegal laws during current different practical scenario.

Pulmonary Arterial Hypertension in Digital Ulcers
Our Publications, Published on: 17 Jun 2020

DUs are a major clinical concern in SSc patients, occurring in 30% of the patients every year. This booklet summarizes the management of digital ulcers

 

Pulmonary Hypertension in Pregnancy
Our Publications, Published on: 17 Jun 2020

Pregnancy represents an enormous cardiovascular challenge for patients with pulmonary hypertension (PH). Notably, PH is four times for more frequently encountered in women, with approximately 80% of the PH patients being in the childbearing age). This booklet summarizes the physiological changes in pregnancy and risk of PAH, followed by treatment approach in pregnant patient with PAH.

 

Heart Failure Associated with PAH
Our Publications, Published on: 17 Jun 2020

Pulmonary hypertension (PH) due to left heart disease (PH-LHD) is an emerging health concern, with increasing hospital admissions. PH-LHD is the most seen subset of PH, resulting from left ventricular dysfunction (systolic and/or diastolic) and/or valvular heart disease (VHD). This booklet summarizes the pathophysiology, diagnosis and management of PH-LHD.

 

Hospitalization in PAH
Our Publications, Published on: 17 Jun 2020

Data from the REVEAL (Registry to Evaluate Early and Long-term PAH Disease Management) registry shows that hospitalization is an important outcome in PAH. Patients who were hospitalized for PAH are more likely to be re-hospitalized and have worse survival at 3 years than those who were not hospitalized. This booklet summarizes the clinical evidence of newer therapies like macitentan and ambrisentan plus tadalafil and its impact on hospitalization in patients with PAH.

 

Combination Therapy - Pulmonary Arterial Hypertension
Our Publications, Published on: 17 Jun 2020

In recent years, there has been a marked improvement in the treatment of pulmonary arterial hypertension (PAH) due to the development of targeted therapies, including the use of upfront combination therapy. This booklet summarizes clinical evidence on upfront combination therapies and its benefits in patients with PAH.

 

PAH associated Congenital Heart Disease
Our Publications, Published on: 17 Jun 2020

PAH in CHD has increasingly become a topic of discussion especially in center’s dealing with PAH patients. This booklet summarizes general aspects of including pathophysiology, types of PAH-CHD and management.

 

Risk Stratification & REVEAL risk score in Pulmonary Arterial Hypertension Management
Our Publications, Published on: 17 Jun 2020

Although treatment advances have improved survival times from 2.8 years to 9 years from the time of diagnosis, PAH remains incurable. Risk assessment is thereby, recommended to guide treatment decisions and potentially improve morbidity and mortality. This booklet summarizes the clinical benefits observed by various studies that have followed risk stratification for treatment decision.

 

FBS AIOS -Why You Should Join?
eCMEs, Published on: 16 Jun 2020

The ophthalmic fraternity is passing through unprecedented times. During and after the lockdown period, we should be able to tackle the various challenges. This webinar by a team of eye consultant will focus on these pertinent points.

 

Osteoporosis and Knee Replacement, An Issue?
eCMEs, Published on: 16 Jun 2020

In this video, the speakers have discussed the cases on complications arising due to osteoporosis during total knee replacement surgery.

 

New Trends in The Diagnosis and Management of Pulmonary Hypertension
eCMEs, Published on: 16 Jun 2020

Discussion from eminent faculty on diagnostic evaluation of patients with PH, emerging concepts, medical management of PH in 2020 & Cardiopulmonary rehabilitation in PAH.

 

Dry Eye Disease among Diabetes Patients- Correlating the Clinical and Cytological Parameters
Key Trials, Published on: 16 Jun 2020

Diabetes patients have a worse ocular surface damage as compared to no-diabetics, as evident form the ocular staining and conjunctival impression cytology tests. Dry eye assessment should therefore be essentially incorporated in the routine ocular assessment of diabetes patients.

 

Amoxicillin and Cefpodoxime Demonstrate Similar Clinical Efficacy in Children with Pneumonia
Key Trials, Published on: 16 Jun 2020

Treatment of pneumonia with amoxicillin and cefpodoxime resulted in a similar response to therapy and the difference was not statistically significant. Both the groups showed a significant improvement in mean body temperature, respiratory rate and wheeze.

 

Is Health Status and Symptom Burden at Baseline Related to the Risk of Exacerbation in COPD?
Key Trials, Published on: 16 Jun 2020

The results of the FLAME study showed that COPD patients with more severe health impairment and greater symptom burden at baseline experienced more exacerbations. The efficacy of indacaterol/glycopyrronium in reducing exacerbations was better as compared to salmeterol/fluticasone.

 

ASCO 2020 Update in Breast Cancer
Conference Proceedings, Published on: 16 Jun 2020

Key highlights in Breast cancer of the American Society of Clinical Oncology (ASCO) 2020 Virtual Conference held from 29th to 31st May 2020.

 

NICE: Diagnosis, Management and Thrombophilia Testing for Venous Thromboembolic Disease (2020)
Guidelines, Published on: 16 Jun 2020
Ovulation Induction & OHSS Free Clinic
eCMEs, Published on: 16 Jun 2020

The speaker provides an extensive overview of various ART protocols as well as risk, importance and management of OHSS.

Webinar Snippet: Where Would You Use Ciclesonide in the Management of Asthma?
Expert's Views, Published on: 15 Jun 2020
Webinar Snippet: Extra Fine Versus Non Extrafine Formulation in Obstructive Lung Disease: Is There an Advantage?
Expert's Views, Published on: 15 Jun 2020
Webinar Snippet: What Are the Advantages of Ciclesonide?
Expert's Views, Published on: 15 Jun 2020
Webinar Snippet: Add-on Extra Fine Ciclesonide in Patients with Poorly Controlled Asthma
Expert's Views, Published on: 15 Jun 2020
Webinar Snippet: Advantages of Add-on Ciclesonide in Difficult to Treat Asthmatics
Expert's Views, Published on: 15 Jun 2020
Webinar Snippet: PK/PD Considerations While Choosing ICS
Expert's Views, Published on: 15 Jun 2020
Webinar Snippet: Clinical Considerations While Choosing ICS
Expert's Views, Published on: 15 Jun 2020
ADVANCE Trial: DTG Combined with TAF or TDF, Noninferior to the Standard -of- care Regimen at Week 48
Key Trials, Published on: 15 Jun 2020

The ADVANCE trial compared the efficacy and safety of a triple-therapy combination of emtricitabine and dolutegravir (DTG)  plus either of two tenofovir prodrugs - tenofovir alafenamide fumarate (TAF) or tenofovir disoproxil fumarate (TDF) against the local standard-of-care regimen of TDF - emtricitabine - efavirenz. The 48-week results showed that DTG, combined with TAF or TDF, was noninferior to the standard of- care regimen.
 

Aerosol Generating Procedures and Nebulizer Use in the Current Era
eCMEs, Published on: 15 Jun 2020

Various studies have determined that Nebulization is not a Viral Aerosol Generating Procedure since the droplets are from the machine and not from the patient. However, sharing of nebulization accessories like facemask and mouthpiece is an unhygienic practice with a high-risk potential of spreading infection. This webinar talks about Nebulization therapy in the current era.

 

Real Symptoms, Virtual Visit – A Specialist Approach to IBS
eCMEs, Published on: 15 Jun 2020

IBS is one of the common GI disorders that significantly affects a patients quality of life. This talk will help to virtually approach IBS patients and provide them with the care they need.

 

Good Nebulization Practices in Clinic Setting – Do’s & Don’ts
Clinical Tools, Published on: 12 Jun 2020

Good nebulization practices are set of recommendations to perform nebulization in the most safe and effective way.

 

Levetiracetam versus Carbamazepine as Monotherapy for Treating Partial Seizures
Key Trials, Published on: 12 Jun 2020

Levetiracetam has comparable efficacy and safety vs. carbamazepine as monotherapy for treating partial seizures. Nevertheless, levetiracetam leads to greater improvement in quality of life and can thus be considered as a better option over carbamazepine for partial seizures.

 

Role of EUS In Esophageal Cancer
eCMEs, Published on: 12 Jun 2020

In this webinar, prominent gastroenterologist Dr. Malay Sharma will explain role of EUS in esophageal cancer including the applications, challenges, and limitations of EUS in the management of this disease.

 

Optimizing use of Minocycline
eCMEs, Published on: 11 Jun 2020

In the era of increasing resistance of Antibiotics, how High Dose of Minocycline plays a pivotal role to manage gram negative Bacilli. Dr Dipnarayan Mukherjee and Infectious Disease specialist from Kolkata shares his experience of High Dose Minocycline in Meningitis & how the bactericidal action of High Dose Minocycline is the need of the hour.

Factors Increasing Risk of Primary Osteoarthritis
Clinical Tools, Published on: 11 Jun 2020

Interventions on modifiable risk factors improve not only the symptoms of knee Osteoarthritis (OA) but also affect the osteoarthritic joint as a whole. Optimal management of knee OA should include, where possible, modification of risk factors through targeted interventions.

 

Salvage Radiotherapy along with Hormone Therapy Improves Outcomes in Prostate Specific Antigen Failure after Radical Prostatectomy
Key Trials, Published on: 11 Jun 2020

Initial salvage radiation therapy (SRT) prior to salvage hormone therapy (SHT) is beneficial in patients with prostate-specific antigen failure after radical prostatectomy and prolongs the time to treatment failure of bicalutamide as compared to SHT alone.

 

Probiotics in treatment of IBS
Expert's Views, Published on: 11 Jun 2020

In this talk, Dr. B. S. Ramakrishna highlights the usage of probiotics in the treatment of IBS.

 

Antibiotics in treatment of IBS
Expert's Views, Published on: 11 Jun 2020

In this talk, Dr. B. S. Ramakrishna highlights the usage of antibiotics in the treatment of IBS.

 

ICSI: When, Why, How?
eCMEs, Published on: 11 Jun 2020

In this talk, the doctor gives an overview of the indications, steps, concerns and advances in ICSI along with surgical videos for better clarity.

A Spotlight on Ocular Surface & OT Protocols
eCMEs, Published on: 11 Jun 2020

The world is passing through unprecedented times. This webinar focuses on the health of ocular surface and on the basic OT protocols.

 

ASCO 2020: Update in Hemat-Oncology
Conference Proceedings, Published on: 10 Jun 2020

Key highlights in hemat-oncology of the American Society of Clinical Oncology (ASCO) 2020 Virtual Conference held from 29th to 31st May 2020.

 

Risk Stratification in PAH with a Comprehensive Echocardiographic Method
Key Trials, Published on: 10 Jun 2020

Integration of the echocardiographic parameters such as tricuspid annular plane systolic excursion (TAPSE), tricuspid regurgitation (TR) grade and inferior vena cava (IVC) was effective in stratifying the risk for all-cause mortality in pulmonary arterial hypertension (PAH) patients.

 

Managing Acute Asthma with pMDI + Spacer in Real Life
Expert's Views, Published on: 09 Jun 2020

Hear from a leading Paediatrician how he  manages Acute asthma in children, at his clinic, without a nebulizer.

 

Perfecting Phakic IOLs In Our Practice
eCMEs, Published on: 09 Jun 2020

The Ophthalmic fraternity is passing through unprecedented times. It becomes a necessity to come together to find ways and means of basic practice measures when it comes for Phakic IOLs that includes scope & post-operative evaluation.

 

Ocular Blood Flow in Glaucoma Management
eCMEs, Published on: 09 Jun 2020

Landmark trials like EMGT have shown that glaucoma patients may progress despite controlled intraocular pressure (IOP). Apart from IOP, ocular perfusion pressure/ low ocular blood flow (OBF) has been identified as an independent risk factor in glaucoma progression. This webinar focused on the role of OBF in glaucoma progression, how comorbid conditions may affect OBF, and role of medications in improving OBF and decreasing progression.

 

 

Pediatric Anterior Segment Trauma Management
eCMEs, Published on: 09 Jun 2020

Pediatric Eye Trauma is one of the common case found in pediatric ophthalmologist OPD. This topic/presentation will demonstrate a wide spectrum of cases and their surgical management. Measures & precaution will be demonstrated during critical surgery cases of pediatric trauma. It is mainly video assisted skill transfer presentation to understand the pediatric anterior segment trauma.

 

Effect of Bilastine on Cognitive Functions at 4000 Meters Altitude Simulated in Hypobaric Chamber
Key Trials, Published on: 09 Jun 2020

Treatment of allergic rhinitis with 20 mg bilastine did not significantly impair the cognitive functions in individuals who require constant attention and are exposed to hypobaric hypoxia.

 

Comparison of Standard-dose Versus High-dose of Amoxicillin/ Clavulanate for the Treatment of Clinically-diagnosed Acute Bacterial Sinusitis
Key Trials, Published on: 08 Jun 2020

This study aimed to address whether higher dose of amoxicillin will lead to more rapid improvement. The study showed that acute bacterial sinusitis adults were more likely to improve rapidly when treated with immediate-release high dose of amoxicillin/clavulanate than with standard dose but not when treated with extended-release HD. 

 

Webinar Snippet: What Indications Can Canagliflozin Be Prescribed In India?
Expert's Views, Published on: 08 Jun 2020
Webinar Snippet: Do We Need To Reduce Dose Of Loop Diuretics When Used Along With SGLT2 Inhibitors?
Expert's Views, Published on: 08 Jun 2020
Webinar Snippet: Can Canagliflozin Be Prescribed Along With Loop Diuretics?
Expert's Views, Published on: 08 Jun 2020
Webinar Snippet: Does Presence Or Absence Of Heart Failure Impact The Cardio-Renal Benefits Of Canagliflozin?
Expert's Views, Published on: 08 Jun 2020
Webinar Snippet: What Is The Effect Of SGLT2 Inhibitors On Incidence Of Stroke?
Expert's Views, Published on: 08 Jun 2020
Prevention & Treatment of Ovarian Hyperstimulation Syndrome
eCMEs, Published on: 08 Jun 2020

In this talk, the doctor provides various challenges and modalities to manage ovarian hyperstimulation syndrome, a serious complication associated with ART.

 

Current Trends in Hypertension Management
eCMEs, Published on: 08 Jun 2020

Dr N Murali Krishna highlights the current recommendations from guidelines on the screening, measurement and diagnosis of Hypertension. Moreover, he also touches upon the role of ambulatory BP measurement and out of office BP measurement, the goals of management, the choice of pharmacotherapy and the use of single pill combinations in the pharmacological management of Hypertension.

L Rhamnosus GG Reduced Duration of Diarrhoea In Children with Acute Gastroenteritis: Result of A Meta-Analysis
Key Trials, Published on: 08 Jun 2020

Irrespective of recent RCT demonstrating no effect of L rhamnosus GG in acute gastroenteritis, the current systematic review showed that L rhamnosus GG reduced the duration of diarrhoea and hospitalization in inpatients. These findings should be viewed in the context of the high heterogeneity and methodological limitations of the included trials.

 

Intervention Strategies as A Function of Total CV Risk and Untreated LDL Levels: ESC 2019 Lipid Guidelines
Clinical Tools, Published on: 05 Jun 2020

The present issue provides the Intervention strategies as a function of total CV risk and untreated LDL levels suggested by ESC 2019 guidelines. These interventions will help patients with moderately high LDL-C( ≥160mg/dl) and high LDL-C (≥190mg/dl) levels to reduce the ASCVD risk.

Cardiovascular Risk Categories: ESC 2019 Lipid Guidelines
Clinical Tools, Published on: 05 Jun 2020

The present issue provides the various CV risk categories recommended by ESC for the management of Dyslipidemia -2019. These risk categoires will help to identify those at high risk and prioritize their management strategies.

 

Hand Hygiene: All you Need to know about Hand Sanitizers!
Patient Education, Published on: 05 Jun 2020

Hand hygiene is a great way to prevent infections. Cleaning hands at key times with soap and water or hand sanitizer is one of the most important steps one can take to avoid getting sick and spreading germs to those around you. CDC recommends washing hands with soap and water whenever possible but if unavailable, using a hand sanitizer with at least 60% alcohol can help avoid getting sick and spreading germs to others. Help your child's parents know when and how to clean their (and the child's) hands with hand sanitizier that will give them the best chance of preventing sickness.

Kangaroo Care
Patient Education, Published on: 05 Jun 2020

Kangaroo care (KC) is a method of developmental care for babies using skin-to-skin contact with the parent. This method provides many parent-infant benefits. In developing countries, KC for low-birthweight infants has been shown to reduce mortality, severe illness, infection and length of hospital stay. Though the focus of KC was once on premature babies, recent research has shown that it has many benefits for all babies. Know how to do KC and its benefits.

 

Breastfeeding Made Simple: Tips for New Moms
Patient Education, Published on: 05 Jun 2020

Breast milk is the natural first food for babies; it provides all the energy and nutrients that the infant needs for the initial months. WHO and UNICEF have recommended initiation of breastfeeding within the first hour of life. While breastfeeding is a natural act, it is also a learned behaviour for both baby and mother.  Here are some simple tips the new mothers can follow that will help in successfully breastfeeding their baby. 

 

Zotide (Teriparatide ) Monograph
Our Publications, Published on: 04 Jun 2020

The currently available pharmacological treatments for osteoporosis are predominantly anti-resorptive. These inhibit osteoclast-mediated bone loss and therefore reduce bone turnover, and increase BMD because bone formation is permitted and bone resorption is inhibited. Teriparatide is a first in class, anabolic agent with a unique mechanism that results in increased bone formation.

 

Pathogen Distribution and Antibiotic Sensitivity in Ocular Bacterial Infections
Key Trials, Published on: 04 Jun 2020

This 5-year study evaluated the distribution and antibiotic sensitivity of bacterial isolates from ocular specimens with suspected microbial infections.
 

Pathogen Distribution and Antibiotic Sensitivity in Ocular Bacterial Infections
Key Trials, Published on: 04 Jun 2020

This 5-year study evaluated the distribution and antibiotic sensitivity of bacterial isolates from ocular specimens with suspected microbial infections.
 

Performance of Revolizer®, using Formoterol/Budesonide* Rotacaps®
Our Research, Published on: 04 Jun 2020

This study evaluates the invitro performance of the Revolizer at various inspiratory flow rates and the consistency of drug delivery across doses.

Can Teriparatide Maintain the Higher Body Heights and Prevent Refracture in Osteoporotic Vertebral Compression Fracture Patient After Vertebroplasty?
Key Trials, Published on: 04 Jun 2020

The present study assessed whether teriparatide (TP) could reduce refracture risk in osteoporotic vertebral compression fracture patients after vertebroplasty (VP) by comparing the radiological and clinical outcomes of cemented vertebrae with TP with those without TP. The study showed that TP treatment resulted in higher body heights and fewer refractures than VP alone, with comparable clinical outcomes 1 year after VP.

 

Scandinavian Cohort Study: Ascertaining the Renoprotection rendered by SGLT2 Inhibitors in the Real World
Key Trials, Published on: 04 Jun 2020

The Scandinavian Cohort Study provides real-world data on the risk reduction of renal events in T2DM patients newly treated with SGLT2 inhibitors vs. an active comparator (DPP-4 inhibitors).

 

ISH: Optimal Recommendations for Hypertension (2020)
Guidelines, Published on: 04 Jun 2020

The present issue summarizes the optimal recommendations for the management of hypertension from International Society of Hypertension (ISH) global clinical practice guideline for hypertension 2020.

 

Experts’ Bytes on BPH: Lifestyle Modification Tips for Patients with LUTS due to BPH
Expert's Views, Published on: 04 Jun 2020
Experts’ Bytes on BPH: Physicians Approach when Taking History of a Patient Having LUTS Suspected to be due to BPH
Expert's Views, Published on: 04 Jun 2020
Experts’ Bytes on BPH: Importance of Taking Medical History in LUTS
Expert's Views, Published on: 04 Jun 2020
Experts’ Bytes on BPH: Prevalence of LUTS in General Population
Expert's Views, Published on: 04 Jun 2020

Prevalence of LUTS in general population and gender-wise preponderance and age-group wise trend.

 

Experts’ Bytes on BPH: Causes of LUTS other than BPH
Expert's Views, Published on: 04 Jun 2020

Causes of LUTS other than BPH and the differential diagnosis of BPH in a patient with LUTS.

 

Webinar Snippet: Collation Of Excerpts Of Dr Sanjay Sinha’s Webcast Talk On The Management Of LUTS With Selected Responses To Audience Queries
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: Applicability Of Urodynamic Studies In Patients With BPH / LUTS
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: What Is The Treatment Of Bedwetting In Children?
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: What Is The Treatment Of A Weak Detrusor?
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: 5-Alpha Reductase Inhibitors & Their Effect On Serum PSA In BPH
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: Case Study: Management Of A Patient With Frequency & Urgency
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: Case Study: Management Of A Patient With Voiding Difficulty
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: How Should Voiding And Storage LUTS Be Managed Medically?
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: Differential Diagnoses Of BPH In A LUTS Patient: How To Carry Out Initial Evaluation
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: What Are The Various Lifestyle Modifications To Be Suggested To A Patient Of BPH / LUTS?
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: Importance Of Serum PSA Vs DRE In Suspecting Prostate Cancer
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: Asymptomatic Bacteriuria: Definition & Latest Understanding On Its Management
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: PVR: What It Is & Its Upper Limit Cut-Off?
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: Nocturia And Its Various Causes
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: Lower Urinary Tract Symptoms (LUTS): Definition, Medical Importance And Relation With BPH / BPE / BOO
Expert's Views, Published on: 03 Jun 2020
Webinar Snippet: What Are The Implications And Significance Of Storage Symptoms?
Expert's Views, Published on: 03 Jun 2020
Antibiotic Combinations Role of ARBs
eCMEs, Published on: 03 Jun 2020

Antibiotic Stewardship is necessary in the ICU & should be comprehensive as compared to other wards. ICU patient have high chances of developing antibiotic resistance if not used judiciously.

 

Severe Asthma Conclave 2020 – A Web Series on Clinical Paradigms: Part 1
eCMEs, Published on: 02 Jun 2020

Watch this web series on Severe Asthma (2 parts) to know the evolution in the understanding of Biologics in Severe Asthma Management. Especially, Omalizumab is widely available in India and is getting acceptance increasingly due to its better clinical outcomes, safety and cost effectiveness in Severe allergic asthma management.

 

3-day Treatment with Azithromycin (10 mg/kg per day once daily), A Promising Alternative Therapy for Tonsillitis in Children
Key Trials, Published on: 02 Jun 2020

The present study compared the 3 regimens (azithromycin vs cefaclor vs amoxicillin) for the treatment of tonsillitis in children.  The study demonstrated that 3 days of therapy with azithromycin at a dose of 10 mg/kg per day once daily showed an effective tendency for the treatment of paediatric tonsillitis with a lower occurrence rate of adverse reactions.

 

Recent Therapeutic Updates on Non-Muscle Invasive Bladder Cancer (NMIBC)
Key Trials, Published on: 02 Jun 2020

Evaluation of intravesical Bacillus Calmette–Guerin (BCG) treatment on outcomes of patients with T0 after repeat Transurethral resection of bladder mass (re-TURBT) with high-risk NMIBC.

 

ISH: Essential Recommendations for Hypertension (2020)
Guidelines, Published on: 02 Jun 2020

The present issue summarizes the essential recommendations for the management of hypertension from International Society of Hypertension (ISH) global clinical practice guideline for hypertension 2020.

 

Webinar Snippet: What Is The Evidence With Dasatinib In The Front-Line Setting In Patients With CML?
Expert's Views, Published on: 02 Jun 2020
IPF Management in 2020 (Focus and Interaction on New ERS Statement)
eCMEs, Published on: 01 Jun 2020

This eCME focuses on latest developments on the diagnosis and management of IPF

Demystifying Chronic HP
eCMEs, Published on: 01 Jun 2020

This eCME focuses on latest developments on the diagnosis and management of chronic hypersensitivity pneumonitis (cHP) including the role of mycophenolate mofetil in cHP.

 

Long-Term Dienogest Treatment Reduces Pelvic Pain, Improves Quality of Life and Sexual Function
Key Trials, Published on: 01 Jun 2020

Long-term treatment with 2 mg daily dienogest significantly reduced chronic pelvic pain and represents a promising medication for the long-term management of endometriosis. Dienogest also improved the quality of life and sexual function in women with endometriosis-associated pain.

 

Long-Term Dienogest Treatment Well Tolerated and Effective in Adenomyosis
Key Trials, Published on: 01 Jun 2020

The long-term treatment until menopause with 2 mg dienogest was well tolerated in women with symptomatic adenomyosis and could be a potential alternative in some patients, especially those with type 2 adenomyosis, to avoid hysterectomy. 

 

Ciclohale (Ciclesonide) Product Monograph
Our Publications, Published on: 01 Jun 2020

Ciclesonide is a nonhalogenated synthetic ICS available in an extra fine formulation that has been approved for the treatment of persistent asthma. The extra fine formulation ensures that the drug not only reaches the central airways but also the peripheral airways, which is a major site of inflammation. As a result, the entire bronchial tree is targeted and minimal deposition occurs in the oropharynx which considerably improves the safety of the formulation. This monograph summarises the unique pharmacological properties & clinical evidences of Ciclesonide for the management of asthma.  It also aims to discuss how this drug might be our answer to the quest for obtaining an ideal corticosteroid having optimum efficacy & high safety with the advantage of once daily dosing.

 

Organ Donation
eCMEs, Published on: 01 Jun 2020

Organ donations are gradually increasing in India which is resulting in major focus on this. It is necessary to take utmost precautions for these set of immunocompromised patients who are susceptible to most infections due to low immunity.

 

Foracort Synchrobreathe (Formoterol fumarate dihydrate and Budesonide) Infoguide
Our Publications, Published on: 01 Jun 2020

Foracort Synchrobreathe is a novel breath-actuated inhaler with a dose counter. This booklet provides detailed information about the technical aspects of the inhaler and data from in-vitro and clinical studies to substantiate the effectiveness and patient benefits of formoterol/budesonide combination in Synchrobreathe inhaler.

 

PSMA-Guided Radiotherapy Offers Promise in Men with Oligorecurrent Prostate Cancer
Key Trials, Published on: 01 Jun 2020
Webinar Snippet: What Are The Pros And Cons Of Telemedicine?
Expert's Views, Published on: 01 Jun 2020
Webinar Snippet: Which Drugs Are Allowed To Be Prescribed During Teleconsultation?
Expert's Views, Published on: 01 Jun 2020
Webinar Snippet: How To Maintain Records As Well As Medical Ethics, Confidentiality And Data Privacy During Teleconsultation?
Expert's Views, Published on: 01 Jun 2020
Webinar Snippet: What Do The Telemedicine Guidelines Say About Patient Consent And Types Of Consultation?
Expert's Views, Published on: 01 Jun 2020
Webinar Snippet: Why Is Telemedicine A Preferred Option By Doctors And Patients?
Expert's Views, Published on: 01 Jun 2020
Renal Replacement Therapy
eCMEs, Published on: 01 Jun 2020

Renal replacement is a challenging therapy & it is important to understand the etiology of the condition. Organ transplant is a very delicate & important procedure which requires utmost care as the patients becomes immunocompromised lifelong.

 

A Case of Swine Flu ARDS
eCMEs, Published on: 01 Jun 2020

Swine Flu in the ICU patients is a very critical condition & it is important to understand the right Clinical Therapy. It’s vital to understand the patient category like Pregnancy. Flu prevention is an important way to reduce patients length of stay in the ICU.

 

Life Threatening Iatrogenic Mistakes Done in ICU
eCMEs, Published on: 30 May 2020

Patients in the ICU are very critical & it is important to understand the right way to interpret the diagnostic reports & vital parameters; based on which the patient can be treated correctly. This will ensure decrease the patient’s stay in the ICU.

 

Webinar Snippet: What Are The Key Recommendations Of The 2020 ELN Guidelines For Treatment Of CML?
Expert's Views, Published on: 30 May 2020
Webinar Snippet: Can TKI Therapy Be Stopped In CML?
Expert's Views, Published on: 30 May 2020
Webinar Snippet: What Are The Key Milestones In The Journey Of Dasatinib?
Expert's Views, Published on: 30 May 2020
Webinar Snippet: What Are The Successes And Failures With Imatinib In CML?
Expert's Views, Published on: 30 May 2020
Webinar Snippet: What Is The History Of CML Therapy?
Expert's Views, Published on: 30 May 2020
Webinar Snippet: What Are The Factors Determining Prognosis In CML?
Expert's Views, Published on: 30 May 2020
Webinar Snippet: What Is The Differential Diagnosis Of CML?
Expert's Views, Published on: 30 May 2020
Role of 2-Gen TKIs in Management of CML: A Spotlight on Dasatinib
eCMEs, Published on: 30 May 2020

Expert talk by leading haematologist, Dr. M B Agarwal on Role of 2nd generation TKI in CML with focus on Dasatinib.

 

Noninferiority of Ceftriaxone, Sulbactam, and Disodium EDTA to Meropenem in Complicated UTIs
Key Trials, Published on: 30 May 2020

This study demonstrated the noninferiority of the novel combination of ceftriaxone, sulbactam, and disodium ethylenediaminetetraacetic acid (CSE) to meropenem in patients with complicated urinary tract infections (cUTIs) including acute pyelonephritis. CSE might be a potential alternative to carbapenems in patients with cUTIs including the infections caused by extended spectrum β lactamase producing gram-negative microorganisms.

 

Higher Efficacy and Drug Adherence with Ciclesonide as Step-Down Therapy than Budesonide in Mild to Moderate Asthma
Key Trials, Published on: 30 May 2020

The efficacy of ciclesonide (CIC) as a step-down therapy was significantly higher than budesonide (BUD) in patients well controlled on combination therapy. CIC had better drug adherence than BUD.

 

Refining the Choice of ICS in OAD Management
eCMEs, Published on: 30 May 2020

This webinar helps in understanding ciclesonide as a molecule. it’s unique properties and it’s therapeutic use in OAD management is discussed.

 

Inferior Oblique Surgeries
eCMEs, Published on: 29 May 2020

Inferior oblique surgeries are commonest surgeries after horizontal muscle surgeries in strabismus. This webinar discusses the various indications of the surgery and the effect of inferior oblique surgery on primary position, secondary position, torsion and unilateral surgeries.

 

ORBIT: Elucidating Patient Characteristics and Six-month Basal Insulin Dose for Achieving HbA1C<7%
Key Trials, Published on: 29 May 2020

Amongst T2DM patients, a six-month dose of 0.2 U/kg/day basal insulin yields effective glycemic control, states the post hoc analysis of the ORBIT trial. The study further identifies the patient characteristics that influence the basal insulin dose at six months.

 

Postoperative Outcomes with Laparoscopic Appendectomy Verses Open Appendectomy for Complicated Appendicitis in Adults
Key Trials, Published on: 29 May 2020

The present randomized controlled trial assessed whether laparoscopic appendectomy for complicated appendicitis effectively reduces the incidence of postoperative complications and improves various measures of postoperative recovery in adults in comparison with open appendectomy. The study showed that laparoscopic appendectomy for complicated appendicitis is safe and feasible.

 

GARFIELD-AF: Comparing the Outcomes for OAC vs. OAC plus Antiplatelet Therapy in Newly Diagnosed AF Patients
Key Trials, Published on: 29 May 2020

Atrial fibrillation (AF) patients who receive oral anticoagulants (OAC) should receive antiplatelet (AP) therapy only if clearly indicated for cardiovascular condition such as ACS, CAD and carotid occlusive disease. The study challenges the practice of coprescribing OAC plus AP in absence of a clear indication for AP in newly diagnosed AF patients.

 

Asthma Management in The Acute Setting: Role of pMDI + Spacer
Our Publications, Published on: 29 May 2020

It is imperative to re-think the way aerosol therapy is being practiced with a mindset shift from the rampant use of nebulizers to an alternative form of drug delivery. GINA and WHO Guidelines have recommended to avoid the use of nebulizers to reduce risk of transmitting viral infection. pMDI + Spacer is the first line of therapy for acute cases as per GINA, has been shown to be equivalent to nebulizer at a much lower dose, it is preferred by patients and requires minimal maintenance.

 

Co-morbidities of Allergic Rhinitis in Children
Slide Library, Published on: 29 May 2020

Allergic rhinitis (AR) is an organ-specific manifestation of allergic disease. It is rarely found in isolation and frequently has numerous associated comorbid disorders. AR is therefore part of a spectrum of allergic disorders that can profoundly affect the well being and quality of life of a child. Because AR is part of a systemic disease process, its management requires a coordinated approach rather than a fragmented, organ-based approach. Take a look at this comprehensive overview on comorbidities of AR in children.

 

Anterior & Posterior Urethroplasty
eCMEs, Published on: 29 May 2020

Urethral stricture is an oft-encountered complication in a urologic setting faced, in conjunction with both common and uncommon causes. Thus, urethroplasty is a much-needed and highly differentiating tool in a practicing urologist’s surgical armamentarium. Know more on the art, skill and science of urethroplasty from a world-renowned and masterful exponent of this technique.

 

Evaluating the Success of Switchover from Traditional Sodium Channel Blockers to Lacosamide in Epilepsy Patients
Key Trials, Published on: 28 May 2020

Adult epilepsy patients can be successfully switched from traditional sodium channel blockers (SCB) to lacosamide. Lacosamide exhibited similar efficacy as traditional SCB with a benefits of lower risks of hepatic enzyme induction and idiosyncratic adverse effects.

 

Webinar Snippet: Treatment Preference: Line Of Treatment For Stage 2 & 3 HTN
Expert's Views, Published on: 27 May 2020
Webinar Snippet: Undesirable Combinations In HTN Management
Expert's Views, Published on: 27 May 2020
Webinar Snippet: Combination Therapy In HTN: Rationale And Benefits
Expert's Views, Published on: 27 May 2020
Webinar Snippet: Diuretics: What Are Possible Clinical Profiles For Diuretic Use And Non-Use?
Expert's Views, Published on: 27 May 2020
Webinar Snippet: Pharmacotherapy: First Line Drugs For HTN Management
Expert's Views, Published on: 27 May 2020
Webinar Snippet: Goal Of HTN Management
Expert's Views, Published on: 27 May 2020
Webinar Snippet: BP Threshold In CAD: BP Threshold And Target Goal In CAD Patient
Expert's Views, Published on: 27 May 2020
Webinar Snippet: CV Risk Assessment: Available Tools For CV Risk Assessment.
Expert's Views, Published on: 27 May 2020
Webinar Snippet: CV Risk Factors: Factors Influencing CV Disease, Mortality And Morbidity
Expert's Views, Published on: 27 May 2020
Evaluation Of HTN- What Should Be The Objective Behind Evaluation Of HTN?
Expert's Views, Published on: 27 May 2020
Webinar Snippet: ABPM: Important Points About ABPM
Expert's Views, Published on: 27 May 2020
Webinar Snippet: Out Of Office BP: Rationale Behind Out Of Office Blood Pressure Monitoring
Expert's Views, Published on: 27 May 2020
Webinar Snippet: BP Cut Off Values: BP Cut Off Values By Different Guidelines
Expert's Views, Published on: 27 May 2020
Webinar Snippet: Diagnosis Of HTN: Available Methods For Diagnosis Of HTN
Expert's Views, Published on: 27 May 2020
Webinar Snippet: Epidemiology: Prevalence Of Uncontrolled Hypertension
Expert's Views, Published on: 27 May 2020
Webinar Snippet: How Can One Get Trained In Practicing Telemedicine?
Expert's Views, Published on: 27 May 2020